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Abstract: 
Colorectal cancer is one of the most common forms of malignancy with 35,000 new 
patients diagnosed annually within the UK. Survival figures show that outcomes are 
less favourable within the UK when compared with the USA and Europe with 1 in 4 
patients having incurable disease at presentation as of data from 2000.  
Epidemiologists have demonstrated that the incidence of colorectal cancer is highest 
on the industrialised western world with numerous contributory factors. These range 
from a genetic component to concurrent medical conditions and personal lifestyle. In 
addition, data also demonstrates that environmental changes play a significant role 
with immigrants rapidly reaching the incidence rates of the host country. 
Detection of colorectal cancer remains an important and evolving aspect of 
healthcare with the aim of improving outcomes by earlier diagnosis. This process 
was initially revolutionised within the UK in 2002 with the ACPGBI 2 week wait 
guidelines to facilitate referrals form primary care and has subsequently seen other 
schemes such as bowel cancer screening introduced to augment earlier detection 
rates. Whereas the national screening programme is dependent on FOBT the 
standard referral practice is dependent upon a number of trigger symptoms that 
qualify for an urgent referral to a specialist for further investigations. This process 
only identifies 25-30% of those with colorectal cancer and remains a labour intensive 
process with only 10% of those seen in the 2 week wait clinics having colorectal 
cancer.  
This thesis hypothesises whether using a patient symptom questionnaire in 
conjunction with knowledge discovery techniques such as data mining and artificial 
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neural networks could identify patients at risk of colorectal cancer and therefore 
warrant urgent further assessment. Artificial neural networks and data mining 
methods are used widely in industry to detect consumer patterns by an inbuilt ability 
to learn from previous examples within a dataset and model often complex, non-
linear patterns. Within medicine these methods have been utilised in a host of 
diagnostic techniques from myocardial infarcts to its use in the Papnet cervical smear 
programme for cervical cancer detection. 
A linkert based questionnaire of those attending the 2 week wait fast track colorectal 
clinic was used to produce a ‘symptoms’ database. This was then correlated with 
individual patient diagnoses upon completion of their clinical assessment. A total of 
777 patients were included in the study and their diagnosis categorised into a 
dichotomous variable to create a selection of datasets for analysis. These data sets 
were then taken by the author and used to create a total of four primary databases 
based on all questions, 2 week wait trigger symptoms, Best knowledge questions and 
symptoms identified in Univariate analysis as significant. Each of these databases 
were entered into an artificial neural network programme, altering the number of 
hidden units and layers to obtain a selection of outcome models that could be further 
tested based on a selection of set dichotomous outcomes. Outcome models were 
compared for sensitivity, specificity and risk. Further experiments were carried out 
with data mining techniques and the WEKA package to identify the most accurate 
model. Both would then be compared with the accuracy of a colorectal specialist and 
GP 
Analysis of the data identified that 24% of those referred on the 2 week wait referral 
pathway failed to meet referral criteria as set out by the ACPGBI. The incidence of 
those with colorectal cancer was 9.5% (74) which is in keeping with other studies 
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and the main symptoms were rectal bleeding, change in bowel habit and abdominal 
pain. The optimal knowledge discovery database model was a back propagation 
ANN using all variables for outcomes cancer/not cancer with sensitivity of 0.9, 
specificity of 0.97 and LR 35.8. Artificial neural networks remained the more 
accurate modelling method for all the dichotomous outcomes. 
The comparison of GP’s and colorectal specialists at predicting outcome 
demonstrated that the colorectal specialists were the more accurate predictors of 
cancer/not cancer with sensitivity 0.27 and specificity 0.97, (95% CI 0.6-0.97, PPV 
0.75, NPV 0.83) and LR 10.6. When compared to the KDD models for predicting the 
same outcome, once again the ANN models were more accurate with the optimal 
model having sensitivity 0.63, specificity 0.98  (95% CI 0.58-1, PPV 0.71, NPV 
0.96) and LR 28.7. 
The results demonstrate that diagnosis colorectal cancer remains a challenging 
process, both for clinicians and also for computation models. KDD models have 
been shown to be consistently more accurate in the prediction of those with 
colorectal cancer than clinicians alone when used solely in conjunction with a 
questionnaire. It would be ill conceived to suggest that KDD models could be used 
as a replacement to clinician- patient interaction but they may aid in the acceleration 
of some patients for further investigations or ‘straight to test’ if used on those 
referred as routine patients.  
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1.1 Epidemiology 
Colorectal cancer remains one of the most common forms of malignancy, with over 
1 million individuals being affected worldwide  [1] Specifically within the United 
Kingdom colorectal is the second most common form of malignancy with 
approximately 35,000 new patients being diagnosed annually. [2-5]  
 
 It has been shown that survival from the disease within the UK is less favourable 
compared with the USA and other European Countries [2, 3, 6, 7]. Whilst causative 
factors may range from fewer doctors per capita to healthcare expenditure, the time 
of presentation has been demonstrated to play a significant role. A study in 2000 
demonstrated that 1 in 4 patients presenting with colorectal cancer had incurable 
disease at diagnosis[2, 4, 8, 9]  
The incidence of colon cancer is at its highest in the industrialised western world 
with epidemiological studies focusing on the identification of factors that influence 
the risk of an individual acquiring colorectal cancer. Whilst there is a genetic aspect 
to developing colorectal cancer and an increased prevalence amongst certain medical 
conditions a number of dietary and lifestyle factors have also been identified and 
proven to modify risk.  
 
International data demonstrates that colorectal cancer is highly sensitive to 
environmental changes with immigrants rapidly reaching the incident rates of the 
host country [3-5] [6]  
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1.2 Colorectal Pathology 
1.2.1  Benign Colonic Pathology 
  
Polyp is a term used to clinically describe any elevated tumour and covers a variety 
of histologically different tumours. They occur either individually, in small numbers 
or can be found ‘carpeting’ the colon in conditions such as Familial Adenomatous 
Polyposis (FAP). Whilst the term polyp can encompass a clinical description it is the 
histological conformation of the polyp that is important as they can be subdivided 
into inflammatory, metaplastic, harmartomatous and neoplastic variants. 
 
Specifically focusing on the neoplastic variant once again gives rise to further sub 
classification of adenomatous polyps which vary from tubular adenomas to the 
villous adenoma. Both of these variants differ in their symptomatology and also the 
potential risk for colorectal cancer. The tubular adenoma is generally identified 
incidentally through investigations for colonic bleeding and has a risk of malignancy 
that increases as the size of the polyp itself increases, a 1cm diameter tubular 
adenoma carrying a 10% risk of colorectal cancer. Villous adenomas tend to present 
with slightly different symptoms, usually those of diarrhoea, mucous and potentially 
hypokalaemia. Tumours of this variety carry a 15% chance of carcinoma if they are 
greater than 2cm in size. 
 
The specific incidence of these polyps in the general population is difficult to 
estimate but autopsy studies have been performed to try and assess their prevalence 
[7] [8] [9]. Willians et al is the only UK study and examined 365 cases in which the 
colon was examined for hyperplastic / metaplastic polyps and neoplastic adenomas. 
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It found a general prevalence of 36.87% in men and 28.74% in women, values that 
may be higher in society today. Similar rates have been found in studies from 
Norway and the USA. 
 
The rate at which a neoplastic polyp undergoes malignant transformation was 
examined retrospectively by Stryker [10] et al in the Mayo Clinic over a period of 6 
years. They examined 226 cases where polyps > 10mm were observed and obtained 
a mean follow up period of 108 months and demonstrated a 37% increase in size and 
at 5 years a 2.5 % transformation to invasive cancer. Further follow up at 10 and 20 
years illustrated rates of 8% and 24% respectively for cancerous change 
 
Those with a history of polyps and who have undergone excision are at higher risk of 
further polyps when compared with an individual who has never been diagnosed 
with polyps [11-13] [14] 
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1.2.2 Inflammatory Bowel Disease 
 
The term inflammatory bowel disease encompasses two different entities, 
specifically ulcerative colitis and Crohn’s disease. The first association between IBD 
and colorectal cancer was documented by Crohn and Rosenberg [15] in 1925, an 
association which nowadays is widely accepted.  Ten to fifteen percent of all deaths 
in those with IBD is due to colorectal cancer [16] with the age at diagnosis of CRC 
being 15-20 years earlier when compared to the general population [17] Ulcerative 
colitis is universally accepted as increasing risk for the development of colorectal 
cancer with and is demonstrated in the meta-analysis by Eden et al [17] . The risk of 
developing colorectal cancer in those with UC increases with time and rates of 1.6% 
at 10 years, 8% at 20 years and 18% at 30 years having been quoted.  Disease 
distribution of UC has also been shown to influence risk of development of CRC 
when compared with the general population, proctitis 1.7 times the risk, left sided 
colitis 2.8 times and pancolitis 14.8 times [18, 19]. More recent data have shown 
Crohn’s disease patients to be at increased risk also [20]  
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1.2.3 Diverticular Disease 
 
Diverticular disease is a benign condition that typically is acquired and affects the 
distal colon. Whilst it is not confined to these areas and can, in rare cases be found 
congenitally in cases of meckel’s diverticulae, approximately 95% affects the 
sigmoid colon. The diverticulae are a herniation of the mucosa through the 
muscularis propria and while the specific aetiology of this condition is unknown the 
theories are that increase intraluminal pressure and weakness within the colonic wall 
can lead to herniation or that defective collagen consistency or defective muscular 
structure may lead to weakness. Primarily it is a disease of western society and it is 
hypothesised that diet is a prime contributing factor with its incidence increasing 
markedly with an ageing population.  
 
Clinically its presentation can vary widely, presenting with generalised abdominal 
pain, alteration in bowel habit, bleeding PR, diverticulitis and complications of 
diverticular disease. These symptoms and the population that diverticulosis is 
commonly found in can make distinguishing it from someone with a colonic cancer 
difficult. 
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1.2.4 Haemorrhoids  
 
Haemorrhoids in the general population are very common and can in many cases be 
the cause of unnecessary individual anxiety. These vascular cushions become 
symptomatic when inflamed, enlarged, prolapsed or thrombosed and it is at these 
times that individuals generally seek medical advice. While common the specific 
aetiology is poorly understood, many authors concur that low fibre diets and 
straining at defecation increases pressure resulting in engorgement of the 
haemorrhoidal cushion, primarily through reduced venous return. The typical ‘bright 
red’ appearance of haemorrhoidal bleeds and the arterial pH support the theory that 
haemorrhoidal bleeding is actually arterial in origin. Anatomically the dentate line is 
the division between internal and external haemorrhoids and histological differences 
being evident in the epithelial covering, internal having columnar and external 
having squamous. The relation to the dentate line is also important in the 
innervation, and thus the potential discomfort caused. Symptomatically the 
difference between internal and external haemorrhoids that can be appreciated on 
clinical evaluation, with external haemorrhoids predominantly causing trouble with  
anal hygiene and redundant skin tags.   
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1.3 Risk Factors for Colorectal Cancer 
1.3.1 Non Modifiable 
 
1.3.1.1 Age related 
 
Ninety percent of colorectal cancers are classed as sporadic in their occurrence, 
making the risk of developing the disease at a young age very low, increasing in later 
years. It is generally accepted that the development of colorectal cancer is from a 
pre-existing adenoma within the colon wall [21] [22]. The incidence of adenoma 
formation also increases with age, one in three people having at least one adenoma at 
the age of 60 years. Studies have examined the natural progression of these lesions, 
demonstrating the progression to adenocarcinoma to be slow, taking up to 10years in 
some instances [10] with small, flat adenomas progressing somewhat faster. Other 
inherent factors in the progression of these lesions are size, number, histological type 
and also the presence of epithelial dysplasia.  
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1.3.1.2 Genetic 
 
The remaining 10% of cancers can generally be attributed to two main hereditary 
conditions, Familial Adenomatous polyposis (FAP) and Hereditary non-polyposis 
colorectal cancer (HNPCC). FAP is caused by a mutation of the Adenomatous 
polyposis coli (APC) gene and leads to the development of multiple polyps within 
the bowel between 10 and 30 years of age, histologically identical to sporadic 
occurrences it is the sheer volume of polyps within the colon almost guarantees 
developing colorectal cancer by the age of 40 years. HNPCC is a dominantly 
inherited condition resulting in an alteration in a mismatch repair gene, diagnosed 
using Amsterdam Criteria with affected individuals at risk of developing colorectal 
cancer predominantly in the proximal colon and in the absence of multiple polyps 
[23, 24]. The most common germline defects in HNPCC are mutations in the 
nMLH1 and hMSH2 genes, essential in the nucleotide mismatch repair system and 
have also been associated with the development of extra colonic tumours. In addition 
to these genetic conditions the personal or family history of colorectal cancer or 
adenomatous polyps increases the risk of developing colorectal cancer and is 
modified by the age and number of family member affected, specifically first degree 
relatives. [23] . 
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1.3.1.3 Inflammatory bowel diseases 
 
Those patients with ulcerative colitis carry an increased risk of developing colorectal 
cancer, up to ten times higher than those in the general population [18] with Crohn’s 
disease being implicated in recent evidence as a risk factor also. [25] Diseases of the 
endocrine system are also linked to an increased risk of colorectal cancer, 
specifically those with Diabetes mellitus who have 1.3-1.5 times increased risk [26] 
and also those with acromegaly who have a 2.5x increased risk [27] Both conditions 
are thought to increase risk via excessive levels of insulin like growth factor (IGF) 
stimulating the proliferation of colonic mucosa.  
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1.3.2 Modifiable 
 
1.3.2.1 Diet 
 
 
1.3.2.1.1 Vegetables and Fruit 
 
A number of studies have examined the role or fruit and vegetable consumption in 
relation to colorectal cancer but findings have been limited. [28] [29] [30]. A follow 
up study in Sweden showed that low fruit and vegetable consumption in women had 
an associated relative risk of 1.65[31] however this conflicted with a larger study in 
both men and women that did not show any relationship [32] . Raw, green and 
cruciferous vegetables have been shown, when consumed , to lower the risk of colon 
cancer [28] [30], and a meta-analysis [33, 34]  demonstrated a relative risk of 0.48 
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1.3.2.1.2 Vitamins 
 
The ACS cancer prevention study II did not show multivitamins to reduce risk of 
colorectal cancer when used as a baseline marker however, reported use of vitamins 
10 years earlier did show a relative risk of 0.71 [35]. A further study in 2002 had 
shown a lower risk in men who took vitamin E [36] supplements and higher 
selenium levels in serum have been associated with a lower risk of colonic polyps 
[37] 
 
 
 
 
1.3.2.1.3 Meat 
 
The association between meat and colorectal cancer has been variable. The Cancer 
Prevention study II showed no difference in the risk of colorectal cancer death in 
men or women when comparing the uppermost and lower most quintiles [35] . More 
recent data from three western society studies suggest that fresh and processed meat 
are each associated with an elevated risk [38] [39] [40] . More recent studies have 
suggested causal agents within meat as an explanation, such as Haeme, Nitrosation 
and O6 carboxymethyl guanine [41] [42] [43] . 
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1.3.2.1.4 Calcium and Vitamin D 
 
Most studies addressing the role of calcium and vitamin D in colorectal cancer have 
shown a reduced risk or no association. [44] [45] [46] [47] Interestingly, a high 
serum vitamin D level had a reduced risk of adenoma only when in association with 
calcium supplements [48]  
 
 
 
1.3.2.2 Exercise 
 
There is a high, consistent association with a reduced risk of colon cancer in those 
undertaking physical activity [49] [50] [51] .  This is attributed to physical activity 
stimulating peristalses thus reducing the time that faecal matter is in contact with the 
epithelium. Conversely rectal cancer does not seem to be modified by exercise. 
 
 
 
1.3.2.3 Obesity 
 
Obesity in association with reduced physical activity increases the risk of developing 
colorectal cancer by 2 [49] [51] [50] [52] . Data from the Framingham study showed 
that waist size rather than BMI was a better predictor for lifetime risk of colorectal 
cancer [53]  
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1.3.2.4 Alcohol 
 
Both colon and rectal cancer have been shown to have a dose response relationship 
to alcohol [54] [30].  This is thought to be due to the inhibition of DNA repair [55] 
,formation of DNA adducts through Acetaldehyde or the associated deficiency of 
nutrients [56] [57]  
 
 
 
1.3.2.5 Smoking 
 
The association between smoking and colon cancer is thought to be through 
microsatellite instability colon cancer [58, 59] and tumours with the loss of MLHI 
expression [60]  
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1.4 Presentation of Colorectal Cancer 
 
It is necessary to recognise the cancers within the colonic tract present with different 
symptoms depending upon their level.   
 
1.4.1 Rectal Bleeding 
 
Significant challenges are faced when trying to identify patients with symptoms 
indicative of colorectal cancer and who thus require urgent investigation. Studies 
have shown consultation rates up of four -- sixteen per thousand patients a year in 
primary care presenting with bleeding per rectum, [61] [62] [63] [64] abdominal pain 
[65]  and alterations in bowel habit [66] . Within the community, these symptoms are 
very high when compared to the actual incidence of colorectal cancer. 
Approximately 19% of patients within general practice reported rectal bleeding in 
the previous year [64]  and it is estimated that 97% of these will not have colorectal 
cancer [67]. The prevalence of altered bowel habit and abdominal pain within the 
community are even higher [68] thus less specific at predicting colorectal cancer. 
Studies undertaken in the late 1990’s aimed to determine the predictive value of 
rectal bleeding in the community for colorectal cancer [63]. This concluded that 
painless rectal bleeding, alteration in bowel habit and dark red bleeding; factors 
previously attributed to a higher risk of colorectal cancer are present in many people 
within their studied community. 
Patients with no anal symptoms but who suffer from rectal bleeding are 3 to 4 times 
more likely to have cancer as opposed to those who have anal symptoms alone [69] 
and this finding is independent of any alteration in bowel habit. In patients who have 
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symptoms of rectal bleeding, bright red rectal bleeding is less predictive as opposed 
to blood mixed with stool. Whilst this combination of symptoms has been shown to 
be of more diagnostic value when compared to other attributes, it is of little 
diagnostic aid [70]. Studies in primary care both in Australia and England have 
shown a 10% prevalence of cancer within the general community [70] [71]  The 
studies made further suggestions that all those over 40 with rectal bleeding should be 
referred for further specialist consultation. Symptoms of rectal bleeding and finding 
a palpable rectal mass are generally indicative of rectal cancers [72] 
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1.4.2  Alteration in Bowel Habit 
 
Along with rectal bleeding, patients commonly notice changes in their bowel habit. 
Whilst there can be numerous causes for an alteration in an individual’s habit of 
defecation studies have shown a fivefold increase in the risk of cancer when 
combined with rectal bleeding than if either symptom occurred on its own. [70] [69] . 
Increased frequency of defecation along with a change in bowel habit to loose 
motions has demonstrated a cancer prevalence of one in seven with those tending 
toward constipation having a prevalence of 1 in 36 [73, 74] One particular study 
found that all patients with colorectal cancer presented with alteration in the bowel 
habit and rectal bleeding [73] giving a positive predictive value of 9.2% as opposed 
to 0% in those with rectal bleeding and no alteration in bowel habit. This study also 
showed a higher predictive value of colorectal cancer in those with rectal bleeding 
with no perianal symptoms when compared with those with perianal symptoms. No 
predictive value was found in the dark or bright red rectal bleeding. . More than 90% 
of those with rectal and sigmoid cancers have alteration in bowel habit resulting in 
loose stool or an increased frequency of defecation. 
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1.4.3 Abdominal Pain 
 
The presence of abdominal pain remains an imprecise diagnostic marker. When 
associated with rectal bleeding and alteration in bowel habit two studies have 
demonstrated a reduction in the probability of cancer [69, 70] with only one study 
showing it to be of benefit in the diagnosis of serious disease. 
 
 
1.4.4 Iron Deficiency Anaemia 
 
The presence of iron deficiency anaemia with a haemoglobin below 10 g can be 
found in a large proportion of patients with colorectal cancer type of presentation 
[74] [75-78] [79] and 50% of these individuals will have no symptoms or clinical 
signs.  
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1.5 Diagnosis of Colorectal Cancer 
 
The diagnosis of colorectal cancer is histological; however this tissue diagnosis 
usually requires a colonoscopy which is not without risk. Given this a number of 
other diagnostic tools are used to facilitate the identification of those likely to have 
positive findings at colonoscopy. These range from simple FOB tests to invasive 
procedures. 
 
 
1.5.1  FOB tests 
 
These tests are simple and non-invasive, requiring a series of stool samples from the 
individual following adherence to specific pre-test instructions. They are used as part 
of the UK screening programme as well as being more widely available. Most FOBT 
testing is undertaken with a guaiac based test such as the Haemoccult 2 which have a 
sensitivity of 40-60% and specificity of 90-98% dependent on dietary adherence of 
the individual before taking the test and rehydration of the sample prior to laboratory 
analysis.[80]. 
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1.5.2 Flexible Sigmoidoscopy 
 
Flexible sigmoidoscopy utilises fibre optic technology and is commonly used for 
evaluation of the distal colon. Whilst not the ‘gold standard’ it is relatively easier to 
undertake, generally without full bowel preparation and in some areas by non-
medical personnel [81-86]thus making its availability greater. As an assessment tool 
it holds a valuable place, detecting 7 adenocarcinomas and 60 high risk adenomas 
per 1000 examinations [87]. Given the distribution of colonic malignancies flexible 
sigmoidoscopy can effectively be used to identify 80% of colonic cancers and both 
detect and remove 70% of adenomas [88]. Whilst not as extensive as a full 
colonoscopy, flexible sigmoidoscopy carries with it as an endoscopic procedure, 
risks of morbidity and mortality, even though they are very small. [89-91]  
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1.5.3 Colonoscopy 
 
Colonoscopy uses the same technology as flexible sigmoidoscopy, allowing the 
endoscopist to visualise the whole colon and in some instances intubate the terminal 
ileum. As with flexible sigmoidoscopy it has the benefit of tissue sampling at time of 
test, thus allowing histological diagnosis as well as providing the option of 
therapeutic treatment in the form of polypectomy, EMR or EMD. [92-99] The 
sensitivity of colonoscopy for adenomas ranges from 90% for large to 75% for 
smaller lesions [100] and its sensitivity for detecting colorectal cancer is greater than 
90%. Whilst a more accurate investigation it does however have some negative 
aspects such as a higher rate of morbidity and mortality as compared with flexible 
sigmoidoscopy and an increased cost. The cost implication is generally attributed to 
the length of the procedure, necessity for sedation and thus monitoring and the 
expertise required to perform the test but there is also the need to provide the patient 
with full bowel preparation prior to undertaking the procedure, a factor that needs to 
be carefully evaluated in some individuals. 
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1.5.4 Radiological Imaging 
 
The use of radiological procedures in the evaluation of the colon remains popular 
with modern techniques augmenting older practices. Double contrast barium enemas 
are of use in fully evaluating the colon in those unable to tolerate endoscopic 
techniques. While full bowel preparation may be required prior to the procedure 
being undertaken there is greater tolerance of the insufflation and contrast and there 
is little need for sedation. There are drawbacks to this method however as direct 
visualisation of the colonic mucosa is not obtained, as such the test has a lower 
sensitivity and specificity than colonoscopy detecting only 48% of polyps >10mm 
[101] with some studies identifying ‘miss rates’ of cancer up to 22.4% [102, 103]. 
An alternative to DCBE and colonoscopy in individuals not deemed fit is that of 
Virtual colonoscopy, a technique that utilises modern CT images in conjunction with 
intravenous contrast and CO2 insufflation per rectum to image the colon. Using 
complex software the images are able to be formatted allowing the intraluminal 
mucosa to be reconstructed in 3D. Studies have shown it to be accurate in detecting 
polyps >10mm in size although there is variation in the percentage accuracies based 
on seniority of reporting radiologist/technician and complexity of the scan. [104] 
[105-111] 
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1.6 Staging of Colorectal cancer 
 
Staging of colorectal cancer is currently done via the TNM classification system 
developed by the American Joint committee on Cancer, assessing tumour depth, 
node status and metastatic disease  [112]. This is commonly used in conjunction with 
the Dukes classification system, classifying the disease into A, B (B1, B2) [113], C1, 
C2 and D [114]. 
  
The TNM classification allows the disease to be staged (ranging from 0- 4) with 
various subdivisions based on TNM status. All of these classification systems are 
used to allow clinical planning of treatment and to aid in the overall prognosis of the 
disease. 
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1.7 Treatment of Colorectal Cancer 
 
The preoperative staging of colorectal cancer is important as this affects the 
treatment pathway, more significantly at present with rectal cancer however with the 
use of preoperative chemoradiotherapy or short course radiotherapy.   
 
1.7.1 Preoperative treatment 
 
Specifically in rectal cancer there has been an increased use of pre-operative 
oncological treatments to optimise the patients before any surgical intervention is 
undertaken. This is in the form of short course radiotherapy or combined 
radiotherapy and chemotherapy which, has been shown in numerous studies to 
improve patient outcome and survival but is associated with slightly higher post-
operative morbidity [115-120] [121]. The benefits of pre-operative chemotherapy in 
patients with colon cancer have not been fully evaluated at this time however there 
are on-going studies assessing the benefits of this in the patient cohort.  
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1.7.2 Surgical Treatment 
 
Surgery is the mainstay treatment option for cancers of the colon and rectum with 
many approaches to the segmental resection of the colon. Surgical techniques vary 
between Open and Laparoscopic approaches, with studies demonstrating no 
oncological difference between the two [122] [123] [124].  
TME dissection of rectal tumour has been shown to have improved oncological 
outcomes[125] [126] and is the widely accepted approach for the removal of rectal 
tumours.  TEMS procedures have been used in the treatment of small rectal tumours 
[127] [128] [129] although this has been in limited cases and the long term outcomes 
have not been assessed by a large study at this time.   
The specific operation that is undertaken is dependent on numerous factors such as 
stage of disease, patient co-morbidities and location of tumour. The operations can 
either be curative in intent or palliative, resecting the necessary amount of colon or 
rectum to ensure good vascularity in the remnants for anastomosis. Above the 
peritoneal reflection commonly performed procedures are right hemicolectomy, 
extended right hemicolectomy, left hemicolectomy and sigmoid colectomy. Below 
the peritoneal reflection for tumours of the upper, mid and at times lower rectum an 
anterior resection is performed, ensuring the distal remnant is of sufficient length to 
allow a healthy anastomosis. Should this not be the case then abdomino perineal 
excision of the rectum can be performed, this non-sphincter saving procedure leaves 
the individual with a permanent end colostomy. If palliation is considered then it 
may be appropriate to defunction the patient and leave the tumour in situ thus 
relieving any obstruction that may be occurring but reducing the operative morbidity 
and mortality.    
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1.7.3 Adjuvant treatment 
 
Post-operative treatment is determined by the histological stage of the specimen in 
association with the radiological staging of the disease. Stage I disease has a 95% 5 
year survival [130] however the presence of lymph node involvement (Stage III 
disease) reduced 5 year survival to between 30-60% with surgery alone. This 
survival rate can be improved by 10-15% with the addition of chemotherapy, for 
which there are many combinations however the main stay remains 5-FU based 
treatments [131] . 
The role of chemotherapy in Stage II disease is becoming more popular, especially if 
there are adverse prognostic factors within the specimen such as vascular invasion. 
Trials have shown an improved survival rate [131] with the use of chemotherapy in 
this cohort however the risks and benefits in this treatment group need discussing on 
an individual patient basis. 
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1.8 Referral Pathways 
1.8.1 Introduction  
 
Referral pathways for those suspected of having colorectal cancer range from direct 
primary care referrals including both 2 week wait and routine OPD referrals, 
interspeciality referrals due to incidental findings during the investigation of other 
complaints, acute referrals generated from emergency admissions and referrals from 
screening programmes. 
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1.8.2 Presentation from primary care 
 
 
1.8.2.1 2 Week wait referrals 
 
In 2002 guidelines were published by the Association of Coloproctology of Great 
Britain and Ireland at the request of the Department of Health. The aim of this 
guidance was to assist those in primary care to refer the most appropriate individuals 
under the ‘2 week wait’ process assisting in allowing everyone with suspected cancer 
to be seen by a specialist within two weeks. By defining the criteria it was important 
to ensure that only those at high risk of colorectal cancer would be identified and 
therefore referred on the urgent two-week basis. Key facts highlighted in this process 
were that whilst patients with lower gastrointestinal symptoms are recommended to 
be referred for prompt investigation in hospital there is no evidence that a delay of 
two or three months after the onset of symptoms is likely to adversely affect the 
outcome [132] [133]. Adverse outcomes of investigating all of those with vague 
symptoms have also been explored on a physical and psychological level [134] 
[135]. 
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Whilst patient symptoms are of importance other attributes have also been shown to 
aid in the diagnosis. 85% of colorectal cancers are in the age group of those over 60 
with only 1.5% being in those less than 40 years of age. This variation in prevalence 
of the different age groups alters the management of these individuals, with those 
over 60 possibly being investigated with more subtle symptoms than someone under 
40. 
 
The development of guidelines remains important due to the high prevalence of 
rectal bleeding within the community [136] [64] [137] previous studies have shown 
an increased risk of cancer and rectal bleeding occurs in association with alteration 
in bowel habit of giving a predictive value of 12% for colorectal cancer [73]  
  
The risk of cancer in patients suffering from rectal bleeding varies in accordance 
with their population. The prevalence within the community is one in 700, in 
primary care this increases to 1 in 30 and for those in hospital surgical clinics one in 
16  
 
It was suggested that 85 to 90% of all patients with symptoms present in table 1 
presenting via the two-week wait referral system would be positive for colorectal 
cancer. The ACPGBI at the time also emphasised the importance of identifying those 
at low risk of rectal cancer who experienced symptoms as defined in table 2. It was 
felt that these individuals could be observed and referred as routine patients to 
specialist services. 
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Table 1.1: Department of Health higher risk criteria 
 
 
Criteria Age threshold 
Rectal bleeding with a change in bowel habit to 
loose stools and/or increased frequency of 
defecation persistent for 6 weeks 
All Ages 
Change in bowel habit as above without rectal 
bleeding and persistent for 6 weeks 
Over 60 Years 
Recta bleeding persistently without anal 
symptoms 
Over 60 years 
A Definite palpable right sided abdominal mass All Ages 
A definite palpable rectal mass All Ages 
Unexplained iron deficiency anaemia 
    Below 11g/dl in men 
    Below 10g/dl in women 
 
All Ages 
Post menopausal women 
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Table 1.2:  Low risk criteria (ASGBI guidelines) 
 
 
Criteria Age Threshold 
Rectal Bleeding WITH anal symptoms All Ages 
Rectal bleeding with an obvious external 
cause for bleeding on simple examination of 
the perineum. E.g. an anal fissure, 
thrombosed or external pile and rectal 
prolapse   
All Ages 
Transient changes in bowel habit, particularly 
to harder stools and/or decreased frequency of 
defecation 
All Ages 
Abdominal pain as a single symptom 
WITHOUT other high 
risk/age/symptoms/sign profiles, an 
abdominal mass, an iron deficiency anaemia 
or intestinal obstruction 
All Ages 
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If patients presented to the GP with any of these symptoms they could then be 
referred to a hospital specialist and seen within a set two-week time period. This 
particular referral pathway became known as the ‘2 week wait’ and, as with most 
guidelines has been subject to revision since its introduction. The most recent 
alteration occurred in 2005 with the introduction of the 31/62 pathway [138] 
The aim of the guidelines and pre determined referral criteria was to 'identify up to 
90% of patients with colorectal cancer[139]. This figure of 90% however, over the 
years that the system has been in place has not been emulated in clinical practice. 
Recent studies have demonstrated that only 10% of patients referred under the two-
week wait criteria have colorectal cancer, with a review article examining the subject 
finding an average of 10.3% when comparing six different studies [142][141]this 
accounts for only approximately 30% of those with the disease [140] approximately 
one quarter of those with colorectal cancer continue to present acutely with the 
disease, with the remainder presenting via alternative routes[141]. Reasons for the 
variation in rates of presentation are multiple; some have advocated that pressure 
within a primary care setting, with an average of seven minutes per consultation 
makes accurate referral of only high risk individuals unachievable. Other factors that 
must be taken into account are patients themselves, some failing to seek medical 
advice for their symptoms until they present to acute services and others who find it 
too embarrassing [142-144]. 
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1.8.2.2 Routine OPD referrals  
 
There are several variations in the approach to the 2WW process, the more 
traditional being dedicated clinic time, in which patients are reviewed by a 
consultant, one of their team or a nurse specialist. Following such a consultation and, 
based on patient history and clinical signs further investigations may be undertaken. 
At this point, unless a definitive sign is found at examination, a rectal lesion for 
example that can be biopsied in an outpatient setting, a further delay will occur prior 
to definitive histological diagnosis. This, as already alluded to, may not clinically 
bear any significance to outcome of disease, but will undoubtedly have some 
psychological implications for the individual [145]. 
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1.8.2.3 Straight to test 
 
The above scenario has evolved quite significantly over recent years with a ‘push’ 
towards a ‘straight to test’ situation. These new routes of access have taken many 
different guises, but all have an underlying theme of diagnostic test at first hospital 
visit. Policies adopted range from the use of dedicated 2 week wait clinics, where 
medical staff not only take a thorough history and examine the patient but also 
undertake an endoscopic examination at this first instance (generally a flexible 
sigmoidoscopy). Whilst not the ‘gold standard’ the benefits of a flexible 
sigmoidoscopy will be examined further later in this chapter. This method is not far 
from the traditional referral route and, allows clinical evaluation by a hospital 
specialist as well as a potentially diagnostic examination to occur simultaneously. 
Whilst remaining labour intensive and somewhat costly in terms of resources (the 
need for dedicated sessions in endoscopy and the trained staff) it is beneficial in 
reducing anxiety and definitive diagnosis of a range of conditions, not only 
colorectal cancer.  
 
The use of non-medical screening for 2WW referrals has been evaluated by 
Hemingway et al  [140]. This particular method utilised a pre-determined protocol, 
based on the ACPGBI guidelines and agreed by both specialists within the hospital 
and the local primary care Services. (Table 1.3) 
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Table 1.3: Non medical screening of 2WW patients  
 
Presenting Symptoms Age Diagnostic Intervention 
Rectal bleeding with 
change in bowel habit 
for at least 6 weeks 
All Ages Same day fibre optic 
sigmoidoscopy and barium 
enema 
Colonoscopy, CT 
Colonography 
Rectal Bleeding 
without anal symptoms 
Recommended over 60 
  Discretionary over 45 
Fibreoptic Sigmoidoscopy 
Change in bowel habit; 
increased frequency 
and/or looser stools for 
at least 6 weeks 
Over 60 Barium Enema 
CT Colonography 
Colonoscopy 
Palpable abdominal 
mass 
All Ages USS / CT Scan 
Palpable intraluminal 
rectal mass 
All Ages Sigmoidoscopy and biopsy 
Unexplained Iron 
Deficiency Anaemia  
  HB <11g/dl in men 
  Hb <10g/dl in post 
menopausal women 
All Ages Barium Enema, CT 
colonography, 
Colonoscopy 
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The outcome of the above interventions achieved 95% of all diagnoses, not just 
colorectal cancer within a 31 day period from initial referral and reduced the number 
of patient clinical consultations. Interestingly, and as has been shown in previous 
examples the detection rate of colorectal cancer in this population was 12%.  
A novel but somewhat more expensive route of referral was assessed by 
Maruthachalam et al, using direct access colonoscopy from primary care as part of 
the 2ww assessment process [146]. They utilised the DOH high risk criteria in 
conjunction with a specialised proforma to allow GP’s to refer patients directly for 
colonoscopy or for an urgent out patient appointment. The study demonstrated a 
reduction in time of diagnosis to 14 days from point of referral and a high level 
(98%) of patient satisfaction but cancer detection rates were comparable to more 
traditional 2ww referral routes. Whilst both a reduction in time to diagnosis and high 
level of patient satisfaction may reduce patient anxiety there is no evidence to 
support a reduction from 31 to 14 days has any benefit to patient survival. This is 
compounded by the associated risks of mortality and morbidity that go with 
colonoscopy and the overall expense of this referral process.     
 
Whilst the above alternative methods for patient access to rapid access services are 
aimed at improving performance, all appear to have a similar rate of detection. The 
use of flexible sigmoidoscopy, a procedure that is regarded as being quicker and 
generally less technically demanding than colonoscopy is, for these reasons easier to 
access. Whilst it may only (on average) reach the splenic flexure, statistically this 
should detect over 70% of colon cancers [147] and can be used to detect and remove 
70% of adenomas [148]. It, like colonoscopy however is associated with risks of 
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mortality and morbidity, even if they are small. The ‘gold standard’ test for colonic 
evaluation is without doubt colonoscopy. It is however also the most expensive 
method and carries with it risks of mortality and morbidity considerably higher than 
flexible sigmoidoscopy.  
 
Taking the above information into account and examining the evidence from the 
numerous trials that have evaluated the 2WW process since its creation in 2000 there 
appears to be a constant theme throughout. 10% appears to be the recurrent level of 
colorectal cancer detection with this particular route of referral, a far cry from the 
original 90% detection rate [139].A great amount of research and one can only 
presume resources have gone into the improvement of this practice but these figures 
remain around the same mark. The utilisation of alternative techniques in increasing 
the speed of diagnosis appears to have altered little other than achieving pre-set 
government targets. Taking this as point in case alternative methods of detection 
have been evaluated and in certain cases put into practice as illustrated below. 
 
 
 
 
 
 
 
53 
 
1.8.3 National Bowel Cancer Screening programme 
The philosophy of early patient identification is one that remains important for any 
malignancy, and whilst the 2 week wait may not have achieved its 90% target other 
methods of early cancer identification have been explored. The most recent of these 
is the Bowel Screening Programme, something that will be explored in further detail 
later in this chapter. Whatever method used in this process is however dependent on 
two main factors, One being patient participation, something without which stops 
any process before it has started, the second being the identification of factors 
pertaining to risk for colorectal cancer. 
 
Mandel et al. [80, 149]  demonstrated a high level of screening compliance with a 
reduction in mortality at 18 years, improved survival and detection of cancer at an 
earlier stage. Studies undertaken in both Denmark [150] and the UK [151, 152] also 
demonstrated a survival advantage with community screening using FOBT. This 
investigation forms the backbone of the recently introduced UK screening 
programme on a biennial basis in those individuals between the ages of 60 and 69 
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1.8.4 Non two week wait colorectal cancer detection 
 
An increased urgency in investigation of those referred via the 2WW system has led 
to an increase in demand for primary diagnostic tests such as flexible sigmoidoscopy 
or colonoscopy. Whilst these investigations may duly be warranted by the 
individuals concerned, due to the method of referral all must be undertaken within a 
pre defined timescale, leading to a diagnosis at 31 days from referral. With only 10% 
of these cases having colorectal cancer, in the region of 25-30% of all colorectal 
cancers over a year, 70% of colorectal cancers will present via alternative routes, and 
thus have to access these scarce resources in an alternative manner. Bowel cancer 
screening is one method of reducing deaths from colorectal cancer within the UK 
and is currently being rolled out. The aim is to detect bowel cancer at an early stage 
[153]  and is supported by a 16 percent reduction in death by colorectal cancer. 
Currently the process of bowel cancer screening is underway with all those aged 
between 60 and 69 being invited to participate on a two yearly basis via letter and 
information booklet. This will be followed by a Faecal Occult Blood test which has 
been quoted in some literature to have a 60% compliance rate [150] and as high as 
81% in others . For polyps ≥ 1 cm, sensitivity estimates range from 13 to 31% [154] 
[155]. Unlike sensitivity, the specificity of Hemoccult II is relatively good, ranging 
from 98–99% in large screening studies [155-158]. If a patient has a positive FOB 
test then they will proceed to further diagnostic tests. This process, whilst of benefit 
albeit to a small age range has some negative aspects, specifically the psychological 
anguish faced by those with a positive FOB and normal colonoscopy, leaving the 
individual and in some cases GP’s wondering how best to further investigate this 
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finding. These criticisms apart there is the undoubted positive aspect of earlier 
cancer detection as some of those who agree to screening will harbour a colorectal 
cancer and be asymptomatic from it, thus this modality of cancer detection is likely 
to grow in popularity over time. 
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1.8.5 Success of the 2ww system 
1.8.5.1 How the two-week wait criteria have worked 
 
Since its introduction in 2000 the two-week wait pathway has been intensively 
monitored with waiting times and diagnostic delay being comprehensively audited 
[159] . Not ignoring the benefits of early cancer detection, this process and pressure 
is only on clinics but also on diagnostic services within the hospital setting. With the 
detection rate of 10% the economic benefit of the system must be questioned. In 
addition to this further pressure was added in 2005 with the diagnostic and treatment 
targets 31/62 days respectively [138]. Chohan et al demonstrated that 92% of those 
with colorectal cancer presented with symptoms that have filled the high risk criteria 
[160]. The appropriateness of those referred under the two week rule has at times 
been questioned [161, 162]. Discrepancies have also been illustrated between referral 
letters and symptoms elicited within clinics [163]. 
 
Detailed analysis of referral criteria were undertaken by Flashman et al in which they 
reviewed all patients diagnosed with cancer in a 1 year period, a total of 249 
individuals. 41% of their cases were assessed in the two week wait clinics which on 
analysis proved to be a statistically higher diagnostic yield as opposed to routine 
clinics. They further showed that 39% of all those referred under 2 week wait criteria 
failed to fulfil at least one of the high risk criteria [164]. Although this study was 
carried out shortly after the introduction of the two week wait rule it highlights the 
fact that more than 50% of cancers in that institution still presented via alternative 
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routes, something that has been demonstrated in studies carried out since this time. 
Promisingly, however, as far as the high risk guidelines perform they found that 85% 
of all cancers presenting to outpatients had at least one of the high risk criteria. The 
point outlined above probably represents the main failing of the 2 week wait system, 
not the fact that the formulated guidelines are inappropriate, but rather that the 
implementation and use of these guidelines has been flawed in some respects. 
Perhaps improved adherence to the criteria within a primary care setting can address 
this problem [67, 165]. 
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1.8.5.2 Effect on Survival  
 
Whilst it is generally accepted that the two-week wait criteria have assisted in the 
identification of those with colorectal cancer the relationship of those to overall 
survival has not been ascertained. One study has shown more advanced disease to be 
more likely in those referred under the two-week wait system [163]. A review 
evaluating the impact of intensive follow-up on long-term survival reported a mean 
of 24 months following surgery for a relapse to occur [166]. Walsh et al did not 
demonstrate any statistically significant medium-term survival benefit in those 
patients presenting via the acute pathway[167]. In a similar study Bevis et al, who 
studied referral source in relation to stage of disease found that whilst a significant 
delay was recorded in time to see a specialist and initiation of treatment, no 
association with advanced disease or reduction in curative surgery was found [168]. 
 
Whether the two week wait system has grossly affected outcome in colorectal cancer 
may be unclear but it has provided primary care with a dedicated rapid access point 
to specialist hospital services. This however does come at a cost and, whilst open to 
abuse from certain quarters is a route of referral that is constantly under review, with 
additional methods of detection, such as bowel cancer screening programmes 
coming into operation. 
 
 
 
59 
 
1.8.6 Alternative detection methods 
 
Alternatives to both screening and the 2WW system have been under evaluation 
since the late 1990’s, one particular area of study has been the use of patient 
questionnaires. Logically this would seem a sensible avenue to explore, given the 
detection rate of the 2WW system and a paper by Selvachandran evaluated the 
accuracy of this method [169]. They assess all hospital referrals from primary care 
with distal colonic symptoms and provided these patients with a questionnaire to 
complete prior to hospital attendance, grading each according to a weighted scoring 
system (known as the Selva score). The patient questionnaire was extensive and 
probed not only a history of patient symptoms but also family history relevant to 
colorectal cancer as already explained earlier in this chapter. Whilst some of the 
questions were similar to the ACPGBI guidelines on the whole the questionnaire was 
more comprehensive in relation to a true patient history. They demonstrated that the 
patient questionnaire, in correlation with a weighted numerical scoring system 
allowed accurate assessment of all referrals from primary care, prioritising those 
with symptoms indicative of colorectal cancer. Whilst this pathway has not been 
widely accepted into clinical practice it highlights that a system able to 
comprehensively assess all colorectal referrals and prioritise those at risk of 
colorectal cancer is achievable. A more recent study undertaken in Leicestershire 
further assessed the feasibility of the afore mentioned scoring system and compared 
it to the 2WW system in practice. The showed that the scoring system, when used 
with a cut off value of 70 had a similar sensitivity but greater specificity in detecting 
colorectal cancer when compared with the 2WW system [170]. 
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Evidence has clearly shown that the 2WW pathway has been unable to reach its 
intended target of 90% detection of those with colorectal cancer. Whether this is due 
to system abuse, patient history at initial presentation or an inherent wish for all 
patients to be seen as soon as possible is unclear. What has been shown is that with 
all the monetary investment and time that is ploughed into the 2WW system, the 
detection rate has remained a constant and, furthermore little has changed in terms of 
patient outcome. It would be correct to assume that the concept is very genuine but 
one has to question whether this concept has been somewhat muddied by political 
interference and the dreaded word ‘targets’. The notion of litigation within the 
medical sector is also something that has increased exponentially over the past 
decade and it would be ignorant not to assume that this has not played a role in both 
patient referral and investigation requests 
 
What has been demonstrated by studies is that the use of patient targeted 
questionnaires can increase the sensitivity and maintain a comparable specificity to 
the current system. Obtaining a sensitivity and specificity of 100 percent is, in all 
practical terms an impossible feat to obtain but it should be possible to increase 
current practice levels utilising the afore mentioned targeted questionnaires. Whilst 
the concept of a weighted, questionnaire based patient scoring system may appear 
unattractive to clinicians, the available evidence at this time illustrates that it is an 
area worthy of further investigation. No system will achieve perfection, but with 
advances in technology and novel techniques in data exploration and analysis it 
should be possible to develop a system that achieves an improved sensitivity and 
specificity compared to current practice 
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1.9 Data Mining 
 
 
 
1.9.1 Introduction 
 
Over the past two decades there has been a rapid increase in the amount of medical 
data available for research. This can be attributed not only to advances in new 
molecular genetics techniques such as protein identification genomic sequencing but 
also due to the increased use of computerised technology within hospital setting. 
Digitisation of medical information such as blood results, radiological investigations 
and patient information have resulted in vast quantities of data specific to patient 
care being available for research. Whilst this data exists its rate of accumulation is 
far greater than the rate of interpretation for research purposes. 
In order to utilise this information as effectively as possible new techniques within 
medicine have been developed such as data mining, text mining and knowledge 
management. Whilst these processes are used effectively in government and business 
settings [171-174] the uptake from a medical point of view has been somewhat 
slower. 
Data mining is primarily a knowledge discovery process, analysing given set of data 
in order to identify potentially novel and useful patterns [175]. Techniques utilised 
range from Bayesian models to artificial neural networks and are used to illustrate 
patterns within the data that are unknown and unrecognised to the users [176, 177] 
Whilst data mining is an important component in the analysis of the status previously 
unrecognised patterns it can be used in conjunction with text mining, with an aim to 
extract information from textual data documents [178, 179] and also as part of 
generalised knowledge management [179]  
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Since the advent of the first computer there has been an array of systems built for 
engineering, business decision making and medical diagnoses [180]. The primary 
drawback to the vast majority of these systems is the manual acquisition of 
knowledge which, is an exceedingly labour-intensive and time-consuming process. 
These systems also draw heavily on human experts for data analysis. To try to 
address this somewhat lengthy process machine learning has been developed to 
acquire this knowledge automatically. This process has been defined as "any process 
by which a system improves its performance." [181] something which in medical 
fields would be classed as data analysis and primarily done using Bayesian statistics. 
 
Data is omnipresent and whilst the amount of data that is collected can to the human 
eye appear overwhelming within a substantial quantity of it lies valuable 
information. The extraction of this information, given the colossal amount of 
variables is something that requires the assistance of an automated computational 
process. The technique of data mining is primarily about problem solving by 
analysing data already present within a database. The process searches the 
characteristics within the data set allowing distinguishing characteristics to be 
extracted. It is a process of discovering data patterns leading to a meaningful 
outcome measure. The ultimate goal of data mining is prediction, usually consisting 
of three distinct stages, and initial exploration, model building and deployment. 
 
Exploration of data combines data preparation and some preliminary feature 
selection. This process may involve the cleaning of data, transformation of data and 
selection of subsets. Depending upon the nature of the problem further analyses may 
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be required using a variety of statistical and graphical methods allowing 
identification of the most relevant variables and to provide information on the 
complexity and nature of the models. Following appropriate data exploration various 
data mining models can be considered, the most appropriate model being chosen 
based on outcome prediction. A variety of techniques exist to achieve this step many 
based on competitive evaluation of models, a process essentially of comparing the 
same data set on numerous different models and comparing the performance. These 
techniques include bagging, boosting, stacking and meta-learning. Following 
successful modelling, deployment of the appropriately identified data mining 
techniques is undertaken. This applied to a virgin data set and is utilised to generate 
predictors of expected outcome. The most important difference between data mining 
and exploratory data analysis and data mining focuses more on application than on 
the basic underlying phenomena. Data mining is therefore less concerned with the 
identification of relations between variables, focusing more on the production of a 
solution that can be utilised in the generation of accurate predictors. A black box 
approach is therefore generally accepted utilising not only traditional techniques but 
also techniques such as artificial neural networks 
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1.9.2 Neural Networks  
 
McCulloch and Pitt in the 1940s [182] were the first to exploit computational 
mathematical models, consisting of a single neurone utilised to construct a network 
able to analyse basic Boolean logical functions. While a fundamentally important 
step these networks in conjunction with very early designs computers were too 
inflexible to be used as cognitive models. Most current neural networks have 
learning rules arising from statistical correlation analysis and gradient descent search 
procedures. In addition, work by Hebb [183] using learning rules that incrementally 
modify the connection weights based on the ON/OFF allocation to the two 
connected nodes is still used with some modifications.  
It was not until the 1950s when Rosenblatt, a psychologist [184] added to the 
development of ‘artificial neural networks’ viewing the brain as an associate of 
learning stimuli and trying to simulate this electronically. To achieve this he 
postulated a new class of networks based on the ‘perceptron’ neural model and 
utilising association learning rules based on descent gradients, in its simplest form 
three layers of designated cells. Learning is undertaken as source material in the first 
layer of cells connected ‘randomly’ to the central otherwise known as ‘association’. 
The output response is not only influenced by positive neuronal association but also 
from inhibitory association as the result of a lack of input. This process enabled 
Rosenblatt to demonstrate that such runs have the ability to not only generalise but 
were also capable of learning, using pre-entered data. This method of learning 
further subdivided into two categories, forced learning and competitive learning. 
Forced learning utilises a specific pattern of inputs to activate a particular response, 
allowing the neurone to grow in strength with recurrent cycles of exposure, 
ultimately to the point where the response neurone is activated appropriately. 
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Competitive learning conversely utilises the continued activation of association units 
whilst various responses gain in strength. This allows for increased sensitivity to 
particular input types.  
 
The further development of Neural Networks with ADALINE (adaptive linear 
neurone) followed by multiple network ADALINE’s known as MADALINE 
(multiple adalines) by Hoff and Widrow took the concept further [185, 186]. These 
methods differed from Rosenblatts work by using a simple neural element in 
addition to developing the least mean square supervised learning procedure. 
 
The theory of associated memory in the 1970s was once again an important step in 
the development of neural networks. This theory is based on the stored pairing of 
patterns, the presentation of one pattern evoking the associated pattern therefore 
allowing the content to be regarded as addressable. Further work with linear 
associated models allowed within the network's output is preventing infinite growth 
as the model strives to identify a solution. 
 
Further modelling of networks was undertaken by Fukushima [187, 188] based on 
biological visual systems. These feed forward networks learn through both 
supervised and unsupervised methods, utilising connected layers such that vague 
features can be recognised and thus cumulatively combined into an identifiable 
output object. Such methods are used routinely for the recognition of handwriting. 
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Werbos,  [189] with the development of the back propagation algorithm made one of 
the most important developments in neural network research. This algorithm has the 
ability to adjust the weights in a multi layer feed forward network. The technique has 
since been described further and is vital in the use of artificial neural networks to 
solve nonlinear problems [190-192]. 
 
The structure of a NN was distinguished by Rumelhart and McClelland [193] as: 
• a set of processing units 
• a state of activation for each  unit  
• connections between units, defined by a weight that effects the output signal 
• a propagation rule  
• an activation function 
• an external input 
• a learning rule 
• a working environment  
 
Within the network, units can be further defined as input units (i.e. receive input data 
from external source), hidden units (input and output signals are ‘hidden’ within the 
network) and output units. Units are connected such that the total input is ‘weighted’ 
via a mathematical rule before a ‘threshold’ is reached and the unit fires in either a 
linear, semi-linear, sigmoid or hyperbolic tangential function. 
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1.9.2.1 Network Topology 
 
Connection patterns within networks fall into two categories, the Feed-Forward 
network where data is processed over multiple layers in a forward direction only 
with no feedback connections and the Recurrent network where feedback 
connections are used. The Perceptron and Adaline networks constitute feed forward 
networks whereas recurrent networks have been presented by Anderson and 
Hopfield [194, 195] . 
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1.9.2.2 Network training 
 
Training of networks can be either by a priori knowledge or providing teaching sets 
of data and allowing the network to evolve and thus alter the weights according to 
the learning rule. This can be undertaken in a supervised or unsupervised manner 
depending on whether the input and output data is provided or simply input data 
inserted. Training and adjustment of weights is then undertaken, commonly using a 
variant of Hebbian learning or occasionally using the delta or Widrow-Hoff rule.  
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1.9.2.3 Network types 
 
 
1.9.2.3.1 Multilayer feed forward networks 
These networks have a number of layers, with the hidden layers taking input from 
the previous layer and sending it directly to the following layer (see diagram). No 
connections exist within the layers and the activation is related to the outcome of the 
function attributed to the unit based on the weighted inputs. 
𝑦𝑘(𝑡+1) = 𝐹𝑘�𝑠𝑘  (𝑡)�= 𝐹𝑘 ��𝜔𝑗𝑘  
𝑗
(𝑡) 𝑦𝑗 (𝑡) + 𝜃𝑘(𝑡)� 
.  
Back-propagation learning rules can be applied to allow the network to adjust the 
weights within the hidden layer and this improves the functionality of the network. 
Whilst this rule can be applied to networks of any number of layers it has been 
shown that provided the activation functions are non linear, only one layer of hidden 
units is required [196, 197]. 
                                      
     Feedforward Network 
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1.9.2.3.2 Recurrent networks 
 
Recurrent networks differ from feed forward networks as they allow connections 
between the hidden units. These can be based on reaching a stable point (attractor 
based) or ones where a learning rule is used after each propagation is performed. 
Examples of this type of network are the Jordan Network [198] where output unit 
values are fed back into the input layer as ‘state units’ and the Hopfield Network 
[195] which consist of a set of interconnected neurones which update their activation 
values asynchronously and independently of the other neurones with binary 
activation values. 
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1.9.2.3.3 Radial Basis Function Networks 
 
These networks use a radial base function to measure the distance between unit 
points and the centre resulting in a Gaussian function [199-201]. The hidden layer of 
units models the bell shaped response surface and as the functions are non-linear, 
more than one hidden layer is unnecessary. Whilst these networks have the 
advantage of modelling nonlinear functions with only one hidden layer they require 
the number of radial units to be decided initially with the centres and deviations 
being set. 
 
1.9.2.3.4 Self Organising Feature Map (SOFM) 
These networks are designed for unsupervised learning [200, 202, 203] allowing 
them to recognise clusters of data and relate these clusters to each other. They only 
have two layers, an input layer and output layer, also known as a topological map.  
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1.9.2.4  Effect of Hidden Units 
Variation in the number of hidden units is undertaken to identify the best fitting 
network for the input and output data. A large number of hidden units however can 
impede the ability of the network, causing ‘overtraining’. This is an effect whereby 
the network trains itself to fit the ‘noise’ of the training data rather than 
approximating it, resulting in a high error rate when the network is used with the test 
set. 
 
 
1.9.2.5  Effect of Hidden layers 
There is no ‘hard and fast’ rule regarding the number of hidden layers required in a 
neural network. Linear models and even mildly non-linear models have been shown 
to have better generalisation with no hidden layers [204]. Auer has also advocated 
the use of a single layer of weight in association with a parallel delta rule on grounds 
that it is a more realistic alternative in the modelling of biological circuits [205]. 
Conversely Sontag suggest two hidden layers in multi-layered perceptron’s with 
Heaviside/step/threshold functions and one hidden layer in MLP’s with a variety of 
non-linear activation functions are a more appropriate modelling method. [197].    
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1.9.3 Decision Trees 
 
The origins of decision trees can be traced back to the late 1950s and the work of 
Hunt, Quinlan and Breiman [206-208]. A decision tree has three main components: 
nodes, arcs and leaves, nodes containing a feature attribute, arcs being labelled with 
a feature value and the Leaf labelled with a class or category. Most decision trees use 
a top-down algorithm i.e. from the branch to the leaf. In addition a technique used as 
pruning is used to simplify decision tree by removing useless information. The 
structure of the decision tree allows it to be easily converted to a classification rule 
Amongst symbolic learning and rule induction techniques learning by example is 
shown to be the most promising approach for data mining. The concept behind this 
technique is the application of an algorithm that tries to best describe numerous 
classes within a training example. The ID3 decision tree algorithm [209] and the 
more recent variation C4 .5 [210] are the most widely utilised symbolic learning 
techniques. These methods use a decision tree and attempt to classify all objects 
correctly; finding the attribute the most appropriately splits data into different classes 
of information uncertainty. Once all attributes have been used the algorithm displays 
the results as a decision tree. Whilst these techniques may not be as powerful as 
neural networks or support vector machines with their accuracy they are more 
efficient and produce outcomes that are easier to interpret. 
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1.9.3.1 Classification of machine learning techniques 
Classification of the five main paradigms of machine learning occurred in 2004 
[176]. These five categories were probabilistic and statistical models, symbolic 
learning and rule induction, neural networks, evolution based models and analytical 
learning and fuzzy logic. 
 
Statistical Models 
Probabilistic models and techniques have the strongest foundation of all methods for 
data analysis. The statistical analysis using popular techniques such as regression or 
multidimensional scaling commonly used with the medical research and in papers 
that have utilised data mining techniques previously have been used as benchmarks 
for comparison.  
 
 
Bayesian classification  
With its roots in pattern recognition research, the Bayesian model [211] is likely to 
be the most popular probabilistic model utilised in medical research. Used to classify 
objects into predefined groups utilising specific features it defines the likelihood of 
each class, each feature and each feature giving each class-based on training data. 
Using these predetermined probabilities when a new instance is encountered the 
model attempts to classify it accordingly [212]. Variants of this model exist, 
specifically one called naive Bayes. In this variant all features are deemed mutually 
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independent in each class. Whilst Bayesian models have been widely used in 
medical data mining, research involving the models has been developed in more 
recent years. One such model is called a support vector machines [213] which uses 
statistical learning to identify and model the best separates classes within the data. 
This particular technique has been shown to perform well in document classification 
[214] and is also being used in medical research to classify disease states or identify 
specific diagnoses utilising patient information. 
 
 
Evolution based algorithms are analogous to Darwinian survival of the fittest and 
analogies of other natural processes. Genetic algorithms [215] are based on genetic 
principle, with population data undergoing a set of operations known as crossover 
and mutation. Crossover is a process aimed specifically at exploitation while 
mutation is aimed at exploration of the data. As with the Darwinian theory of 
evolution, there is a continuous filtering process selecting better solutions followed 
by repetition of the above sequence in order to produce a further generation, with 
selection of the best solution undertaken once again. Such algorithms are of great use 
in medical research being one of the most robust techniques for feature selection due 
to their global search capabilities. 
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Analytical learning utilises logical rules on which it performs reasoning in order to 
search for proofs. These proofs can then be arranged into more complex rules in 
order to solve similar problems. Whilst these traditional learning systems rely upon 
computing rules generally there is no distinction between the values and classes in 
the real world. This has been tackled by proposing fuzzy Logic Systems, allowing 
true or false values operate over numbers from 0 to 1[216]. 
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1.9.3.2 Methods of evaluation 
 
It is necessary to thoroughly evaluate any data mining system before it is put into 
practice. In cases of limited data availability estimating system accuracy is difficult 
to undertake [217] . Several methods are used for the evaluation process including 
bootstrap something, cross validation, holdout sampling and leave one out [218, 
219]. Each of the above methods has both strengths and weaknesses, many studies 
have compared in terms of their accuracy.  
The bootstrap method takes an independent and random sample from the original 
data set. These samples were then used to train the system allowing fresh data (in the 
remaining samples) to be used to test the system [219].  
Cross validation randomly divided the data into X subsets all of roughly equal size, 
generally this is 10 subsets and a process called ' tenfold cross validation ' is 
undertaken. In this process training and testing is undertaking with 10 iterations, nine 
subsets of data used for training and the 10th remaining subsets used for testing. This 
process is performed in rotation with the accuracy of the system being the average 
accuracy over 10 cycles. 
The holdout method splits the dataset into two subsets, the training set and the 
testing set. Generally speaking two thirds of the data is put forward as the training set 
with the remaining third being used for testing. Once trained the system will use the 
testing set to predict the outcome and accuracy  determined by comparison with the 
real output value. Leave one out is a variant of cross validation whereby the original 
dataset is split into multiple subsets of equal size. . Training is undertaken for N 
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iterations and as before n -1 instances are used for training purposes, the remaining 
used for testing. As before the accuracy is the average over the N cycles. 
 
Studies have compared the accuracy of the above methods however the ability to 
implement them should be taken into account. The easiest method to implement is 
that of holdout sampling however the training set and testing steps are not mutually 
independent. With up to one third of the data being removed from training the 
efficiency of this technique has been questioned [217] . The most unbiased method 
has been shown to the leave one out [220, 221] but its estimations have high 
variances and this is more pronounced with a small dataset. Independent comparison 
of all methods showed tenfold cross validation to be the most appropriate model 
selection. 
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Rule induction 
Rule induction systems are based on a process of if -- then rules, if X then Y 
For an example to be correctly predicted by the above rule, its attributes must fulfil 
the ‘if’ conditions. 
 
 
 
Decision tree induction 
Decision trees are constructed by choosing the most informative attribute of each 
step. Construction stops are when all data examples in a specific node are of the 
same class. This mode is known as a leaf and is labelled by the value of the class 
variable. Ideally each leaf has one class name label however some leaves may be 
empty if no training examples have attribute values leading to it all can be labelled 
by more than one class name. The most important feature for handling noisy data is a 
mechanism known as tree pruning. This is aimed at producing decision trees that do 
not over fit potentially erroneous data. Unreliable parts of the tree are eliminated 
therefore increasing classification accuracy of the tree on unseen cases. Techniques 
pruning are based on expected/predicted classification accuracy or expected 
classification error[210].  
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Instance-based learning  
 
Algorithms of this type require specific instances in order to perform classification 
tasks. These differ from the rule induction method which uses generalisations based 
upon if -- then rules. Instance-based learning on occasion is referred to as a lazy 
learning algorithm as they save part or the entire training set postponing inductive 
generalisation until the time of classification. They are based on the assumption that 
similar instances have similar classifications. As an algorithm they are derived from 
nearest neighbour classifier algorithms. In these algorithms all attributes are treated 
as a dimensional within a space with examples and specific points within this space.  
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1.9.4 Uses of Data Mining 
 
Recent years have seen an increase in the use of artificial neural networks and 
support vector machines within the medical field. The use of data mining techniques 
within health care is augmented by their predictive power. Algorithms have the 
ability to learn from prior examples within a clinical dataset; they then have the 
ability to model often complex nonlinear relationships between variables. Such 
patterns may very well be unclear when other analytical techniques are undertaken. 
The most extensively used data mining technique in the medical field is that of 
classification, used to analyse various signals and their relationship with diseases or 
symptoms. Neural networks have been utilised to classify outcome in post-operative 
colorectal cancer patients [222] and also to classify lung sounds in two distinct 
categories to assist diagnoses [223] data mining has also been used to extract 
diagnostic rules for breast cancer data [224] and also to identify new medical 
knowledge [225]. 
This process utilises patient data and corresponding diagnoses, allowing data mining 
techniques to diagnose outcome in new cases. This is undertaken using a predefined 
set of examples with known classifications. Each example is described by a fixed 
collection of features (known as attributes) each attribute can be discreet or 
continuous data. To correctly classify new cases different data mining processes can 
take different approaches. Sets of symbolic rules to generalise training cases can be 
constructed, and further analysed for accuracy when used to predict outcome in each 
separate data cohort. 
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1.9.4.1   Data Mining in Medicine 
 
The last decade has seen exponential increase in the use of data mining techniques in 
the field of medicine [226]. Initial studies into the use of artificial neural networks 
and medical purposes centred on the diagnosis of myocardial infarction[227]). 
Subsequent prospective studies have illustrated the ability of new networks to be 
able to outperform alternative computer packages statistical techniques and 
clinicians achieving sensitivities and specificity in excess of 95% [228]. Artificial 
neural networks have subsequently been both in the assessment of protein function 
[229, 230] used as supportive systems in the diagnosis of gastrointestinal bleeding, 
GORD [231], pancreatitis [232], obesity[233], pulmonary emboli[234], tuberculosis 
and cancer outcome. Within medical fields neural networks have further been 
utilised in imaging recognition[235], Cardiology [236, 237], Gastroenterology [238] 
Histopathology and cytology [239, 240]. The ability of neural networks at data 
recognition has also led to the development of their use in analysis of waveforms 
such as electrocardiograms, electromyograms and electro encephalograms. A further 
area within medicine that artificial neural networks have proven their worth is that of 
outcome prediction with the associated strengths and weaknesses of such 
practice[241]. The use of such techniques has been examined in many medical fields 
such as cardiac surgery [242-244], colorectal surgery [245, 246], anaesthesia [247] 
,breast cancer [248-251] and oncology [252] .  
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The use of logistical regression has since the early 1990’s been utilised in outcome 
prediction in a host of surgical specialities. Copeland’s initial work [253] , based on 
the weighting of input factors followed by logistical regression analysis has been 
modified, initially be Prytherch to formulate the P possum model [254] and 
subsequently by a number of surgical specialities [255, 256]. Whilst the validation of 
these scoring systems has been addressed in a number of studies it consistently over 
compensates for mortality and morbidity in numerous circumstances. 
 
Neural networks have been used in intensive care setting with cardiology patients to 
try and predict mortality in outcome. With the continued increase in delivery costs 
the state of rationing within the health system specifically with expensive services 
the ability of the physician to identify patients who would benefit most from 
treatment courses is important. This not only optimises outcome for individuals but 
equally reduces costs across the board and along with it wastage. 
 
The first use of artificial neural networks in the area of chest pain was in 1989 [257]. 
It analysed 174 patients with anterior chest pain using a multi-layered network and 
categorised them into one of three diagnostic groups, high-risk low risk and non-
cardiac. Another application utilised was based on a retrospective analysis of 356 
patients admitted to the cardiac ICU. 120 of these had myocardial infarctions and the 
network was trained utilising back propagation on half of the patients with and 
without myocardial infarctionss prior to being tested on the remainder of the patients 
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who had not been exposed. Sensitivity for this procedure was 92% and the 
specificity  96% [228] [258]. Prior to this study the most accurate computer aided 
method of diagnosing myocardial infarction was 88% sensitivity and 74% specificity 
[259] A further study was undertaken independently analysing two types of network, 
one maximum likelihood and the other a least squares method.. Sensitivity 
specificity and accuracy were in the region of 86 to 80%. Further prospective 
analysis of 320 patients presenting with acute chest pain compared the diagnostic 
accuracy of the physician with that of the neural network. This demonstrated the 
physician's accuracy of sensitivity 78% specificity 85% and the network had a 
sensitivity of 97% and specificity of 96% respectively [227]. 
  
Possibly the most well known commercially available medical use for neural 
networks it the Papnet cervical smear programme. [260] This network has the ability 
to constantly assess cells taken from the cervix and assess for signs of precancerous 
or cancerous change. This has the benefit of allowing greater numbers of smears to 
be assessed and, in conjunction with clinical lab staff assessment allows more 
accurate assessment than human assessment alone. As with most cancers this is 
important as the early detection of cervical cancer allows prompt treatment and 
results in an almost 100% chance of cure.  
Artificial Neural Networks have also been analysed in the prediction of cancer 
survival in both breast and colorectal cancer [245, 261]. In the case of colorectal 
cancer an improvement in predicting mortality was achieved with a neural network 
when compared to clinical estimation (90% vs. 79%). Similar work in breast cancer 
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using backpropogation proved a more accurate predictor of survival compared to 
clinical evaluation alone. 
Further studies have evaluated the potential of Artificial Neural Networks at making 
a correct diagnosis. Fraser et al used radial base function networks to diagnose 
myocardial infarction, achieving sensitivities of 85.7% and specificity of 86.1%, 
results suggesting that this technique can accurately be used in clinical diagnosis 
[262]. Another study from Sweden trained and assessed a Neural Net in assessing an 
MI by examining the ECG and compared the results with an experienced 
cardiologist. Results demonstrated that in all but the most obvious MI the neural 
network was better at identifying abnormalities than the cardiologist [263]. 
Chu et al have utilised ANN techniques in the creation of a system to aid in 
managing those who present with GI bleeding to hospital. Pre-determining a set of 
input criteria they proceeded to assess the ability of a range of data mining and ANN 
algorithms in obtaining the correct diagnosis. Their results showed that whilst most 
of the computer models were effective, the RandomForest, a form of decision tree 
model proved to be the most accurate. [264] . 
 
The above examples demonstrate that these ‘black box’ methods of data analysis are 
able to draw valid and accurate conclusions to clinical scenarios. What they also 
show is that the outcome is dependent on the data used to train the model and the 
data model itself. This was demonstrated most effectively by Chu, proving that 
whilst all of the algorithms were effective in prediction there was one that was more 
effective. Accepting the above points then means that it is necessary to carefully 
86 
 
collect data in the first instance, ensuring that you collate all variables that are 
deemed relevant to the outcome and then assess them in multiple data mining 
algorithms, a process facilitated with programmes such as WEKA [265]. 
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1.10 Summary of Introduction 
 
As explained in chapter one, the current technique for identifying those with 
colorectal cancer, the 2WW system, whilst providing a rapid access service only 
detects between 25 and 30 % of colorectal cancers, only 10 % of those seen via this 
pathway.  Many alternatives in modality of assessment once referred have been 
explored such as telephonic triage, straight to test or the ability of the GP to send 
straight to colonoscopy. Once again, these improvements show similar detection 
rates, even though they do reduce patient waiting time. The basis of the 2WW 
system is a set of high risk criteria, identified by a panel of experts to be the most 
accurate way of a primary care physician identifying someone at risk of colorectal 
cancer. Evidence shows that these criteria, whilst indicative of colorectal cancer are 
also found in a wide range of other benign conditions, which are more prevalent in 
the community. There has been evidence to show that the use of a weighted scoring 
system can assist in increasing the diagnosis of those with colorectal cancer but this 
as yet has not been widely accepted or put into practice. 
 
Data mining techniques are of benefit to medical practice and studies have shown 
that they can be accurate in both image assessment, prediction of survival and 
clinical diagnosis.  Utilisation of this technique has been shown to be of clinical use 
in acute GI bleeding, facilitating diagnosis and destination of referral. Current high 
risk patient selection uses information obtained via the GP. By its nature this is 
second hand upon reaching the hospital and, as shown in studies already mentioned, 
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variations in GP interpretation of patient symptoms exist. Using the above data 
mining techniques, in conjunction with a pre-formulated questionnaire to explore the 
potential of creating an algorithm that is more accurate than the current process in 
identification of those with colorectal cancer or polyps would be worthy of 
assessment. The benefits of a successful algorithm are not only more accurate patient 
identification but on a wider spectrum would reduce the number of unnecessary 
‘urgent’ appointments thus freeing up clinical staff to undertake alternative duties. 
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1.11 Hypothesis 
The use of data knowledge discovery databases within industry and other medical 
areas indicates that it has functional uses in the detection of patterns within datasets 
that are not visible via standard statistical techniques. This may prove to be 
beneficial in the detection of patients with colorectal cancer therefore the aims of this 
thesis will be to: 
 
1. Establish a prospective database of patient symptoms with basic 
demographic data and diagnostic outcome 
2. Assess the data for referral patterns, symptoms associated with 
adenocarcinoma and symptoms associated with polyps as well as 
distribution of diagnoses within the data. 
3. Construct a logistical regression model for the data, assessing the accuracy 
of fit 
4. Using ANN, experiment with the datasets and different outcome 
classifications to determine the optimum model for outcome classification, 
altering the hidden layers and units. 
5. Using DM techniques, model the data further to assess whether alternative 
methods provide a more optimal modelling technique for the data. 
6. Compare the above techniques with that of two primary care physicians and 
2 post CCT Colorectal surgeons. 
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2 Methods 
 
2.2 Prospective Data Collection 
The author (JC) gained approval from the local Ethics Committee and approval 
within the trust. All patients who were attending the ‘2ww’ outpatient clinics at 
Castle Hill Hospital over a 12 month period were identified and invited to participate 
in the completion of an internal symptom questionnaire (Appendix A). The 
questionnaire is a linkert based questionnaire that covers most of the common 
symptoms that are seen in patients with colorectal carcinoma as per 1.1.4 with the 
addition of further information. Data collection was facilitated with the assistance of 
the colorectal nurse specialists (JE and MB) who aided clinic attendees in the 
completion of the questionnaires where necessary. 
 
Only patients attending the ‘2ww’ clinics were included in this data collection as 
they were deemed to have fulfilled the current referral criteria for this route. The 
collected data was entered into an Access database (Microsoft, Seattle USA) and 
Excel spread sheet (Microsoft, Seattle USA).   
 
Those attending clinic were then investigated as per local practice via Colonosocpy, 
BE, CT or MRI to determine the cause of their symptoms before attending a surgical 
outpatient clinic for review by one of the Colorectal consultants (JEH, JG, JRTM, 
RB, KC) or one of their team. All investigation results were reported or undertaken 
by appropriately qualified medical personnel working for Hull and East Yorkshire 
NHS trust. The diagnosis made at this clinic was taken as the final diagnosis and was 
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retrieved and correlated with the completed questionnaire. Where available the 
Haemoglobin of the patient at time of referral was also recorded 
Once correlation of the questionnaire to the diagnosis was completed the data was 
anonymised by the author with each dataset given a unique reference number.   
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2.3 Referral pattern analysis 
 
In October 2006 the 2ww referral pathway for suspected lower GI cancers was 
changed to facilitate earlier diagnosis or discharge. This resulted in dedicated 2ww 
referral clinics led by the colorectal specialist nurses (JE, MB and MH). These 
clinics comprise of initial clinical assessment and examination followed by flexible 
sigmoidoscopy at this initial visit. Following initial assessment and flexible 
sigmoidoscopy further investigations were initiated as clinically indicated prior to 
the patietns being reviewed by a consultant with all results.  
Data collected from this study was analysed, looking at outcomes such as fulfilment 
of referral criteria, rates of anaemia, factors associated with polyps and factors 
associated with adenocarcinoma. 
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2.4 Data Cleaning  
 
All data from the 777 patients was included in the study. As stated in 2.1 data was 
anonymised with only basic demographic data being included. Data was coded in a 
binary fashion where it was dichotomous. The final diagnosis was coded into the 
following data sets: 
 
Table 2.1: Table demonstrating data sets and binary outcomes 
  
The categorising of outcome diagnosis was undertaken to increase the breadth of 
models to be assessed given the variation in diagnoses commonly seen in those 
referred via the 2ww pathway. The classification ‘Urgent’ included patients with 
Cancer, Polyps, and IBD. The classification Normal / Abnormal related to those with 
any pathology other than haemorrhoids, this group included those with conditions 
such as cancer, polyps, inflammatory bowel conditions and diverticular disease.. 
 
 
 1 0 
Cancer/NoCacer Cancer Not Caner 
CancerPolyp/ Not Cancer or Polyp Not Cancer or Polyp 
Urgent/NonUrgent Urgent Non urgent 
Normal/Abnormal Normal Abnormal 
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Further sets of data were created for model analysis by varying the number of input 
variables. Input variables were adjusted based on: 
 
1. All variables 
2. ‘2ww’ based variables 
3. Variables based on univariate analysis (V2T) 
4. Variables selected on clinical knowledge 
Each set of outcomes was then modelled with each set of input variables. 
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2.5 Neural Network Design 
 
All data sets were taken by the author (JC) and entered into Artificial Neural 
Network software (Alyula Neurointelligence. USA). A multi-layered feed forward 
network was selected for experimenting with back-propagation for error reduction 
and learning. Outcome target measures were set and data was processed within the 
software package ensuring that its format was compatible for further analysis.  
Experiments were then undertaken on each dataset to evaluate the optimal 
architecture of the ANN. This was performed by altering the number of hidden units 
and hidden layers. A maximum of 2 hidden layers were used in modelling with the 
number of hidden units varying according to the number of input variables. A 
logistic (Sigmoid) activation function was used in modelling with the 5 best models 
being assessed further. Data was divided into a test, validation and training set for 
analysis with outcomes being assessed for sensitivity, specificity and Risk.   
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2.6 Data Mining Methods 
 
Using WEKA explorer and experimenter (WEKA), data sets were converted by the 
author to the necessary .arff format. This software uses JAVA code and is available 
on a general user licence. It is a powerful piece of software allowing analysis of data 
models based on a number of different model classifiers, ranging from simple linear 
regression to complex decision trees.  
 
 All datasets were then run through the software using the following classifiers in the 
experimenter: 
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Table 2.2: WEKA Classifiers 
 
Key     
     
     
1 .ZeroR  28 Grading 
2 OneR  29 LogitBoost 
3 BayesNet  30 MultiBoostAB 
4 NaiveBayes  31 MultiClassClassifier 
5 NaiveBayesUpdateable  32 MultiScheme 
6 Logistic  33 ConjunctiveRule 
7 MultilayerPerceptron  34 DecisionTable 
8 RBFNetwork  35 DTNB 
9 SimpleLogistic  36 JRip 
10 SMO  37 NNge 
11 SPegasos  38 PART 
12 VotedPerceptron  39 Ridor 
13 ADTree  40 BFTree 
14 IB1  41 DecisionStump 
15 IBk  42 FT 
16 KStar  43 J48graft 
17 LWL  44 LADTree 
18 AdaBoostM1  45 LMT 
19 AttributeSelectedClassifier  46 NBTree 
20 Bagging  47 RandomForest 
21 ClassificationViaClustering  48 RandomTree 
22 ClassificationViaRegression  49 REPTree 
23 CVParameterSelection    
24 Dagging    
25 Decorate    
26 END    
27 FilteredClassifier    
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2.7 Analysis of Methods 
 
2.7.1 Comparison of Methods 
Outcome data from this analysis was compared using the t test for significant 
difference in outcome prediction, with the most accurate models being further 
assessed in the explorer GUI 
 
2.7.2 Comparison with specialists 
Data from 100 respondents in an anonymous form was provided to two independent 
practicing primary care physicians (GP1 and GP2) and two post CCT Colorectal 
surgeons (C1 and C2). All variables recorded were provided from the study 
questionnaires. The assessing GP’s and Colorectal Surgeons assessed the 
questionnaires and were invited to identify those likely to have colorectal cancer 
based on questionnaire data. The responses were collected by the author (JC) and 
compared to the optimal data mining model.  
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2.8 Statistical Analysis 
All statistical analysis was undertaken using either SPSS17 (SPSS inc, Chicago, Il) 
or the WEKA software by the author (JC). 
Univariate analysis was be performed on basic demographics using descriptive 
statistics and frequencies and 2x2 contingency tables for Chi squared analysis. 
Analysis of the variables with an outcome of Adenocarcinoma was undertaken using 
logistical regression analysis by the author using Hosmer and Lemenshow’s χ2, 
Nagelkerke’s χ2 and the Wald statistic for variable association with output. 
 
Graphical display of demographic data was performed illustrating distribution of Hb 
levels and the distribution of actual outcomes within the study population. Further 
graphical analysis of models was be performed with ROC curves. 
 
The sensitivity, specificity, PPV, NPV and LR of each model was calculated and 
tabulated where appropriate. 
 
Comparison of models was undertaken with t tests and chi squared analysis. All tests 
were undertaken with a p <0.05. 
 
 
 
 
 
101 
 
 
Results 
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3 Results 
 
3.2 Patients 
 
Data was collated over the 12 month study period from July 2007 to July 2008. A 
total of 1212 patients were referred via the 2ww pathway, 777 completed the 
questionnaire successfully. A further 100 samples were collected for testing of 
models independently. Analysis was undertaken assessing referral patterns, 
Symptoms commonly found in those with adenocarcinoma, symptoms commonly 
found in those with polyps and the role of anaemia in the identification of those with 
colorectal cancer. 
 
3.2.1 Univariate analysis 
 
Mean age  67 years Range 20-96 
Sex Distribution  57% Male  
 
Frequencies are demonstrated in Table 3.1  
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Table 3.1: Symptom frequency 
 Yes No 
PR Bleeding 382 (49%) 395 (51%) 
Dark Red 731 (64%) 46 (36%) 
Bright Red 440 (57%) 337 (43%) 
On Motion 690 (89%) 87 (11%) 
On Toilet Paper 458 (59%) 319 (41%) 
Mixed with stool 650 (84%) 127 (16%) 
More than once in 6 weeks 486 (63%) 291 (37%) 
Mucous PR 616 (80%) 161 (20%) 
Pus PR 769 (99%) 8 (1%) 
Alteration in Bowel Habit 240 (31%) 537 (69%) 
Change in 12 months 731 (94%) 46 (6%) 
Constipated 601 (77%) 176 (23%) 
Loose Stool 451 (58%) 326 (42%) 
Diarrhoea 559 (72%) 218 (28%) 
Straining at defecation 624 (80%) 153 (20%) 
Complete Evacuation 275 (35%) 502 (65%) 
Urgency 483 (62%) 294 (38%) 
Pain at defecation 681 (88%) 96  (12%) 
Incontinence 701 (90%) 76 (10%) 
Abdominal Pain 415 (53%) 362 (47%) 
Lethargy 544 (70%) 233 (30%) 
SOB at activity 666 (86%) 111 (14%) 
SOB on stairs 684 (88%) 93 (12%) 
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Change in Weight 548 (71%) 229 (29%) 
Loss of Weight 595 (77%) 182 (23%) 
Loose Clothing 680 (88%) 97 (12%) 
Increased Weight 739 (95%) 38 (5%) 
Increased Appetite 751 (97%) 26 (3%) 
Decreased Appetite 638 (82%) 139 (18%) 
Aspirin 700 (90%) 77 (10%) 
Painkillers 682 (88%) 95 (12%) 
Polyp 752 (97%) 25 (3%) 
Ca Colon 773 (99.5%) 4 (0.5%) 
Ca Elsewhere 754 (97%) 23 (3%) 
Family Polyp 759 (98%) 18 (2%) 
Family Ca Colon 704 (91%) 73 (9%) 
Family Ca Elsewhere 660 (85%) 117 (15%) 
Relative polyp 775 (99.7%) 2 (0.3%) 
Relative Ca Colon 729 (94%) 48 (6%) 
Relative Ca Elsewhere 730 (94% 47 (6%) 
Crohns / UC 766 (99%) 11 (1%) 
Family Hx IBD 752 (97%) 25 (3%) 
Smoker 611 (79%) 166 (21%) 
Ex Smoker 480 (62%) 297 (38%) 
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There was a significant association between lower GI adenocarcinoma and the 
following variables following χ2 : 
 
 
• Blood mixed with stool  χ2 = 13.1   p<0.01 
• Mucus PR   χ2=  5.2  p<0.05    
• Alteration in bowel habit  χ2= 15.59 p<0.01 
• Loose stools   χ2=  12.87 p<0.01 
• Abdominal pain  χ2= 10.8 p<0.01 
• Decreased weight  χ2= 5.1  p<0.05 
• Ex smoker   χ2= 4.79 p<0.05 
 
Table 3.2: Significant variables at Univariate analysis – used as V2T group for 
model analysis 
 
 
These variables were isolated into a single data set and assessed against all models. 
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3.2.2 Referral Patterns 
 
Using the Referral pathway (fig 3.1) as the optimal model the route of referral of 
each patient was examined to assess local compliance with referral guidance. 
 
From the 777 referred as 2ww patients 174 (24%) failed to meet the high risk referral 
criteria as published [139]. 
 
 
Figure 1: Diagram of referral pathways for those with lower GI symptoms  
 
 
 
Further analysis was performed on those who did fulfil the high risk criteria to assess 
the number who met each measurable criterion and determine the number of polyps 
and cancers identified within each of those groups (table 3.3) 
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Table 3.3: Table demonstrating frequency of Cancer / Polyps found based on 2WW 
referral statements. 
 
 Total 
number 
 number 
Rectal bleeding with a change in 
bowel habit to looser stools 
and/or increased frequency of 
defecation persisting for more 
than 6 weeks 
 
163 
Adenocarcinoma 16 
Polyp 18 
Change in bowel habit as above 
without rectal bleeding persisting 
for more than 6 weeks (over 60) 
 
123 
Adenocarcinoma 10 
Polyp 12 
Rectal bleeding without anal 
symptoms (over 60) 
 
286 
Adenocarcinoma 36 
Polyp 27 
Hb <11g/dl in men*  
54 
Adenocarcinoma 1 
Polyp 8 
Hb <10g/dl women* (post 
menopause) 
 
44 
Adenocarcinoma 5 
Polyp 4 
* Not all patients had recorded Hb 
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3.2.3 Symptoms associated with Adenocarcinoma 
 
The dataset of those patients with a diagnosis of Colorectal Adenocarcinoma was 
analysed to assess the frequency of symptoms associated with this diagnosis. A total 
of 74 Adenocarcinomas were diagnosed in the study, accounting for 9.5% of the 
group. This level is in keeping with the findings in other studies of the percentage of 
patients referred via the 2ww pathway who have an underlying adenocarcinoma. 
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Table 3.4: Frequency of symptoms in those with diagnosis of Adenocarcinoma  
 
 
Demographics (n=74) 
Mean age   
    
70 years   
(range 39-89) 
Males    
    
46          (62%) 
  
Rectal Bleeding 
    
50 (68%) 
 Bright Red 
        
35 (70%) 
 Dark Red 
        
15 (30%) 
  
Change in Bowel Habit
    
50 (68%) 
 Constipation 
        
17 (34%) 
 Diarrhoea 
        
16 (32%) 
 Loose stool 
        
17 (34%) 
  
Abdominal Pain 
   
35 (47%) 
Weight Loss  
    
28 (38%) 
Anaemic per guidelines
     
6(8%) 
NEITHER rectal bleeding 
NOR CIBH  
11 (15%) 
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Figure 2: Hb levels in those diagnosed with adenocarcinoma 
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3.2.4 Symptoms associated with polyps 
 
Table 3.5: Table demonstrating frequency of symptoms in those found to have 
colonic polyps  
 
Demographics (n=89)  
Mean age   67 years 
 (range 23-92) 
Males   
   
44 (50%) 
  
Rectal Bleeding  
   
51 (57%) 
Bright Red  
       
38 (43%) 
Dark Red  
       
5 (6%) 
  
Change in Bowel Habit  
  
56 (63%) 
Constipation  
       
20 (36%) 
            Diarrhoea  
       
18 (32%) 
Loose stool  
       
18 (32%) 
  
Abdominal Pain  
   
42 (47%) 
Weight Loss  
  
  
27 (19%) 
Anaemic per guidelines  
  
6 (7%) 
NEITHER rectal bleeding NOR 
CIBH  
11 (13%) 
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3.2.5 Disease Distribution within cohort 
 
 
Figure 3: Chart demonstrating frequency of diagnoses in those referred to 2ww 
clinic 
Graph showing distribution of diagnoses 
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Logistical Regression analysis 
 
Logistical regression is a statistical method modelling data with a dichotomous 
categorical outcome variable (i.e. binary) and input variables that are either 
continuous or categorical. It enables the transformation of the data using a 
logarithmic function thus creating the effect of a linear relationship that is necessary 
for regression modelling [266]. As illustrated in fig 3.4 the logistic regression 
equation is similar to a linear regression equation, but in logarithmic terms. 
 
Figure 4: logistic regression equation 
 
𝑃(𝑌) =  11 + 𝑒−(𝑏𝑜+𝑏1𝑋1+𝑏2𝑋2+⋯….𝑏𝑛𝑋𝑛+𝜀𝑖) 
 
Data was analysed using logistical regression and tested for accuracy of fit using 
Hosmer and Lemenshow’s Chi squared R2L and Nagelkerke’s R2N. The contribution 
in the model of each independent input variable was assessed with the Wald statistic. 
Modelling was undertaken using SPSS 17.0 using the Forced entry model [267] to 
reduce the influence from any random data variation therefore provide more 
replicable results 
Table 3.6: Table demonstrating accuracy of logistical regression model 
 
Chi Squared -2 Log likelihood 
Nagelkerke R 
Square 
Hosmer and 
Lemeshow Chi S 
116.54  45 df         Sig <0.01 372.179a .298 1.29. 8df.   Sig .829 
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Table 3.7: Table demonstrating weighting of each variable in logistical 
regression analysis 
 
 
 
Variables in the Equation 
  
B S.E. Wald df Sig. Exp(B) 
 Male(1) -.796 .299 7.080 1 .008 .451 
PRBleeding(1) -.489 .747 .428 1 .513 .613 
DarkRed(1) -1.395 .635 4.827 1 .028 .248 
BrightRed(1) -.143 .639 .050 1 .823 .867 
OnMotion(1) .488 .505 .936 1 .333 1.629 
ONToiletPaper(1) -.074 .453 .026 1 .871 .929 
Mixedwithstool(1) -1.278 .450 8.067 1 .005 .279 
Morethanoncein6weeks(1) .488 .440 1.230 1 .267 1.630 
MucousPR(1) -.594 .354 2.809 1 .094 .552 
PusPR(1) -3.685 1.385 7.077 1 .008 .025 
AlterationinBowelHabit(1) .026 .478 .003 1 .957 1.026 
Changein12months(1) .485 .739 .431 1 .512 1.625 
Constipated(1) .319 .534 .357 1 .550 1.376 
Loosestool(1) .093 .430 .047 1 .829 1.097 
Diarrhoea(1) .601 .387 2.408 1 .121 1.823 
Strainingatdefecation(1) -.330 .498 .440 1 .507 .719 
Completeevacuation(1) .405 .317 1.634 1 .201 1.499 
Urgency(1) .253 .370 .466 1 .495 1.288 
Painondefectation(1) 2.838 .883 10.335 1 .001 17.074 
incontinence(1) -.133 .546 .060 1 .807 .875 
abdominalpain(1) -.199 .312 .405 1 .525 .820 
lethargy(1) -.020 .383 .003 1 .959 .980 
SOBonactivities(1) -.221 .541 .167 1 .683 .802 
SOBonstairs(1) -.580 .579 1.001 1 .317 .560 
ChangeinWt(1) 1.314 1.110 1.403 1 .236 3.723 
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LossofWt(1) -2.563 1.109 5.337 1 .021 .077 
Looseclothing(1) -.035 .503 .005 1 .944 .965 
IncWt(1) -1.568 1.193 1.728 1 .189 .208 
AppetiteInc(1) .629 1.190 .280 1 .597 1.876 
AppetiteDec(1) .156 .422 .137 1 .711 1.169 
Aspirin(1) -.062 .538 .013 1 .909 .940 
Painkiller(1) .296 .520 .324 1 .569 1.344 
Polyp(1) 19.486 6616.913 .000 1 .998 2.901E8 
CAColon(1) 19.283 18982.887 .000 1 .999 2.369E8 
Cancerelsewhere(1) .481 1.151 .174 1 .676 1.617 
FamilyPolyp(1) -.480 1.175 .167 1 .683 .619 
FamilyCaColon(1) .906 .808 1.256 1 .262 2.474 
FamilyCaElsewhre(1) -.234 .458 .262 1 .609 .791 
RelativePolyp(1) 17.309 25782.017 .000 1 .999 3.291E7 
RelativeCaColon(1) 19.100 4854.938 .000 1 .997 1.973E8 
RelativeCaElsewhere(1) 1.297 .878 2.179 1 .140 3.657 
CrohnsUC(1) 18.317 10418.510 .000 1 .999 9.017E7 
FamilyHxIBD(1) .637 1.208 .278 1 .598 1.891 
Smoker(1) -.059 .372 .025 1 .874 .942 
ExSmoker(1) -.096 .322 .088 1 .766 .909 
Constant -93.212 34654.905 .000 1 .998 .000 
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3.3 Artificial Neural Networks 
 
For a detailed review of Artificial neural networks please refer to sections 1.3.2, a 
brief summary follows. Artificial Neural Networks (ANN) are computer based 
models that are able to model data by computing weights between variables and use 
internal algorithms to learn from  errors within the analysis thus improving 
efficiency. 
 
For these experiments a Multi-layered Feed forward network was selected with back 
propagation for error reduction. Alyuda Neurointelligence 2.2 software (Alyuda, 
California, USA) was used to assist the author in the design and testing of the 
different ANN models. This is an industrial software package, used by both the 
research community and multinational corporations such as Boeing and NASA. It is 
very versatile and, unlike other software or trial packages is able to analyse data sets 
with more than 200 cases. 
 
The number of hidden layers and units was varied per dataset. A maximum of two 
hidden layers was used in model selection to try and avoid any ‘over fitting’ of the 
data. An Exhaustive search pattern was employed when assessing models allowing 
exploration of all topologies within the defined number of layers and units. The 
number of hidden units within the model was varied depending on the number of 
input variables and a logistic activation function was used for data analysis with a 
cross entropy network error function. The accept level was >0.5 and reject level 
<0.5. Output data was binary and related to the defined values within the data set 
being assessed. 
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3.3.1 Comparison of networks 
 
Attributes were selected by the author as stated in table 3.2. Three of the four groups 
were based on best knowledge and the remaining attribute selection was based on 
Univariate analysis outcomes per section 3.1. 
 
 
Data was analysed using ANN software. Following reprocessing of the data multiple 
experiments were undertaken to assess the optimal design of the network. This 
involved the variation of hidden layers and nodes to find the optimal network design. 
A comprehensive record of outcomes from this process can be seen in appendix 1. 
The best performing network design was then trained, validated and tested on the 
data using 500 iterations with comparisons done between two different algorithms; 
Quick Propagation and Online back propagation. The same process was undertaken 
for all data sets for each outcome variation. Results of this analysis are documented 
below. 
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3.3.1.1   All Variables 
 
Using the 46 attributes related to the dataset assessment of different network designs 
was undertaken. Variation in the number of hidden units and layers was as below: 
 Hidden layers:  1-2 
 Hidden units:  
  Layer 1: 7 - 115 
  Layer 2: 4 - 76 
Network designs, covering all possible combinations of units and layers per each 
outcome measure were assessed and verified with the top 10 networks compared for 
sensitivity, specificity, PPV, NPV and LR as per tables 3.8-3.11 
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3.3.1.1.1  
 
Table 3.8: Top 10 neural networks and accuracy at modelling prediction for all 
variables against outcome Urgent / Not Urgent 
 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 46-98-1 BP .63 .86 .11 .98 4.8 
OBP .57 .86 .01 .98 4.3 
2 46-94-1 BP .88 .96 .79 .98 26.2 
OBP .44 .88 .23 .95 3.8 
3 46-93-1 BP .93 .96 .77 .99 24.6 
OBP .74 .88 .18 .98 6.1 
4 46-9-1 BP .76 .92 .52 .97 10.1 
OBP .8 .88 .18 .99 6.6 
5 46-10-1 BP .75 .87 .08 .99 5.6 
OBP .66 .87 .12 .98 5.2 
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3.3.1.1.2  
 
Table 3.9: Top 10 neural networks and accuracy at modelling prediction for all 
variables against outcome Normal / Abnormal 
 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 46-61-
4-1 
BP .65 .68 .75 .57 2.1 
OBP .56 .75 .93 .22 2.3 
2 46-72-
4-1 
BP .63 .66 .76 .51 1.9 
OBP .81 .72 .70 .82 2.9 
3 46-99-
4-1 
BP .64 .66 .73 .56 1.9 
OBP .89 .78 .79 .90 4.4 
4 46-70-
5-1 
BP .64 .68 .77 .53 2.1 
OBP .86 .68 .61 .89 2.7 
5 46-51-
5-1 
BP .63 .69 .79 .50 2.1 
OBP .89 .69 .63 .92 2.9 
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3.3.1.1.3  
 
Table 3.10: Top 10 neural networks and accuracy at modelling prediction for all 
variables against outcome Cancer / Not Cancer 
 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 46-70-1 BP .88 .94 .43 .99 16.5 
OBP .90 .96 .62 .99 24.3 
2 46-77-1 BP .89 .94 .48 .99 16.9 
OBP .85 .95 .55 .99 18.8 
3 46-89-1 BP .90 .97 .6 .99 35.9 
OBP .90 .96 .66 .99 26.2 
4 46-23-
2-1 
BP .5 .91 .14 .98 5.9 
OBP .88 .95 .59 .99 21.3 
5 46-45-
2-1 
BP .66 .94 .41 .97 11.1 
OBP .92 .93 .31 .99 13.5 
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3.3.1.1.4  
 
Table 3.11: Top 10 neural networks and accuracy at modelling prediction for all 
variables against outcome Cancer or Polyp / Not Cancer or polyp 
 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 46-61-
4-1 
BP .66 .82 .22 .96 3.7 
OBP .68 .92 .69 .91 8.2 
2 46-51-
5-1 
BP .71 .92 .71 .92 9.04 
OBP .58 .83 .34 .93 3.66 
3 46-99-
4-1 
BP .58 .83 .34 .93 3.66 
OBP X .77 0 1 x 
4 46-61-
5-1 
BP .62 .84 .34 .94 3.89 
OBP .77 .92 .71 .94 10.2 
5 46-7-1 BP .63 .80 .13 .98 3.2 
OBP .82 .89 .59 .96 7.9 
  X= Incalculable 
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3.3.1.2 2ww selected variables 
 
Using the 18 attributes related to the dataset assessment of different network designs 
was undertaken. Variation in the number of hidden units and layers was as below: 
 Hidden layers:  1-2 
 Hidden units:  
  Layer 1: 3-45 
  Layer 2: 2-36 
1548 network designs, covering all possible combinations of units and layers per 
each outcome measure were assessed and verified with the top 10 networks as per 
tables3.12-3.15 
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3.3.1.2.1  
 
Table 3.12: Top 10 neural networks and accuracy at modelling prediction for 2ww 
selected variables against outcome Urgent / Not Urgent 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 18-5-5-
1 
BP .42 .85 .02 .99 3.0 
OBP X .79 0 1 X 
2 18-43-1 BP X .85 0 1 X 
OBP .79 .87 .17 .99 6.5 
3 18-31-1 BP .66 .86 .04 .99 4.8 
OBP .78 .90 .40 .98 8.5 
4 18-30-1 BP .82 .90 .37 .98 8.6 
OBP .85 .87 .15 .99 6.8 
5 18-19-1 BP .53 .86 .07 .98 3.9 
OBP .87 .88 .24 .99 7.7 
  X= Incalculable 
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3.3.1.2.2  
 
Table 3.13: Top 10 neural networks and accuracy at modelling prediction for 2ww 
variables against outcome Normal / Abnormal 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 18-6-
15-1 
BP .75 .72 .74 .72 2.6 
OBP .58 .71 .87 .32 2.1 
2 18-6-
20-1 
BP .63 .69 .80 .40 2.1 
OBP .65 .66 .74 .56 1.9 
3 18-23-
23-1 
BP .65 .68 .75 .56 2.0 
OBP .59 .78 .92 .61 2.8 
4 18-32-
25-1 
BP .64 .67 .57 .55 1.9 
OBP .66 .72 .80 .55 2.3 
5 18-31-
29-1 
BP .64 .66 .74 .55 1.9 
OBP .57 .81 .95 .21 3.0 
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3.3.1.2.3  
 
Table 3.14: Top 10 neural networks and accuracy at modelling prediction for 2ww 
variables against outcome Cancer / Not Cancer 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 18-4-2-
1 
BP .35 .92 .23 .95 4.5 
OBP .33 .90 .02 .99 3.5 
2 18-30-
2-1 
BP .54 .92 .24 .97 7.2 
OBP .50 .90 .04 .99 5.4 
3 18-10-
4-1 
BP .70 .95 .51 .97 14.13 
OBP 0 .90 .0 .99 0 
4 18-17-
6-1 
BP .68 .93 .29 .98 9.8 
OBP 1 .90 .02 .1 10.7 
5 18-9-9-
1 
BP .55 .93 .40 .96 8.6 
OBP .66 .90 .05 .99 7.3 
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3.3.1.2.4   
 
Table 3.15: Top 10 neural networks and accuracy at modelling prediction for 2ww 
variables against outcome Cancer or polyp / Not Cancer or polyp 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 18-27-
5-1 
BP .73 .82 0.25 0.98 4.3 
OBP .67 .89 0.58 0.92 6.1 
2 18-32-
15-1 
BP .71 .83 0.28 0.97 4.3 
OBP X .78 0 1 x 
3 18-12-
20-1 
BP .67 .83 0.27 0.96 3.9 
OBP X .79 0 1 x 
4 18-43-
5-1 
BP .67 .83 0.29 0.96 4.0 
OBP .61 .91 0.67 0.88 6.7 
5 18-23-
6-1 
BP .69 .85 0.4 0.95 4.8 
OBP .68 .87 0.5 0.94 5.4 
  X= Incalculable 
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3.3.1.3    Selected variables through best knowledge 
 
Using the 22 attributes related to the dataset assessment of different network designs 
was undertaken. Variation in the number of hidden units and layers was as below: 
 Hidden layers:  1-2 
 Hidden units:  
  Layer 1: 3-55 
  Layer 2: 2-36 
1908 network designs, covering all possible combinations of units and layers per 
each outcome measure were assessed and verified with the top 10 networks as per 
tables 3.16 – 3.19 
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3.3.1.3.1  
 
Table 3.16: Top 10 neural networks and accuracy at modelling prediction for 2ww 
selected variables against outcome Urgent / Not Urgent 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 22-6-
31-1 
BP .66 .88 .21 .98 5.6 
OBP .82 .89 .28 .98 7.6 
2 22-42-
31-1 
BP .86 .98 .77 .98 23.5 
OBP .90 .93 .61 .98 16.8 
3 22-13-1 BP .75 .78 .16 .99 6.1 
OBP .90 .95 .69 .98 18.4 
4 22-48-
2-1 
BP .84 .88 .18 .99 7.1 
OBP .89 .90 .36 .99 9.3 
5 22-46-
4-1 
BP .88 .91 .42 .99 10.0 
OBP .90 .91 .43 .99 10.4 
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3.3.1.3.2  
 
Table 3.17: Top 10 neural networks and accuracy at modelling prediction for 2ww 
variables against outcome Normal / Abnormal 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 22-39-
9-1 
BP .87 .81 .82 .86 4.6 
OBP .85 .71 .68 .87 3.1 
2 22-28-
29-1 
BP .77 .78 .80 .74 3.5 
OBP .83 .77 .78 .83 3.7 
3 22-53-
10-1 
BP .86 .84 .85 .85 5.4 
OBP .71 .74 .79 .66 2.8 
4 22-3-
15-1 
BP .70 .68 .71 .66 2.1 
OBP .62 .67 .78 .48 1.9 
5 22-37-
19-1 
BP .70 .71 .76 .64 2.5 
OBP .88 .76 .74 .89 3.6 
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3.3.1.3.3  
 
Table 3.18: Top 10 neural networks and accuracy at modelling prediction for 2ww 
variables against outcome Cancer / Not Cancer 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 22-42-
2-1 
BP .61 .91 .10 .99 7.1 
OBP 1 .91 .12 1 11.8 
2 22-53-
2-1 
BP .88 .90 .72 .99 31.6 
OBP .81 .91 .12 .99 9.6 
3 22-32-
4-1 
BP .64 .91 .12 .99 7.5 
OBP .92 .96 .64 .99 25.7 
4 22-36-
4-1 
BP .87 .97 .74 .98 32.8 
OBP .87 .93 .37 .99 14.1 
5 22-44-
4-1 
BP .54 .91 .12 .98 6.1 
OBP 1 .92 .28 1 14.2 
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3.3.1.3.4  
 
Table 3.19: Top 10 neural networks and accuracy at modelling prediction for 2ww 
variables against outcome Cancer or polyp / Not Cancer or polyp 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 22-4-1 BP .68 .84 .33 .95 4.3 
OBP .29 .84 .58 .61 1.8 
2 22-28-
6-1 
BP X .78 0 1 X 
OBP X .78 0 1 X 
3 22-6-8-
1 
BP X .78 0 1 X 
OBP X .78 0 1 X 
4 22-8-6-
1 
BP X .78 0 1 X 
OBP X .78 0 1 X 
5 22-45-
12-1 
BP X .78 0 1 X 
OBP X .78 0 1 X 
  X= Incalculable 
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3.3.1.4 Univariate selected variables 
 
Using the 7 attributes, selected due to Univariate analysis the assessment of different 
network designs was undertaken. Variation in the number of hidden units and layers 
was as below: 
 Hidden layers:  1-2 
 Hidden units:  
  Layer 1: 1 - 18 
  Layer 2: 1 - 12 
234 network designs, covering all possible combinations of units and layers per each 
outcome measure were assessed and verified with the top 5 networks as per tables 
3.20-3.23 
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3.3.1.4.1  
 
Table 3.20: Top 10 neural networks and accuracy at modelling prediction for 
Univariate selected variables against outcome Urgent / Non Urgent 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 7-14-4-
1 
BP .65 .88 .23 .97 5.6 
OBP .72 .87 .11 .99 5.9 
2 7-4-6-1 BP .58 .87 .18 .97 4.6 
OBP 1 .85 .01 1 7.1 
3 7-15-8-
1 
BP .70 .91 .18 .99 8.1 
OBP 73 .86 .10 .99 5.5 
4 7-14-
11-1 
BP .60 .87 .16 .98 4.8 
OBP .77 .86 .60 .99 5.7 
5 7-12-
12-1 
BP .68 .86 .10 .99 5.2 
OBP .73 .86 .10 .99 5.5 
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3.3.1.4.2  
 
Table 3.21: Top 10 neural networks and accuracy at modelling prediction for 
Univariate selected variables against outcome Normal / Abnormal  
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 7-6-9-1 BP .62 .62 .70 .53 1.6 
OBP .57 .70 .88 .29 1.9 
2 7-10-
10-1 
BP .65 .60 .61 .63 1.6 
OBP .58 .70 .88 .60 1.9 
3 7-8-6-1 BP .62 .60 .55 .57 1.6 
OBP .58 .71 .88 .30 2.0 
4 7-15-
11-1 
BP .60 .59 .58 .50 1.4 
OBP .58 .70 .87 .32 1.9 
5 7-11-
12-1 
BP .60 .59 .68 .50 1.4 
OBP .58 .71 .89 .29 2.0 
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3.3.1.4.3  
 
Table 3.22: Top 10 neural networks and accuracy at modelling prediction for 
Univariate selected variables against outcome Cancer / Not Cancer  
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 7-1-1 BP X .90 0 1 X 
OBP X .90 0 1 X 
2 7-2-1 BP X .90 0 1 X 
OBP X .90 0 1 X 
3 7-3-1 BP X .90 0 1 X 
OBP X .90 0 1 X 
4 7-4-1 BP .33 .90 .01 .99 3.5 
OBP X .90 0 0 X 
5 7-5-1 BP X .90 0 0 X 
OBP X .90 0 0 X 
 X= Incalculable 
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3.3.1.4.4  
 
Table 3.23: Top 10 neural networks and accuracy at modelling prediction for 
Univariate selected variables against outcome Cancer or polyp / Not Cancer or polyp 
 
Order Design Method Sensitivity  Specificity  PPV NPV LR 
1 7-1-10-
1 
BP .52 .81 .23 .94 2.8 
OBP X .78 0 0 x 
2 7-9-1 BP .65 .81 .18 .97 3.5 
OBP .31 .86 .62 .63 2.3 
3 7-10-1 BP .74 .81 .15 .98 3.9 
OBP .24 .79 .22 .80 1.1 
4 7-11-1 BP .73 .81 .19 .98 4.0 
OBP X .78 0 1 X 
5 7-13-1 BP .71 .81 .19 .97 3.8 
OBP X .78 0 1 X 
  X= Incalculable 
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3.4 Data Mining 
 
Data mining was undertaken using the WEKA platform by the author (JC). Data was 
cleaned as per the method. Each experimental dataset was assessed using the 
experimenter function using the classifiers as listed in table 3.24. Each variation in 
dependent variables was analysed with each listed classifier to identify the optimal 
model for this data. Classifier outcomes were compared using t tests for significant 
differences in correctly predicting outcome against the baseline classifier (ZeroR). 
Detailed results of this analysis can be seen in tables 3.25-3.28. The top 5 classifiers 
were then assessed further, examining the sensitivity and specificity of the model at 
predicting the dependent variable when tested. Model comparisons are illustrated 
below in tables 3.29-3.32.  The numbers in the variables column relates to the name 
of the classifier used (listed in table 3.24). 
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Table 3.24: Table illustrating WEKA classifiers 
 
Key     
     
     
1 ZeroR  28 Grading 
2 OneR  29 LogitBoost 
3 BayesNet  30 MultiBoostAB 
4 NaiveBayes  31 MultiClassClassifier 
5 NaiveBayesUpdateable  32 MultiScheme 
6 Logistic  33 ConjunctiveRule 
7 MultilayerPerceptron  34 DecisionTable 
8 RBFNetwork  35 DTNB 
9 SimpleLogistic  36 JRip 
10 SMO  37 NNge 
11 SPegasos  38 PART 
12 VotedPerceptron  39 Ridor 
13 ADTree  40 BFTree 
14 IB1  41 DecisionStump 
15 IBk  42 FT 
16 KStar  43 J48graft 
17 LWL  44 LADTree 
18 AdaBoostM1  45 LMT 
19 AttributeSelectedClassifier  46 NBTree 
20 Bagging  47 RandomForest 
21 ClassificationViaClustering  48 RandomTree 
22 ClassificationViaRegression  49 REPTree 
23 CVParameterSelection    
24 Dagging    
25 Decorate    
26 END    
27 FilteredClassifier    
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Table 3.25: Table comparing accuracy of WEKA classifiers as predictors (1) 
 
Dataset V2T   2ww 
Outcome 
CA/ 
Polyp
/N 
Ca / 
No 
Ca 
Norm / 
Abnor 
Urgent 
/ Non 
Urgent 
  
CA/ 
Polyp/
N 
Ca / 
No 
Ca 
Norm / 
Abnor 
Urgent / 
Non 
Urgent 
1 78.6 90.5 52.3 85.7   78.6 90.5 52.2 85.7 
2 78.6 90.5 57.2 85.7   73.7 86.5 61.3 81.1 
3 78.6 90.5 52.1 85.7   76.4 88.9 56.4 84.4 
4 78.4 90.5 52.1 85.7   77.8 89.1 58.4 85 
5 78.4 90.5 59.3 86.1   77.8 89.1 58.4 85 
6 78.3 90.5 58.3 85.9   74.7 87.1 58.1 82.7 
7 77.4 89 58.4 85.9   75 87.3 55.8 82.6 
8 78.2 90.3 58.6 85.4   77.6 89.3 56.8 84.6 
9 78.2 90.5 58.2 85.7   78.4 90.2 61.2 85.6 
10 78.6 90.5 56.2 85.7   76.9 89.4 58.9 85.1 
11 78.6 90.5 57.1 85.7   76.9 89.4 58.9 85.1 
12 78.6 90.4 58.2 85.6   78.6 90.5 52.3 85.7 
13 78.7 90.3 59.3 85.8   79.2 90.3 61 85.7 
14 69.7 83.4 54.5 77.5   69.7 87.2 51.3 79.7 
15 77.1 88.5 58.2 84.8   69.3 86.8 51.7 79.5 
16 78.5 90.4 58.1 85.3   73.5 88.9 55.6 82.6 
17 78.6 90.5 58.8 85.7   78.6 90.5 61.4 85.7 
18 78.7 90.5 58.6 85.9   78.6 90.5 62.5 85.5 
19 78 90.4 57.9 85.7   78.6 90.5 60.2 85.7 
20 78.3 90.4 57.9 85.7   76.7 90.3 54.6 85.4 
21 58 62.7 52.5 60.8   55.5 53.4 50.3 54.5 
22 78.6 90.5 58.2 85.5   75.2 88.3 57.3 83.4 
23 78.6 90.5 52.3 85.7   78.6 90.5 52.3 85.7 
24 78.7 90.5 58.8 85.7   78.8 90.3 59.8 85.4 
 
 = Statistically worse at the 0.05 
level compared to ZeroR 
 = Statistically better at the 
0.05 level compared to ZeroR 
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Table 3.26: Table comparing accuracy of WEKA classifiers as predictors (2) 
 
 Dataset V2T   2ww 
Outcome 
CA/ 
Polyp
/N 
Ca / 
No 
Ca 
Norm / 
Abnor 
Urgent 
/ Non 
Urgent 
  
CA/ 
Polyp
/N 
Ca / 
No 
Ca 
Norm / 
Abnor 
Urgent / 
Non 
Urgent 
26 77.4 90.5 56.7 85   78.2 90.5 60.4 85.7 
27 78.6 90.5 52.1 85.7   78.6 90.5 61.5 85.7 
28 78.6 90.5 52.3 85.7   78.6 90.5 52.3 85.7 
29 78.4 90.5 58.6 86   77.9 90.2 62.1 84.9 
30 78.6 90.5 56.3 85.7   78.6 90.5 61.2 85.7 
31 78.3 90.5 58.3 85.9   74.7 87.1 58.1 82.7 
32 78.6 90.5 52.3 85.7   78.6 90.5 52.3 85.7 
33 78.6 90.5 52.8 85.7   78.6 90.5 60.4 85.7 
34 78.6 90.5 56.9 85.6   78.1 90.5 61.2 85.7 
35 78.9 90.5 58.4 85.6   78 90.4 63 84.8 
36 77.9 90.5 58.4 85.3   78.7 89.6 61.4 84.5 
37 68.3 82.7 52.1 77   80.1 84.1 52.2 78.9 
38 77.3 89.8 59.1 85.7   73.1 88.9 55.8 83 
39 78.2 90.3 57.9 85.5   79.2 90.1 58.8 85.2 
40 77.7 90.4 57.8 85.2   78.6 90.5 54.8 85.5 
41 78.6 90.5 52.9 85.7   78.6 90.5 61.5 85.7 
42 77.7 90.5 59.9 86.3   73 87.1 55.6 80.3 
43 77.4 90.5 56.7 85   78.3 90.5 60.4 85.7 
44 78.4 90 59.5 85.8   78.3 88.8 60.8 84.6 
45 78.2 90.5 57.6 85.4   78.1 90.1 61.1 85.6 
46 78.6 90.5 56.6 85.7   77.7 89.8 57.3 85.1 
47 77.3 88.8 58.3 85.1   75.4 89.6 53.9 84.2 
48 76.6 88 58.1 84.4   69.8 86.5 52.1 78.5 
49 78 90.4 57.9 85.5   78.4 90.4 51.8 85.7 
 
 = Statistically worse at the 0.05 
level compared to ZeroR 
 = Statistically better at the 
0.05 level compared to ZeroR 
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Table 3.27: Table comparing accuracy of WEKA classifiers as predictors (3) 
 
Dataset Best Knowledge    
All 
Outcome 
CA/ 
Polyp
/N 
Ca / 
No 
Ca 
Norm / 
Abnor 
Urgent 
/ Non 
Urgent 
  
CA/ 
Polyp
/N 
Ca / 
No 
Ca 
Norm / 
Abnor 
Urgent / 
Non 
Urgent 
1 78.6 90.5 52.3 85.7   78.6 90.5 52.3 85.7 
2 73.7 86.5 61.3 81.1   73.8 86.5 61.3 81.1 
3 76.4 88.5 56.4 84.5   76.4 88.5 56.4 84.5 
4 76.9 90.8 58.9 85.1   75.1 90.7 57.4 85.5 
5 76.9 90.8 58.9 85.1   75.4 90.7 57.4 85.5 
6 74.9 87.5 57.7 82.7   73.3 85.4 57.4 81.8 
7 74.7 87.5 56.1 81.8   74.1 87.7 57.6 81.8 
8 77.5 90.3 58.4 85.4   77.9 90.5 52.3 85.6 
9 78.4 90.4 61.4 86.5   78.3 90.6 61.4 86.5 
10 77.3 90.2 59.7 86.1   76.3 89.5 59.4 84.8 
11 76.9 88.3 58.1 83.8   74.4 87.6 57.8 81.9 
12 78.6 90.5 52.2 85.7   78.6 90.5 52.3 85.7 
13 79 90.1 62.6 86.1   78.5 90.2 62.2 86.3 
14 72.1 88.3 56.1 80.7   72.1 86.7 56.6 81.3 
15 71.9 88.1 56.2 80.5   71.9 86.7 56.1 81.3 
16 76.9 89.1 59.2 82.6   74.5 88.5 56.3 83.2 
17 78.6 90.5 61.2 85.7   78.6 90.5 61.1 85.7 
18 79.2 90.5 62.4 85.6   79.2 90.5 62.3 85.5 
19 78.6 90.5 60.2 85.7   78.6 90.5 60.1 85.7 
20 76.6 90.3 54 85.3   76.8 90.3 53.1 85.2 
21 54 51.5 49.1 52.9   56.2 56.4 49.4 56.8 
22 75.8 87.8 58.1 83.8   75.9 88.1 57.1 83.5 
23 78.6 90.5 52.3 85.7   78.6 90.5 52.3 85.7 
24 79.1 90.6 60.6 86.3   77.8 90.8 59.7 86.1 
 
 = Statistically worse at the 0.05 
level compared to ZeroR 
 = Statistically better at the 
0.05 level compared to ZeroR 
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Table 3.28: Table comparing accuracy of WEKA classifiers as predictors (4) 
 
 Data
set Best Knowledge   All 
Outc
ome 
CA/ 
Polyp
/N 
Ca / 
No 
Ca 
Norm / 
Abnor 
Urgent 
/ Non 
Urgent 
  
CA/ 
Polyp
/N 
Ca / 
No 
Ca 
Norm / 
Abnor 
Urgent / 
Non Urgent 
26 78.2 90.5 60.4 85.6   78.4 90.7 59.8 85.5 
27 78.6 90.5 61.5 85.7   78.6 90.5 61.5 85.7 
28 78.6 90.5 52.3 85.7   78.6 90.5 52.2 85.7 
29 78.4 90.8 64.1 86.3   78.1 90.8 61.6 86.3 
30 78.6 90.5 61.2 85.7   78.6 90.5 61.1 85.7 
31 74.9 87.5 57.7 82.7   73.3 85.4 57.3 81.8 
32 45.3 60.5 52.3 85.7   78.6 90.5 52.3 85.7 
33 78.6 90.5 60.4 85.7   78.6 90.5 60.2 85.7 
34 78.2 90.4 61.1 85.8   78.1 90.4 60.8 85.8 
35 78.1 90.1 63.5 83.3   78 90 62.9 82.5 
36 78.8 90.6 63.2 84.5   78.3 90.6 62.1 84.6 
37 70.7 84.3 51.6 79.1   71.1 84.5 51.9 79.2 
38 70.9 89.3 54.2 82.4   70.5 88.5 54.2 81.8 
39 78.6 90.4 55.4 85.4   78.6 90.7 59.5 85.4 
40 78.6 90.5 61.5 85.7   78.6 90.4 55 85.6 
41 78.6 90.5 61.5 85.7   78.6 90.5 61.5 85.7 
42 73.1 87.1 55.8 81.4   70.1 87.6 56.7 80.8 
43 78.3 90.7 60.3 85.6   78.1 90.9 59.8 85.6 
44 78.4 88.9 62.1 84.6   77.5 88.9 61.7 84.3 
45 78.2 90.6 61.6 86.4   78.3 90.7 61.5 86.4 
46 77.4 90.7 56.9 85.1   76.5 90.7 57.1 85.2 
47 76.5 90.1 54.9 84.8   77.1 90.4 55.2 85.3 
48 71.2 86.9 54.4 80.1   70.7 85.3 53.5 78.2 
49 78.5 90.4 51.5 85.7   78.4 90.4 51.3 85.7 
 
 = Statistically worse at the 
0.05 level compared to ZeroR 
 = Statistically better at the 0.05 
level compared to ZeroR 
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3.4.1 Model comparison 
 
3.4.1.1   
 
Table 3.29: Top 5 WEKA models demonstrating predictive accuracy for data 
outcome Cancer / No Cancer. 
 
 Variables % CC Sensitivity  Specificity  PPV NPV LR 
1 All 42 88.4 .34 .92 .23 .95 4.3 
2 All 25 90.86 .62 .91 .11 .99 7.1 
3 All 24 90.34 .45 .90 .06 .99 5.0 
4 Jc 4 89.6 .18 .91 .03 .98 1.9 
5 Jc 5 89.7 .42 .92 .22 .97 5.4 
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3.4.1.2   
 
Table 3.30: Top 5 WEKA models demonstrating predictive accuracy for data 
outcome Cancer or polyp / No Cancer or polyp. 
 
Outcome 
B 
Variables % 
CC 
Sensitivity  Specificity PPV NPV LR 
1 2ww 37 72.4 .33 .81 .29 .74 1.8 
2 2ww 13 79.8 .60 .81 .17 .96 3.1 
3 Jc 18 79.2 .65 .79 .07 .99 3.1 
4 All 18 78.9 .63 .79 .03 .99 2.9 
5 Jc 24 79.1 .58 .80 .09 .98 2.8 
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3.4.1.3   
 
Table 3.31: Top 5 WEKA models demonstrating predictive accuracy for data 
outcome Urgent / Not Urgent 
 
 
Outcome 
C 
Variables % 
CC 
Sensitivity  Specificity  PPV NPV LR 
1 Jc 9 86.4 .62 .91 .12 .99 6.7 
2 All 45 86.5 .67 .87 .10 .99 5.1 
3 All 29 86.4 .61 .87 .13 .99 4.7 
4 All 13 85.0 .42 .87 .14 .97 3.3 
5 V2T 42 86.0 .55 .87 .15 .98 4.4 
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3.4.1.4   
 
Table 3.32: Top 5 WEKA models demonstrating predictive accuracy for data 
outcome Normal / Abnormal 
 
Outcome 
D 
Variables % 
CC 
Sensitivity  Specificity  PPV NPV LR 
1 Jc 29 63.1 .63 .63 .371 .54 1.7 
2 Jc 35 62.4 .62 .62 .72 .52 1.7 
3 Jc 36 62.6 .63 .62 .69 .55 1.6 
4 2ww 18 61.2 .60 .63 .76 .45 1.6 
5 Jc 13 61.9 .62 .61 .69 .51 1.6 
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3.4.2 Assessment of ‘best fit’ 
 
The top 5 overall models in predicting outcome for each data set are illustrated 
below.  
 
3.4.2.1   
 
Table 3.33: Best performing KDD models for Cancer / Not Cancer 
 
 Model Topology Sensitivity Specificity LR 
1 ANN with all 
variables  
46-89-1 BP .90 .97 35.8 
2  ANN with best 
knowledge 
selected variables 
22-36-4-1 BP .87 .97 32.8 
3 ANN with best 
knowledge 
selected variables 
22-53-2-1 BP .88 .97 31.6 
4 ANN with all 
variables 
46-89-1 OBP .90 .96 26.2 
5 ANN with best 
knowledge 
selected variables 
22-32-4-1 OBP .92 .96 25.7 
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3.4.2.2    
Table 3.34:  Best performing KDD models for Cancer or polyp / Not Cancer or 
polyp 
 
 Variables Model Sensitivity Specificity LR 
1 ANN with all 
variables 
46-61-5-1 BP .77 .92 10.2 
2 ANN with all 
variables 
46-51-5-1 BP .71 .92 9.04 
3 ANN with all 
variables 
46-61-4-1 OBP .68 .91 8.2 
4 ANN with all 
variables 
46-7-1 OBP .82 .89 7.9 
5 ANN with 2ww 
selected variables 
18-43-5-1 OBP .61 .90 6.7 
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3.4.2.3   
Table 3.35: Best performing KDD models for Urgent / Non Urgent 
 
 
 Variables Model Sensitivity Specificity LR 
1 ANN with all 
variables 
46-94-1 BP .88 .96 26.2 
2 ANN with all 
variables 
16-93-1 BP .93 .96 24.6 
3 ANN with best 
knowledge 
selected variables 
22-42-31-1 BP .86 .96 23.5 
4 ANN with best 
knowledge 
selected variables 
22-13-1 OBP .90 .95 18.4 
5 ANN with best 
knowledge 
selected variables 
22-42-31-1 
OBP 
.90 .93 14.8 
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3.4.2.4   
 
Table 3.36: Best performing KDD models for outcome Normal / Abnormal 
 
 
 Variables  Model  Sensitivity Specificity LR 
1 ANN with best 
knowledge 
selected variables 
22-53-10-1 BP .86 .84 5.4 
2 ANN with best 
knowledge 
selected variables 
22-39-9-1 BP .86 .81 4.6 
3 ANN with all 
variables 
46-99-4-1 OBP .89 .79 4.4 
4 ANN with best 
knowledge 
selected variables 
22-28-29-1 
OBP 
.83 .77 3.7 
5 ANN with best 
knowledge 
selected variables 
22-37-19-1 
OBP 
.88 .76 3.6 
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3.5 Specialist comparison 
 
100 independent datasets were provided to two GP partners (GP1 + 2) and two 
post CCT hospital specialists in Colorectal Surgery (Sp1 + 2) for assessment. The 
information provided was per patient response to questionnaires thus the same level 
of detail as the KDD models received. The requested outcome for this analysis was 
simply Adenocarcinoma or Not Adenocarcinoma. No further information was 
provided to the assessors. The age and sex distribution within this cohort was similar 
to the main group, mean age was 66 years (range 23-90) and number of males within 
cohort was 48 (48%).    
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Figure 5: ROC curve comparing accuracy of GP’s with Colorectal Specialists at 
predicting outcome
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Table 3.37: Table demonstrating accuracy of clinicians in identifying those with 
lower GI cancer from questionnaire data 
 
 
Specialist % 
Correct 
Sensitivity Specificity 95% 
CI 
PPV NPV LR 
Gp1 62 0.12 0.95 .42-.83 .63 .62 2.5 
Gp2 68 0.15 0.95 .53-.90 .63 .68 3.2 
Sp1 81 0.26 0.97 .60-.96 .75 .82 10.0 
Sp2 82 0.27 0.97 .60-.97 .75 .83 10.6 
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3.5.1 Comparison of Clinicians with Models 
 
Assessment of the models against the specialists was performed using the same data 
that had been provided to the Clinical assessors. As the clinical assessment had been 
to solely predict the presence of a lower GI cancer the only dataset assessed was Set 
A (outcome Cancer / Not Cancer). 
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Table 3.38: Comparison of all clinicians and the top 5 KDD models 
 
 
Specialist % 
Correct 
Sensitivity Specificity 95% 
CI 
PPV NPV LR 
Gp1 62 0.12 0.95 .42-
.83 
.63 .62 2.5 
Gp2 68 0.15 0.95 .53-
.90 
.63 .68 3.2 
Sp1 81 0.26 0.97 .60-
.96 
.75 .82 10.0 
Sp2 82 0.27 0.97 .60-
.97 
.75 .83 10.6 
Model 1 93 0.55 .97 .58-
.99 
.62 .95 16.8 
Model 2 93 0.13 1 .34-
.79 
1 .92 X 
Model 3 93 0.13 1 .34-
.79 
1 .92 X 
Model 4 94 .43 .98 .44-
.91 
.6 .95 19.9 
Model 5 95 .63 .98 .58-
1 
.71 .96 28.7 
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Figure 6: ROC curve comparing top 5 KDD models and clinicians at accuracy of 
prediction 
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Discussion 
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4 Discussion  
 
4.1 Assessment of Referral patterns 
 
This thesis has confirmed that the proportion of patients referred via the 2ww 
pathway with colorectal cancer is approximately 10%. Univariate analysis using Chi 
Squared showed blood mixed with stool, mucus pr, alteration in bowel habit, loose 
stools, abdominal pain, decreased weight and ex-smoker to be significantly 
associated with colorectal adenocarcinoma (p<0.05) which are all symptoms that 
would clinically be associated with an increased suspicion of colorectal malignancy. 
Previous studies have shown abdominal pain, change in bowel habit and occult 
blood in the stool to be the most common presenting symptoms in colorectal cancer 
[268]. Rectal bleeding has been found to be present in up to 25% of cases of colon 
cancer [269] [270] with variation in quantity and colour. 5 demonstrated an 
incidence of 17.5% of colorectal adenocarcinoma in a series of patients 50 years old 
and younger.  
 
In total 164 patients (21%) of those in this cohort failed to meet any of the 2ww 
criteria as defined for urgent colorectal assessment. This is a significant number of 
individuals being assessed on an urgent basis with the associated utilisation of 
resources, not only clinical but radiological and managerial resources to ensure that 
the 31/62 breech date timeline is complied with. Similar percentages have been 
found in other studies evaluating the success of the 2 week wait process, Leung et al 
found 15% of referrals over a 12 month period in the West midlands to fail to meet 
referral criteria [271] and Smith et al found 49.6% of referrals to their colorectal 
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practice failed to conform to the guidelines[272]. Similar service evaluations in 
Cambridge  [160]  found 27% of 2WW referrals failed to meet the criteria, however 
of those with colorectal adenocarcinoma only 8% failed to meet the criteria. 
 
The use of anaemia as an accurate surrogate for lower GI cancer appears, certainly in 
this study to be a poor prognostic indicator. Only 8% of those with a colorectal 
malignancy were found to be anaemic per the current guidelines. Whilst it may be an 
important factor to consider it does not appear to be an accurate prognostic indicator 
in identifying those with a lower GI malignancy. Gastrointestinal blood loss remains 
the most common cause of iron deficiency anaemia in men and postmenopausal 
women with 5-10% attributed to colonic carcinoma [79] [273] [274] [275] [276] with 
numerous other pathologies identified on endoscopic evaluation. 
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4.2 Reflection of KDD methods 
 
The use of data mining software such as WEKA provides the user with a powerful 
tool in the search for patterns within the data set. This can be explored with an array 
of different classifiers which incorporate methods of attribute selection. Whilst it 
may seem logical that a data mining classifier such as a decision tree would be useful 
in determining a pathway for the identification of those with a lower GI 
adenocarcinoma they did not perform well within this cohort. It is possible that the 
data was too ‘noisy’ for the machine learning tools to define an accurate model for 
prediction or that there were insufficient actual cases of lower GI cancer within the 
cohort for these classifiers to make an accurate prediction. Previous studies 
comparing decision trees with ANN and logistical regression for diagnosing gastro-
oesophageal reflux also found the performance of decision trees to be inferior to 
ANN although they failed to hypothesise as to reasons for this[231].    
 
Whilst the classifiers used within this study are all suitable for the data as it was 
presented to the e software, it may be that an alternative method of attribute selection 
or an alternative scale for the data would have improved the model performance but 
within the e confines of this work these potentially infinite transformations were not 
explored further.  
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4.3 Reflection on ANN techniques 
 
Artificial Neural networks have been used in a number of fields of medicine with 
generally positive results and the outcome of this study correlates with this. The 
variability in the design of the networks made them very adaptive to the data cohort 
with the various combinations of hidden units and layers. Specific to colorectal 
cancer work has been done to assess the validity of outcome prediction for those 
with colorectal cancer based on pre, peri- and post-operative factors including 
histological staging[245]. This demonstrated a higher predictive accuracy with 
neural networks for both death and survival when compared to the prediction of 
clinicians. Similar studies have been performed using variants of Neural Networks 
such as the partial Logistic neural network (PLANN) [246] which allowed the 
creation of a web based survival prediction environment with the option of multiple 
online users. 
 
The input data obtained from the patient questionnaires is quite complex in relation 
to the diagnosis related to the symptoms of the patients. While it appeared that the 
WEKA classifiers did not manage to find clarity within this a number of the neural 
networks evaluated managed to predict outcome to a high standard. The neural 
network performance was of a high standard and accuracy with a larger number of 
attributes for selection when compared with models containing fewer attributes.  
Whilst it is generally accepted that 10 times as many datasets are required as 
attributes, something that this study complied with it is plausible that had the dataset 
contained more patient episodes then model refinement could have been furthered. 
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4.4 Reflection on comparison model 
 
The kind participation of two GP partners and colorectal consultants and their 
assessment of the test cases allowed the top performing models to be assessed with a 
‘virgin’ set of data. When comparing the clinicians and GP’s it was interesting to see 
the correlation in predictive accuracy between the clinical specialists, something that 
makes logical sense and is appropriate for their area of expertise.  
 
One major drawback of this assessment of acumen is the lack of realism; primarily 
that an error in this model does not relate to a negative outcome in a patient.  It is not 
realistic to suggest that such specificity would be a positive clinical attribute 
therefore the clinical index of suspicion that would instigate further appropriate tests 
is likely a lot lower than predicting the likelihood of a lower GI malignancy. In 
addition to this it is not only lower GI malignancy that is an important clinical 
finding; the majority of the other diagnoses seen within the cohort are in need of 
diagnosis and in some cases treatment. 
 
Overall in the comparisons between the Neural network models, GP’s and clinicians 
it was interesting to see just how accurate the Neural networks were in their levels of 
prediction. All of the neural networks performed better than their human 
counterparts in terms of percentage correct, sensitivity and specificity, PPV and 
NPV.  This consistent level of performance may make the use of neural networks 
feasible as a screening tool in determining which patients should be ‘fast tracked’ 
and which should be seen on a slightly less urgent basis therefore not focusing 
resources inappropriately. 
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4.5 Overall assessment of Study 
 
The study was able to compare a variety of KDD methods in the search for the most 
accurate model in terms of predicting the diagnosis of those referred as a 2ww 
patient. All of the models were based on the accuracy of the data provided in the 
patient’s response to the questionnaires. While this information was transformed into 
a binary response it cannot be ignored that ‘change in bowel habit’ for example can 
mean one thing to one person and something completely different to another. 
Notwithstanding this fact, this is the same sort of clinical information that is 
provided by the patient to either their GP or Hospital specialist therefore remains the 
foundation for the basis of further clinical investigation.  
 
Within the literature there are a few studies that have assessed prediction of 
colorectal cancer utilising both patient consultation questionnaires with scoring 
systems [169] and a smaller study from our unit that assessed the predictive capacity 
of neural networks for colorectal cancer found them to be of a higher predictive 
accuracy to clinicians although the training and validation sets were small compared 
to the number of variables assessed [277]. This study has corroborated the accuracy 
of neural networks at predicting those to be found with a colorectal malignancy 
compared to both alternative KDD classification methods and clinicians. This has 
been undertaken using robust methods of development, both of the neural networks 
and all appropriate KDD classifiers. 
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In terms of model development, a cohort of patient and their responses who all have 
a lower GI malignancy may have improved the accuracy of some of the KDD 
classifier models but it would not have been consistent with the environment that the 
model would be used in.  
 
The use of alternative outcome measures in the model design process was an 
important part of the development. As already alluded to there is a large amount of 
pathology within patients referred via the 2ww pathway despite the main diagnosis 
only being found in 10% of  cases. The ability to identify patients with a number of 
conditions and assess them on an urgent basis may be beneficial, not only in this 
dataset but in general for all patients referred from primary to secondary care. The 
best neural network model assessing outcome as Urgent / Non urgent had a 
sensitivity of 0.88 and specificity of 0.96. Once again the performance of the model 
deteriorated as the number of attributes used in its development was reduced. 
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4.6 Justification of methods 
 
4.6.1   
The 2ww referral pathway is the foundation for most urgent referrals from primary 
care with lower GI symptoms [139]. It was conceived in 2002 based on levels of 
evidence available at the time. These levels ranged between B (Fairly strong 
evidence) and D (Weak evidence) however there have been a number of subsequent 
studies undertaken to assess the accuracy of this referral pathway, all showing a 
similar low detection rate for colorectal cancer [162, 278-280]. 
 
Predictive accuracy is dependent on three primary components: 
1. Predictive power of prognostic variables 
2. Amount and quality of the data 
3. Ability of method to capitalise on the prognostic indicators 
These components require careful consideration prior to the conception of any 
predictive modelling task as they determine the suitable coding of variables, the 
collation of data, selection of models and based on the models how to measure 
model success. Within this study the majority of variables were Boolean in coding 
thus there was no requirement to collapse data into pre-determined categories as is 
commonly encountered. 
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Traditional statistical techniques for analysis of categorical data include logistical 
regression which makes linear assumptions between input variables and outcome. 
Such methods utilise the following function: 
𝐺 = 𝑏 + 𝑥1 + 𝑥2 𝑒𝑡𝑐 
The result of this function is then used to predict survival within this model.  
 
Alternative methods in KDD include data mining methods have been established for 
many years and have been used in a wide variety of situations [281] [282-284]. They 
incorporate many techniques, including ANN and decision trees in the process of 
exploring data. They have the benefit of active learning from the input data and 
allow large data sets to be analysed to find a model that best fits the ‘problem’ 
 
Medical problems are invariably complex and such tools have been used in various 
medical fields to improve rates of detection / prediction. Whilst there remains a 
conceptual issue with these methods when taken in conjunction with traditional 
statistical techniques they do enable the multidimensionality of the data to be 
assessed and thus may provide answers to complex problems that would not be 
available by more standard methods 
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4.6.2 Advantages of Data Mining Techniques 
 
Predictive modelling within medicine is more commonly based on regression 
analysis, a more traditional statistical technique therefore, as outcome measures are 
categorical, binary logistical regression is frequently used. Whilst this method of 
modelling is widely accepted and can be performed with relative ease on numerous 
software packages, with statistical theory to validate the model fit, they depend on a 
linear relationship between input variables and outcome.  
 
Data mining techniques differ in these assumptions and theoretically should offer 
advantages in complex modelling when compared to statistical approaches. They 
presume nonlinear relationships between variables and allow relationships between 
units to be arbitrary therefore permit the discovery of ‘rules’ that may not be 
apparent with more traditional methods. It is this ability of the KDD process that 
makes the technique worthy of assessment when modelling complex clinical 
outcomes.  
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4.6.3 Limitations of Data Mining techniques 
 
The primary limitation with data mining techniques is the apparent lack of 
transparency within the model. It is conceptually difficult to gain insight into how 
the model uses the input data to derive an output value. Certain methods are less 
obscure than others, decision trees for example allowing a schematic flow diagram to 
illustrate the data pathway. Others however have a ‘black box’ approach, such as 
ANN whereby unless the user undertakes feature extraction, a complex and time 
consuming approach to deriving the intricacies of the model, the method used to 
apply weights to attributes remains unknown. This conceptual lack of clarity is likely 
the main reason for hesitancy in the use of these methods more frequently. 
As with statistical methods the risk of ‘over fit’ is present in data mining 
methodology. There are a number of techniques that are used to avoid over fitting 
data to the model  such as cross validation, bootstrapping and data splitting [217, 
219, 285]. It is recognised and accepted that to accurately assess the predictive 
performance of the model a data set that was not part of the model-building process 
must be used. This, as is similar in regression analysis makes modelling small 
datasets difficult as over fitting can increase model error thus enforce erroneous 
conclusions.    
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4.7 Are KDD techniques viable in the identification of those with CRC? 
 
Despite best efforts in early detection colorectal cancer remains difficult to diagnose 
based on clinical symptoms alone. This is likely attributable to numerous factors 
such as stage of disease, location of tumour and patients themselves to identify a 
few. Efforts are on-going to increase the detection rate of those with colorectal 
cancer at an earlier stage within the UK in the form of the national screening 
programme and FOB screening [148, 151]. Whilst very sensitive this compliance in 
the screening population is variable [151, 153] likely due to the method by which the 
individual provides the samples. In addition to the above, the use of flexible 
sigmoidoscopy in a mobile setting is being evaluated to optimise detection rates of 
colorectal cancer within the general population[286] [287]. 
 
Notwithstanding above, Colonoscopy remains the gold standard method of diagnosis 
[13, 288, 289] for colorectal cancer and it is not within the bounds of this study to 
compare KDD methods to colonoscopy, nor was it the aim to compare these 
techniques with screening tools. The aim was to optimise the referral pattern in those 
who attended their primary care physician with symptoms and were referred onto 
secondary care for further assessment, attempting to classify those who needed more 
urgent assessment and as such potentially assist in the more appropriate distribution 
of resources. 
  
In this study KDD methods varied in their ability to predict patients with colorectal 
cancer. These ranged from the best model accurately predicting 95% of those within 
the dataset with sensitivity 0.63 and specificity 0.98. 
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In studies assessing prediction it is important to ensure the sample studied is 
sufficiently large to safeguard reliability. As such the ration of input variables to 
outcomes should be 10:1 [217] as failure to achieve this level has resulted in unstable 
models being created. In this study, all models explored had an appropriate ratio of 
input and output variables. 
 
The use of KDD has a broad spectrum across all fields of medicine. The most 
commonly used method to date has been that of ANN with studies showing 
comparability, if not some degree of superiority to traditional techniques. [290] [291] 
[236] [292] [237]. The nonlinearity and ability of ANN to learn has made their use 
attractive when trying to stratify and predict outcomes in the field of medicine. 
Studies assessing outcomes of mortality and morbidity following cardiac surgery 
have been undertaken with positive results [242]  
 
Alternative KDD methods used, specifically in the field of medicine include fuzzy 
logic classification systems such as PROAFTN [293] which has been applied to 
assist in diagnosing bladder tumours and acute leukaemia. Fuzzy KNN classifiers 
have been used and have been shown to produce a more robust model of prognostic 
markers than logistic regression and MLP’s [294]. Fuzzy rule generation in 
conjunction with breast cancer datasets has been used with accuracy rates of 97% 
[295] [296]. 
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The clinical environment in which a predictive system is used is the primary 
determinate of the model and its classification cut off point. In clinical settings such 
as this study’s model the optimal system is one that has a small number of false 
positives and no false negatives. This will result in preference being given to model 
sensitivity at the cost of specificity. Whilst there is no theoretical guidance as to how 
the ideal cut off point in an ANN is chosen it may be possible to alter the number of 
cut off points in the ROC curve but studies looking at this have shown minimal gain 
[297]). 
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4.8 Limitations 
The use of KDD is reliant upon the quality of information entered into the 
database for analysis. Whilst the data entry within this study was a direct 
reflection upon the answers given by patients regarding their symptoms it is 
feasible that the questionnaire may have been too complex. The initial 
questionnaire had been validated within a cohort of patients within the 
department however some additions were made prior to the distribution of the 
questionnaire for use within this study to try and increase the amount of data 
received. It is feasible that the addition of extra questions may have misled or 
confused those completing the questionnaire thus reducing its reproducibility. 
It is accepted that once any changes had been made to the questionnaire this 
should once again have been tested and validated on an independent cohort of 
patients both prior to and on attendance at a clinic to ensure that the answers 
were reproducible. Whilst this technique in itself may, due to human nature 
result in some anomalies it would allow the rigorous testing of the 
questionnaire and increase its validity within the setting of this study.  
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4.9 Conclusion 
 
The complexity of medical diagnosis remains challenging both to the physician and 
computation models. Risk prediction remains central to a clinician’s ability to 
successfully perform their duties, be it in a primary care setting, secondary or tertiary 
care. An array of tests and tools are at the disposal of those in a hospital setting, 
allowing the investigation of those deemed to be at increased risk of a condition. 
Clinicians use clinical evidence in conjunction with experience to initiate further 
investigations however there is variation in experience depending on the 
specialisation of the clinician.  
 
This study has shown that the use of KDD tools as an adjuvant to clinical acumen 
can prove beneficial in identifying patients with lower GI pathology therefore 
expedite their diagnosis and treatment. While it would be ill-conceived to suggest 
that such computer models can replace physician-patient interaction further work 
assessing the feasibility of models such as the ones in this study directing patients 
‘straight to test’ are worthy of consideration for both 2ww pathway patients and 
those referred in the low risk groups.  
 
 
 
 
 
 
 
175 
 
Appendix A 
Bowel Symptom Questionnaire 
We would be grateful if you could complete the following questions regarding 
symptoms you may have experienced recently. 
Once completed please sign the bottom as evidence of consent as explained on 
the information sheet 
 
1)Have you had any bleeding from your bottom 
 
- Was this dark red 
 - Was this bright red 
 - Was it on your motion 
 - Was it on the toilet paper 
 - Was it mixed with your motion 
 
 
Yes         No  
 
Yes         No     
Yes         No    
Yes         No     
Yes         No     
Yes         No     
 
2) Has this happened more than once in 6 weeks 
                         - If yes, how often? 
 
Yes         No     
 
3) Have you passed any mucus / slimy stuff from 
your bottom? 
                         - If yes, how often? 
 
Yes         No     
4) Have you passed any pus from your bottom in the 
past 6 weeks? 
                         - If yes, how often? 
Yes         No     
 
5) Has your bowel habit changed in the past few 
months? 
            - If Yes, how many times a day do you open 
them? 
 
            - If No, has it changed in the last 12 months  
  - Are you more constipated 
  - Are your motions looser than normal 
  - Have you had any diarrhoea 
Yes         No     
 
 
Yes         No     
Yes         No     
Yes         No     
Yes         No     
6) Do you have to strain to open your bowels? 
 
Yes         No     
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7) When you open your bowels do you feel as if you 
have completely emptied them? 
 
Yes         No     
 
8) Have you had any urgency when opening your 
bowels? 
Yes         No     
 
9) Do you have any pain when you open your 
bowels in the past 6 weeks? 
 
Yes         No     
 
10) Have you had any ‘accidents’ when opening your 
bowels recently? 
 
Yes         No     
 
11) Have you have any abdominal pain in the past 6 
weeks? 
Yes         No 
     
12) Have you felt more tired than usual recently? Yes         No 
     
13) Have you recently found yourself short of breath 
doing activities that previously caused you no 
problems? 
 
Yes         No     
 
14) Do you get Short of Breath walking up stairs? Yes         No     
 
15) Has your weight been stable in the past 6 
months? 
        
            - Have you lost any weight recently?    
            - Are your clothes looser fitting than before? 
            - Have you gained any weight recently? 
Yes         No     
 
Yes         No     
Yes         No     
Yes         No     
 
16) Has your appetite: 
 Increased 
 Decreased 
 
Yes         No     
Yes         No     
 
17) Do you take regular Aspirin Yes         No     
 
18) Do you take regular Painkillers Yes         No     
 
19) Have you ever had: 
 
 - Polyps in your bowel 
 - Bowel Cancer 
 - Cancer elsewhere 
 
 
Yes         No     
Yes         No     
Yes         No     
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20) With reference to your immediate family 
(mother, father, brother and sister), have they ever 
had: 
 - Polyps in the bowel 
 - Bowel Cancer 
 - Cancer elsewhere 
 
 
Yes         No     
Yes         No     
Yes         No     
 
             -If so who and at what age? 
 
 
 
21) With reference to other family members        
(aunts/uncles/cousins), have they ever had: 
- Polyps in the bowel 
 - Bowel Cancer 
 - Cancer elsewhere 
 
 
Yes         No     
Yes         No     
Yes         No     
 
             -If so who and at what age? 
 
 
22) Have you ever been diagnosed with 
Inflammatory Bowel Disease (Ulcerative Colitis / 
Crohns) 
Yes         No     
 
23) Has anyone in your family ever been diagnosed 
with Inflammatory bowel disease  
Yes         No     
 
             -If yes, what relationship? 
 
 
24) Do you Smoke? Yes         No     
 
25) Have you ever Smoked? Yes         No     
 
178 
 
 
References 
 
1. GLOBOSCAN Database. 2002. 
2. Baig, M.K. and C.G. Marks, Referral guidelines for colorectal cancer: a 
threat or a challenge? Hosp Med, 2000. 61(7): p. 452-3. 
3. Haenszel, W., Mortality and morbidity statistics on all forms of cancer. Acta 
- Unio Internationalis Contra Cancrum, 1961. 17: p. 837-47. 
4. Haenszel, W., Incidence of and mortality from stomach cancer in the United 
States. Acta - Unio Internationalis Contra Cancrum, 1961. 17: p. 347-64. 
5. Haenszel, W., Cancer mortality among the foreign-born in the United States. 
Journal of the National Cancer Institute, 1961. 26: p. 37-132. 
6. McMichael, A.J. and G.G. Giles, Cancer in migrants to Australia: extending 
the descriptive epidemiological data. Cancer research, 1988. 48(3): p. 751-6. 
7. Rickert, R.R., et al., Adenomatous lesions of the large bowel: an autopsy 
survey. Cancer, 1979. 43(5): p. 1847-57. 
8. Arminski, T.C. and D.W. McLean, Incidence and Distribution of 
Adenomatous Polyps of the Colon and Rectum Based on 1,000 Autopsy 
Examinations. Diseases of the colon and rectum, 1964. 7: p. 249-61. 
9. Williams, A.R., B.A. Balasooriya, and D.W. Day, Polyps and cancer of the 
large bowel: a necropsy study in Liverpool. Gut, 1982. 23(10): p. 835-42. 
179 
 
10. Stryker, S.J., et al., Natural history of untreated colonic polyps. 
Gastroenterology, 1987. 93(5): p. 1009-13. 
 
11. Winawer, S.J. and A.G. Zauber, Colorectal cancer screening: now is the 
time. CMAJ : Canadian Medical Association journal = journal de 
l'Association medicale canadienne, 2000. 163(5): p. 543-4; discussion 548. 
 
12. Winawer, S.J., et al., The National Polyp Study. European journal of cancer 
prevention : the official journal of the European Cancer Prevention 
Organisation, 1993. 2 Suppl 2: p. 83-7. 
 
13. Winawer, S.J., et al., Prevention of colorectal cancer by colonoscopic 
polypectomy. The National Polyp Study Workgroup. The New England 
journal of medicine, 1993. 329(27): p. 1977-81. 
14. Henry, L.G., et al., Risk of recurrence of colon polyps. Annals of surgery, 
1975. 182(4): p. 511-5. 
15. CROHN, B.B. and H. ROSENBERG, The Sigmoidoscopic Picture of 
Chronic Ulcerative Colitis (Non-Specific). The American Journal of the 
Medical Sciences, 1925. 170(2): p. 220-227. 
16. Munkholm, P., Review article: the incidence and prevalence of colorectal 
cancer in inflammatory bowel disease. Alimentary pharmacology & 
therapeutics, 2003. 18 Suppl 2: p. 1-5. 
180 
 
17. Eaden, J.A., K.R. Abrams, and J.F. Mayberry, The risk of colorectal cancer 
in ulcerative colitis: a meta-analysis. Gut, 2001. 48(4): p. 526-35. 
18. Ekbom, A., et al., Ulcerative colitis and colorectal cancer. A population-
based study. The New England journal of medicine, 1990. 323(18): p. 1228-
33. 
19. Ekbom, A., et al., Increased risk of large-bowel cancer in Crohn's disease 
with colonic involvement. Lancet, 1990. 336(8711): p. 357-9. 
20. Terdiman, J.P., et al., 5-Aminosalicylic acid therapy and the risk of colorectal 
cancer among patients with inflammatory bowel disease. Inflammatory 
bowel diseases, 2007. 13(4): p. 367-71. 
21. Muto, T., H.J. Bussey, and B.C. Morson, The evolution of cancer of the colon 
and rectum. Cancer, 1975. 36(6): p. 2251-70. 
22. Hoff, G. and M.H. Vatn, Colonic adenoma: natural history. Digestive 
diseases, 1991. 9(2): p. 61-9. 
23. Lynch, H.T. and A. de la Chapelle, Hereditary colorectal cancer. The New 
England journal of medicine, 2003. 348(10): p. 919-32. 
24. Lynch, H.T., et al., Genetics, natural history, tumor spectrum, and pathology 
of hereditary nonpolyposis colorectal cancer: an updated review. 
Gastroenterology, 1993. 104(5): p. 1535-49. 
25. Jess, T., et al., Increased risk of intestinal cancer in Crohn's disease: a meta-
analysis of population-based cohort studies. The American journal of 
gastroenterology, 2005. 100(12): p. 2724-9. 
181 
 
26. Larsson, S.C., N. Orsini, and A. Wolk, Diabetes mellitus and risk of 
colorectal cancer: a meta-analysis. Journal of the National Cancer Institute, 
2005. 97(22): p. 1679-87. 
27. Ron, E., et al., Acromegaly and gastrointestinal cancer. Cancer, 1991. 68(8): 
p. 1673-7. 
28. Potter, J.D., Colon cancer--do the nutritional epidemiology, the gut 
physiology and the molecular biology tell the same story? The Journal of 
nutrition, 1993. 123(2 Suppl): p. 418-23. 
29. Steinmetz, K.A. and J.D. Potter, Vegetables, fruit, and cancer prevention: a 
review. Journal of the American Dietetic Association, 1996. 96(10): p. 1027-
39. 
30. Research., W.C.R.F.A.I.f.C., ., and W.D. AICR, Food, Nutrition, Physical 
Activity, and the Prevention of Cancer: a Global Perspective. 2007. 
31. Terry, P., et al., Fruit, vegetables, dietary fiber, and risk of colorectal cancer. 
Journal of the National Cancer Institute, 2001. 93(7): p. 525-33. 
32. Michels, K.B., et al., Prospective study of fruit and vegetable consumption 
and incidence of colon and rectal cancers. Journal of the National Cancer 
Institute, 2000. 92(21): p. 1740-52. 
33. Trock, B., E. Lanza, and P. Greenwald, Dietary fiber, vegetables, and colon 
cancer: critical review and meta-analyses of the epidemiologic evidence. 
Journal of the National Cancer Institute, 1990. 82(8): p. 650-61. 
182 
 
34. Trock, B.J., E. Lanza, and P. Greenwald, High fiber diet and colon cancer: a 
critical review. Progress in clinical and biological research, 1990. 346: p. 
145-57. 
35. Jacobs, E.J., et al., Multivitamin use and colorectal cancer incidence in a US 
cohort: does timing matter? American journal of epidemiology, 2003. 
158(7): p. 621-8. 
36. Wu, K., et al., A prospective study on supplemental vitamin e intake and risk 
of colon cancer in women and men. Cancer epidemiology, biomarkers & 
prevention : a publication of the American Association for Cancer Research, 
cosponsored by the American Society of Preventive Oncology, 2002. 11(11): 
p. 1298-304. 
37. Connelly-Frost, A., et al., Selenium, apoptosis, and colorectal adenomas. 
Cancer epidemiology, biomarkers & prevention : a publication of the 
American Association for Cancer Research, cosponsored by the American 
Society of Preventive Oncology, 2006. 15(3): p. 486-93. 
38. Norat, T., et al., Meat, fish, and colorectal cancer risk: the European 
Prospective Investigation into cancer and nutrition. Journal of the National 
Cancer Institute, 2005. 97(12): p. 906-16. 
39. English, D.R., et al., Red meat, chicken, and fish consumption and risk of 
colorectal cancer. Cancer epidemiology, biomarkers & prevention : a 
publication of the American Association for Cancer Research, cosponsored 
by the American Society of Preventive Oncology, 2004. 13(9): p. 1509-14. 
183 
 
40. Chao, A., et al., Meat consumption and risk of colorectal cancer. JAMA : the 
journal of the American Medical Association, 2005. 293(2): p. 172-82. 
41. Bingham, S.A., R. Hughes, and A.J. Cross, Effect of white versus red meat on 
endogenous N-nitrosation in the human colon and further evidence of a dose 
response. The Journal of nutrition, 2002. 132(11 Suppl): p. 3522S-3525S. 
42. Cross, A.J., J.R. Pollock, and S.A. Bingham, Haem, not protein or inorganic 
iron, is responsible for endogenous intestinal N-nitrosation arising from red 
meat. Cancer research, 2003. 63(10): p. 2358-60. 
43. Lewin, M.H., et al., Red meat enhances the colonic formation of the DNA 
adduct O6-carboxymethyl guanine: implications for colorectal cancer risk. 
Cancer research, 2006. 66(3): p. 1859-65. 
44. Kampman, E., et al., Calcium, vitamin D, sunshine exposure, dairy products 
and colon cancer risk (United States). Cancer causes & control : CCC, 2000. 
11(5): p. 459-66. 
45. Baron, J.A., et al., Calcium supplements for the prevention of colorectal 
adenomas. Calcium Polyp Prevention Study Group. The New England 
journal of medicine, 1999. 340(2): p. 101-7. 
46. Flood, A., et al., Calcium from diet and supplements is associated with 
reduced risk of colorectal cancer in a prospective cohort of women. Cancer 
epidemiology, biomarkers & prevention : a publication of the American 
Association for Cancer Research, cosponsored by the American Society of 
Preventive Oncology, 2005. 14(1): p. 126-32. 
184 
 
47. Slattery, M.L., et al., Dietary calcium, vitamin D, VDR genotypes and 
colorectal cancer. International journal of cancer. Journal international du 
cancer, 2004. 111(5): p. 750-6. 
48. Grau, M.V., et al., Vitamin D, calcium supplementation, and colorectal 
adenomas: results of a randomized trial. Journal of the National Cancer 
Institute, 2003. 95(23): p. 1765-71. 
49. Giovannucci, E., et al., Physical activity, obesity, and risk for colon cancer 
and adenoma in men. Annals of internal medicine, 1995. 122(5): p. 327-34. 
50. Slattery, M.L., Physical activity and colorectal cancer. Sports medicine, 
2004. 34(4): p. 239-52. 
51. Samad, A.K., et al., A meta-analysis of the association of physical activity 
with reduced risk of colorectal cancer. Colorectal disease : the official 
journal of the Association of Coloproctology of Great Britain and Ireland, 
2005. 7(3): p. 204-13. 
52. Slattery, M.L., Diet, lifestyle, and colon cancer. Seminars in gastrointestinal 
disease, 2000. 11(3): p. 142-6. 
53. Moore, L.L., et al., BMI and waist circumference as predictors of lifetime 
colon cancer risk in Framingham Study adults. International journal of 
obesity and related metabolic disorders : journal of the International 
Association for the Study of Obesity, 2004. 28(4): p. 559-67. 
54. Cho, E., et al., Alcohol intake and colorectal cancer: a pooled analysis of 8 
cohort studies. Annals of internal medicine, 2004. 140(8): p. 603-13. 
185 
 
55. Farinati, F., et al., Effect of chronic ethanol consumption on activation of 
nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung, and 
hepatic tissue. Drug metabolism and disposition: the biological fate of 
chemicals, 1985. 13(2): p. 210-4. 
56. Garro, A.J. and C.S. Lieber, Alcohol and cancer. Annual review of 
pharmacology and toxicology, 1990. 30: p. 219-49. 
57. Giovannucci, E., et al., Alcohol, low-methionine--low-folate diets, and risk of 
colon cancer in men. Journal of the National Cancer Institute, 1995. 87(4): p. 
265-73. 
58. Terry, P., et al., Long-term tobacco smoking and colorectal cancer in a 
prospective cohort study. International journal of cancer. Journal 
international du cancer, 2001. 91(4): p. 585-7. 
59. Slattery, M.L., et al., Associations between cigarette smoking, lifestyle 
factors, and microsatellite instability in colon tumors. Journal of the National 
Cancer Institute, 2000. 92(22): p. 1831-6. 
60. Luchtenborg, M., et al., Cigarette smoking and colorectal cancer: APC 
mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms. 
American journal of epidemiology, 2005. 161(9): p. 806-15. 
61. Fijten, G.H., et al., The incidence and outcome of rectal bleeding in general 
practice. Family practice, 1993. 10(3): p. 283-7. 
62. Wauters, H., V. Van Casteren, and F. Buntinx, Rectal bleeding and 
colorectal cancer in general practice: diagnostic study. Bmj, 2000. 
321(7267): p. 998-9. 
186 
 
63. Thompson, et al., Rectal bleeding in general and hospital practice; ‘the tip of 
the iceberg’. Colorectal Disease, 2000. 2(5): p. 288-293. 
64. Crosland, A. and R. Jones, Rectal bleeding: prevalence and consultation 
behaviour. BMJ, 1995. 311(7003): p. 486-8. 
65. Sandler, R.S., Epidemiology of irritable bowel syndrome in the United States. 
Gastroenterology, 1990. 99(2): p. 409-15. 
66. Everhart, J.E., et al., A longitudinal survey of self-reported bowel habits in 
the United States. Digestive diseases and sciences, 1989. 34(8): p. 1153-62. 
67. Thompson, M.R., et al., Identifying and managing patients at low risk of 
bowel cancer in general practice. Bmj, 2003. 327(7409): p. 263-5. 
68. Morrell, D.C. and C.J. Wale, Symptoms perceived and recorded by patients. 
The Journal of the Royal College of General Practitioners, 1976. 26(167): p. 
398-403. 
69. Fijten, G.H., et al., Predictive value of signs and symptoms for colorectal 
cancer in patients with rectal bleeding in general practice. Family practice, 
1995. 12(3): p. 279-86. 
70. Metcalf, J.V., et al., Incidence and causes of rectal bleeding in general 
practice as detected by colonoscopy. The British journal of general practice : 
the journal of the Royal College of General Practitioners, 1996. 46(404): p. 
161-4. 
71. Mant, A., et al., Rectal bleeding. Do other symptoms aid in diagnosis? 
Diseases of the colon and rectum, 1989. 32(3): p. 191-6. 
187 
 
72. Shallow, T.A., F.B. Wagner, Jr., and R.E. Colcher, Clinical evaluation of 750 
patients with colon cancer; diagnostic survey and follow-up covering a 
fifteen-year period. Annals of surgery, 1955. 142(2): p. 164-75. 
73. Ellis, B.G. and M.R. Thompson, Factors identifying higher risk rectal 
bleeding in general practice. The British journal of general practice : the 
journal of the Royal College of General Practitioners, 2005. 55(521): p. 949-
55. 
74. Calvey, H.D. and C.M. Castleden, Gastrointestinal investigations for 
anaemia in the elderly: a prospective study. Age and ageing, 1987. 16(6): p. 
399-404. 
75. Rockey, D.C., Gastrointestinal tract evaluation in patients with iron 
deficiency anemia. Seminars in gastrointestinal disease, 1999. 10(2): p. 53-
64. 
76. Rockey, D.C., Occult gastrointestinal bleeding. Gastroenterology clinics of 
North America, 2005. 34(4): p. 699-718. 
77. Rockey, D.C., Lower gastrointestinal bleeding. Gastroenterology, 2006. 
130(1): p. 165-71. 
78. Rockey, D.C., Occult and obscure gastrointestinal bleeding: causes and 
clinical management. Nature reviews. Gastroenterology & hepatology, 2010. 
7(5): p. 265-79. 
79. Kepczyk, T. and S.C. Kadakia, Prospective evaluation of gastrointestinal 
tract in patients with iron-deficiency anemia. Digestive diseases and 
sciences, 1995. 40(6): p. 1283-9. 
188 
 
80. Mandel, J.S., et al., The effect of fecal occult-blood screening on the 
incidence of colorectal cancer. The New England journal of medicine, 2000. 
343(22): p. 1603-7. 
81. Duthie, G.S., et al., A UK training programme for nurse practitioner flexible 
sigmoidoscopy and a prospective evaluation of the practice of the first UK 
trained nurse flexible sigmoidoscopist. Gut, 1998. 43(5): p. 711-4. 
82. Maslekar, S., et al., Patient satisfaction with lower gastrointestinal 
endoscopy: doctors, nurse and nonmedical endoscopists. Colorectal disease : 
the official journal of the Association of Coloproctology of Great Britain and 
Ireland, 2010. 12(10): p. 1033-8. 
83. Maslekar, S., et al., Quality assurance in flexible sigmoidoscopy: medical 
and nonmedical endoscopists. Surg Endosc, 2010. 24(1): p. 89-93. 
84. Pathmakanthan, S., et al., Nurse endoscopists in United Kingdom health 
care: a survey of prevalence, skills and attitudes. J Adv Nurs, 2001. 36(5): p. 
705-10. 
85. Schoenfeld, P., et al., Accuracy of polyp detection by gastroenterologists and 
nurse endoscopists during flexible sigmoidoscopy: a randomized trial. 
Gastroenterology, 1999. 117(2): p. 312-8. 
86. Schoenfeld, P.S., et al., Effectiveness and patient satisfaction with screening 
flexible sigmoidoscopy performed by registered nurses. Gastrointest Endosc, 
1999. 49(2): p. 158-62. 
87. Atkin, W.S., et al., Uptake, yield of neoplasia, and adverse effects of flexible 
sigmoidoscopy screening. Gut, 1998. 42(4): p. 560-5. 
189 
 
88. Imperiale, T.F., et al., Risk of advanced proximal neoplasms in asymptomatic 
adults according to the distal colorectal findings. The New England journal 
of medicine, 2000. 343(3): p. 169-74. 
89. Levin, T.R., Flexible sigmoidoscopy for colorectal cancer screening: valid 
approach or short-sighted? Gastroenterology clinics of North America, 
2002. 31(4): p. 1015-29, vii. 
90. Levin, T.R., et al., Complications of screening flexible sigmoidoscopy. 
Gastroenterology, 2002. 123(6): p. 1786-92. 
91. Levin, T.R. and A.M. Palitz, Flexible sigmoidoscopy: an important screening 
option for average-risk individuals. Gastrointestinal endoscopy clinics of 
North America, 2002. 12(1): p. 23-40, vi. 
92. Ahmad, N.A., et al., Efficacy, safety, and clinical outcomes of endoscopic 
mucosal resection: a study of 101 cases. Gastrointest Endosc, 2002. 55(3): p. 
390-6. 
93. Conio, M., et al., EMR of large sessile colorectal polyps. Gastrointest 
Endosc, 2004. 60(2): p. 234-41. 
94. Jameel, J.K., et al., Endoscopic mucosal resection (EMR) in the management 
of large colo-rectal polyps. Colorectal disease : the official journal of the 
Association of Coloproctology of Great Britain and Ireland, 2006. 8(6): p. 
497-500. 
95. Sano, Y., et al., A newly developed bipolar-current needle-knife for 
endoscopic submucosal dissection of large colorectal tumors. Endoscopy, 
2006. 38 Suppl 2: p. E95. 
190 
 
96. Fujishiro, M., et al., Outcomes of endoscopic submucosal dissection for 
colorectal epithelial neoplasms in 200 consecutive cases. Clin Gastroenterol 
Hepatol, 2007. 5(6): p. 678-83; quiz 645. 
97. Repici, A., et al., Insulated-tip knife endoscopic mucosal resection of large 
colorectal polyps unsuitable for standard polypectomy. Am J Gastroenterol, 
2007. 102(8): p. 1617-23. 
98. Hurlstone, D.P., et al., Salvage endoscopic submucosal dissection for 
residual or local recurrent intraepithelial neoplasia in the colorectum: a 
prospective analysis. Colorectal disease : the official journal of the 
Association of Coloproctology of Great Britain and Ireland, 2008. 10(9): p. 
891-7. 
99. Zhou, P., et al., Endoscopic submucosal dissection for locally recurrent 
colorectal lesions after previous endoscopic mucosal resection. Diseases of 
the colon and rectum, 2009. 52(2): p. 305-10. 
100. Rex, D.K., et al., Colonoscopic miss rates of adenomas determined by back-
to-back colonoscopies. Gastroenterology, 1997. 112(1): p. 24-8. 
101. Winawer, S.J., et al., A comparison of colonoscopy and double-contrast 
barium enema for surveillance after polypectomy. National Polyp Study 
Work Group. The New England journal of medicine, 2000. 342(24): p. 1766-
72. 
102. Kung, J.W., et al., Colorectal cancer: screening double-contrast barium 
enema examination in average-risk adults older than 50 years. Radiology, 
2006. 240(3): p. 725-35. 
191 
 
103. Toma, J., et al., Rates of new or missed colorectal cancer after barium enema 
and their risk factors: a population-based study. Am J Gastroenterol, 2008. 
103(12): p. 3142-8. 
104. Pickhardt, P.J., et al., Computed tomographic virtual colonoscopy to screen 
for colorectal neoplasia in asymptomatic adults. The New England journal of 
medicine, 2003. 349(23): p. 2191-200. 
105. Pescatore, P., et al., Diagnostic accuracy and interobserver agreement of CT 
colonography (virtual colonoscopy). Gut, 2000. 47(1): p. 126-30. 
106. Cotton, P.B., et al., Computed tomographic colonography (virtual 
colonoscopy): a multicenter comparison with standard colonoscopy for 
detection of colorectal neoplasia. JAMA : the journal of the American 
Medical Association, 2004. 291(14): p. 1713-9. 
107. Arnesen, R.B., et al., Missed lesions and false-positive findings on computed-
tomographic colonography: a controlled prospective analysis. Endoscopy, 
2005. 37(10): p. 937-44. 
108. Rockey, D.C., et al., Analysis of air contrast barium enema, computed 
tomographic colonography, and colonoscopy: prospective comparison. 
Lancet, 2005. 365(9456): p. 305-11. 
109. Burling, D., et al., Polyp measurement and size categorisation by CT 
colonography: effect of observer experience in a multi-centre setting. Eur 
Radiol, 2006. 16(8): p. 1737-44. 
192 
 
110. Burling, D., et al., CT colonography interpretation times: effect of reader 
experience, fatigue, and scan findings in a multi-centre setting. Eur Radiol, 
2006. 16(8): p. 1745-9. 
111. Thomas, S., J. Atchley, and A. Higginson, Audit of the introduction of CT 
colonography for detection of colorectal carcinoma in a non-academic 
environment and its implications for the national bowel cancer screening 
programme. Clin Radiol, 2009. 64(2): p. 142-7. 
112. AJCC Cancer Staging Manual. 7th ed, ed. S.B.B. Edge, D.R.; Compton, 
C.C.; Fritz, A.G.; Greene, F.L.; Trotti, A.2010: Springer. 
113. Astler, V.B. and F.A. Coller, The prognostic significance of direct extension 
of carcinoma of the colon and rectum. Annals of surgery, 1954. 139(6): p. 
846-52. 
114. Dukes, C., Histological Grading of Rectal Cancer: (Section of Pathology). 
Proceedings of the Royal Society of Medicine, 1937. 30(4): p. 371-6. 
115. Quirke, P., et al., Effect of the plane of surgery achieved on local recurrence 
in patients with operable rectal cancer: a prospective study using data from 
the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet, 
2009. 373(9666): p. 821-8. 
116. Sebag-Montefiore, D., et al., Preoperative radiotherapy versus selective 
postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 
and NCIC-CTG C016): a multicentre, randomised trial. Lancet, 2009. 
373(9666): p. 811-20. 
193 
 
117. Siegel, R., et al., Preoperative short-course radiotherapy versus combined 
radiochemotherapy in locally advanced rectal cancer: a multi-centre 
prospectively randomised study of the Berlin Cancer Society. BMC cancer, 
2009. 9: p. 50. 
118. Jensen, L.H., et al., Clinical outcome in 520 consecutive Danish rectal 
cancer patients treated with short course preoperative radiotherapy. 
European journal of surgical oncology : the journal of the European Society 
of Surgical Oncology and the British Association of Surgical Oncology, 
2010. 36(3): p. 237-43. 
119. Latkauskas, T., et al., Initial results of a randomised controlled trial 
comparing clinical and pathological downstaging of rectal cancer after 
preoperative short-course radiotherapy or long term chemoradiotherapy 
both with delayed surgery. Colorectal disease : the official journal of the 
Association of Coloproctology of Great Britain and Ireland, 2011. 
120. Senapati, A., et al., Low rates of local recurrence after surgical resection of 
rectal cancer suggest a selective policy for preoperative radiotherapy. 
Colorectal disease : the official journal of the Association of Coloproctology 
of Great Britain and Ireland, 2011. 
121. Hartley, A., et al., Retrospective study of acute toxicity following short-
course preoperative radiotherapy. The British journal of surgery, 2002. 
89(7): p. 889-95. 
194 
 
122. Hazebroek, E.J., COLOR: a randomized clinical trial comparing 
laparoscopic and open resection for colon cancer. Surgical endoscopy, 2002. 
16(6): p. 949-53. 
123. A comparison of laparoscopically assisted and open colectomy for colon 
cancer. The New England journal of medicine, 2004. 350(20): p. 2050-9. 
124. Guillou, P.J., et al., Short-term endpoints of conventional versus 
laparoscopic-assisted surgery in patients with colorectal cancer (MRC 
CLASICC trial): multicentre, randomised controlled trial. Lancet, 2005. 
365(9472): p. 1718-26. 
125. Heald, R.J. and R.D. Ryall, Recurrence and survival after total mesorectal 
excision for rectal cancer. Lancet, 1986. 1(8496): p. 1479-82. 
126. Scott, N., et al., Total mesorectal excision and local recurrence: a study of 
tumour spread in the mesorectum distal to rectal cancer. The British journal 
of surgery, 1995. 82(8): p. 1031-3. 
127. Buess, G., et al., Technique and results of transanal endoscopic microsurgery 
in early rectal cancer. American journal of surgery, 1992. 163(1): p. 63-9; 
discussion 69-70. 
128. Steele, R.J., et al., Transanal endoscopic microsurgery--initial experience 
from three centres in the United Kingdom. The British journal of surgery, 
1996. 83(2): p. 207-10. 
129. Bretagnol, F., et al., Local excision of rectal tumours by transanal 
endoscopic microsurgery. The British journal of surgery, 2007. 94(5): p. 627-
33. 
195 
 
130. Jemal, A., et al., Cancer statistics, 2002. CA: a cancer journal for clinicians, 
2002. 52(1): p. 23-47. 
131. Andre, T., et al., Oxaliplatin, fluorouracil, and leucovorin as adjuvant 
treatment for colon cancer. The New England journal of medicine, 2004. 
350(23): p. 2343-51. 
132. Hackett, T.P., N.H. Cassem, and J.W. Raker, Patient delay in cancer. The 
New England journal of medicine, 1973. 289(1): p. 14-20. 
133. Holliday, H.W. and J.D. Hardcastle, Delay in diagnosis and treatment of 
symptomatic colorectal cancer. Lancet, 1979. 1(8111): p. 309-11. 
134. Blakeborough, A., M.B. Sheridan, and A.H. Chapman, Complications of 
barium enema examinations: a survey of UK Consultant Radiologists 1992 to 
1994. Clinical radiology, 1997. 52(2): p. 142-8. 
135. Waye, J.D., O. Kahn, and M.E. Auerbach, Complications of colonoscopy and 
flexible sigmoidoscopy. Gastrointestinal endoscopy clinics of North America, 
1996. 6(2): p. 343-77. 
136. Talley, N.J. and M. Jones, Self-reported rectal bleeding in a United States 
community: prevalence, risk factors, and health care seeking. The American 
journal of gastroenterology, 1998. 93(11): p. 2179-83. 
137. Fijten, G.H., G.H. Blijham, and J.A. Knottnerus, Occurrence and clinical 
significance of overt blood loss per rectum in the general population and in 
medical practice. The British journal of general practice : the journal of the 
Royal College of General Practitioners, 1994. 44(384): p. 320-5. 
196 
 
138. DOH, Department of Health. Cancer Waiting Targets: a guide (Version 4) 
2005. 
139. Thompson, M.R., ACPGBI Referral guidelines for colorectal cancer. 
Colorectal disease : the official journal of the Association of Coloproctology 
of Great Britain and Ireland, 2002. 4(4): p. 287-297. 
140. Hemingway, D.M., J. Jameson, and M.J. Kelly, Straight to test: introduction 
of a city-wide protocol driven investigation of suspected colorectal cancer. 
Colorectal Disease, 2006. 8(4): p. 289-295. 
141. Thorne, K., H.A. Hutchings, and G. Elwyn, BMC Health Services Research, 
2006. 6(1): p. 43. 
142. Pearse IH, C., LH, The Peckham Experiment; a Study of the Living Structure 
of Society, 1985: Edinburgh & London  
143. Wadsworth MEJ, B.W., Blaney R Health and Sickness, the Choice of 
Treatment. Perception of Illness and Use of Services in an Urban 
Community1971, London & Southampton: Tavistock Publications, Camelot 
Press Ltd. 
144. DR, H., The Symptom Iceberg: a Study of Community Health, 1979, 
Routledge & Kegan Paul: London. 
145. Kelly, S.B., et al., Nurse specialist led flexible sigmoidoscopy in an 
outpatient setting. Colorectal disease : the official journal of the Association 
of Coloproctology of Great Britain and Ireland, 2008. 10(4): p. 390-3. 
197 
 
146. Maruthachalam, K., et al., Evolution of the two-week rule pathway--direct 
access colonoscopy vs outpatient appointments: one year's experience and 
patient satisfaction survey. Colorectal disease : the official journal of the 
Association of Coloproctology of Great Britain and Ireland, 2005. 7(5): p. 
480-5. 
147. Corman, M.L., M.C. Veidenheimer, and J.A. Coller, Colorectal carcinoma: a 
decade of experience at the Lahey Clinic. Diseases of the colon and rectum, 
1979. 22(7): p. 477-9. 
148. Paul Tappenden, S.E., Richard Nixon, Jim Chilcott, Hannah Sakai, Jon 
Karnon, Cost-effectiveness, cost-utility and resource impact of alternative 
screening options for colorectal cancer, 2004, ScHARR. 
149. Mandel, J.S., et al., Reducing mortality from colorectal cancer by screening 
for fecal occult blood. Minnesota Colon Cancer Control Study. The New 
England journal of medicine, 1993. 328(19): p. 1365-71. 
150. Kronborg, O., et al., Randomised study of screening for colorectal cancer 
with faecal-occult-blood test. Lancet, 1996. 348(9040): p. 1467-71. 
151. Hardcastle, J.D., et al., Randomised controlled trial of faecal-occult-blood 
screening for colorectal cancer. Lancet, 1996. 348(9040): p. 1472-7. 
152. Hardcastle, J.D. and T.A. Justin, Screening high-risk groups for colorectal 
neoplasia. The American journal of gastroenterology, 1996. 91(5): p. 850-2. 
153. Results of the first round of a demonstration pilot of screening for colorectal 
cancer in the United Kingdom. BMJ, 2004. 329(7458): p. 133. 
198 
 
154. Ahlquist, D.A., et al., Accuracy of fecal occult blood screening for colorectal 
neoplasia. A prospective study using Hemoccult and HemoQuant tests. 
JAMA : the journal of the American Medical Association, 1993. 269(10): p. 
1262-7. 
155. Mandel, J.S., et al., Sensitivity, specificity, and positive predictivity of the 
Hemoccult test in screening for colorectal cancers. The University of 
Minnesota's Colon Cancer Control Study. Gastroenterology, 1989. 97(3): p. 
597-600. 
156. Allison, J.E., R. Feldman, and I.S. Tekawa, Hemoccult screening in detecting 
colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term 
follow-up in a large group practice setting. Annals of internal medicine, 
1990. 112(5): p. 328-33. 
157. Allison, J.E., et al., Improving the fecal occult-blood test. The New England 
journal of medicine, 1996. 334(24): p. 1607-8. 
158. Uno, Y. and A. Munakata, Endoscopic and histologic correlates of colorectal 
polyp bleeding. Gastrointestinal endoscopy, 1995. 41(5): p. 460-7. 
159. Hanna, S.J., A. Muneer, and K.H. Khalil, The 2-week wait for suspected 
cancer: time for a rethink? International journal of clinical practice, 2005. 
59(11): p. 1334-9. 
160. Chohan, D.P.K., et al., How has the 'two-week wait' rule affected the 
presentation of colorectal cancer? Colorectal Disease, 2005. 7(5): p. 450-
453. 
199 
 
161. Debnath, D., N. Dielehner, and K.A. Gunning, Guidelines, compliance, and 
effectiveness: a 12 months' audit in an acute district general healthcare trust 
on the two week rule for suspected colorectal cancer. Postgraduate medical 
journal, 2002. 78(926): p. 748-51. 
162. Eccersley, A.J., et al., Referral guidelines for colorectal cancer--do they 
work? Annals of the Royal College of Surgeons of England, 2003. 85(2): p. 
107-10. 
163. Chohan, D.P., et al., How has the 'two-week wait' rule affected the 
presentation of colorectal cancer? Colorectal disease : the official journal of 
the Association of Coloproctology of Great Britain and Ireland, 2005. 7(5): p. 
450-3. 
164. Flashman, K., The Department of Health's "two week standard" for bowel 
cancer: is it working? Gut, 2004. 53(3): p. 387-391. 
165. Cantillon, P. and R. Jones, Does continuing medical education in general 
practice make a difference? BMJ, 1999. 318(7193): p. 1276-9. 
166. Renehan, A.G., et al., Impact on survival of intensive follow up after curative 
resection for colorectal cancer: systematic review and meta-analysis of 
randomised trials. BMJ, 2002. 324(7341): p. 813. 
167. Walsh, S.R., et al., Trends in colorectal cancer survival following the 2-week 
rule. Colorectal Disease, 2007. 9(3): p. 207-209. 
168. Bevis, P.M., et al., The association between referral source and stage of 
disease in patients with colorectal cancer. Colorectal disease : the official 
200 
 
journal of the Association of Coloproctology of Great Britain and Ireland, 
2008. 10(1): p. 58-62. 
169. Selvachandran, S., et al., Prediction of colorectal cancer by a patient 
consultation questionnaire and scoring system: a prospective study. The 
Lancet, 2002. 360(9329): p. 278-283. 
170. Rai, S., et al., Assessment of a patient consultation questionnaire-based 
scoring system for stratification of outpatient risk of colorectal cancer. The 
British journal of surgery, 2008. 95(3): p. 369-74. 
171. Bouckaert, G.H., J., Performance and Performance Management. Handbook 
of Public Policy, ed. J. B.G. Peter and Pierre2006, London: SAGE 
Publications. 
172. Burke, W., Organization Change – Theory and Practice. 2nd ed2008, New 
York: SAGE Publication. 
173. Hamlin, R.G., Evidence based Policy and Performance Management. The 
American Review of 
Public Administration, 2007. 37(3): p. 255-277. 
174. Krone, O., Syväjärvi, A. & Stenvall, J, Knowledge Integration for Enterprise 
Resources Planning 
Application Design. Knowledge and Process Management, 2009. 16(1): p. 1-12. 
175. Fayyad, U.M., Data mining and knowledge discovery: making sense out of 
data. IEEE Expert Intelligent Systems & Their Applications, 1996. 11(5): p. 
20-23. 
201 
 
176. Chen, H.C., M, Web Minind: Machine Learning for Web Applications, in 
Annual Review of Information Science and Technology2004. p. 289-329. 
177. Dunham, M., Data Mining: Introductory and Advanced Analysis2002, New 
Jersey: Prenhall. 
178. Hearst, M. Untangling text data mining. in ACL '99 Proceedings of the 37th 
annual meeting of the Association for Computational Linguistics on 
Computational Linguistics. 1999. Stroudsburg, PA, USA. 
179. Chen, Z., Data Mining and Uncertain Reasoning: An Integrated 
Approach2001, New York: John Wiley& Sons. 
180. Hayes-Roth, F. and N. Jacobstein, The state of knowledge-based systems. 
Commun. ACM, 1994. 37(3): p. 26-39. 
181. Simon, H., Search and reasoning in problem solving. Search and reasoning 
in problem solving, 1983. 
182. McCulloch, W. and W. Pitts, A logical calculus of the ideas immanent in 
nervous activity. Bulletin of Mathematical Biology, 1943. 5(4): p. 115-133. 
183. Hebb, D., The Organization of behavior1949, New York: Wiley. 
184. Rosenblatt, F., The perceptron: a probalilistic model for information storage 
and organization in the brain. Psycological Review, 1958. 65(6): p. 386-408. 
185. Widrow, B.A., JB, Reliable, Trainable Networks for Computing and Control. 
Aerospace Engineering 1962: p. 78-123. 
186. Widrow, B.H., ME, ADAPTIVE SWITCHING CIRCUITS.1960: Wescon 
Convention Record. 
202 
 
187. Fukushima, K. and S. Miyake, Neocognitron: A new algorithm for pattern 
recognition tolerant of deformations and shifts in position. Pattern 
Recognition, 1982. 15(6): p. 455-469. 
188. Fukushima, K. and N. Wake, Handwritten alphanumeric character 
recognition by the neocognitron. IEEE transactions on neural networks / a 
publication of the IEEE Neural Networks Council, 1991. 2(3): p. 355-65. 
189. Werbos, P., Beyond Regression: New Tools for Prediction and Analysis in 
the Behavioral Sciences, 1974, Harvard University. 
190. Le Cun, Y., A Theoretical Framework for Back-Propagation. 1988: p. 1-8. 
191. Parker, D., Learning Logic, in Invention Report1982, Stanford UNiversity: 
Stanford. p. S64-81. 
192. Rumelhart, D.E., G.E. Hinton, and R.J. Williams, Learning representations 
by back-propagating errors. Nature, 1986. 323(6088): p. 533-536. 
193. Rumelhart, D.E., McClelland, J L, Parallel distributed processing: 
Explorations in the microstructures of cognition1986, Cambridge, MA: MIT 
Press. 
194. Anderson, J.A.S., Jack W.;Ritz, Stephen A.;Jones, Randall S, Distinctive 
features, categorical perception, and probability learning: Some applications 
of a neural model. Psychological Review, 1977. 84(5): p. 413-451. 
195. Hopfield, J.J., Neural networks and physical systems with emergent collective 
computational abilities. Proceedings of the National Academy of Sciences, 
1982. 79(8): p. 2554-2558. 
203 
 
196. Hartman, E.J., J.D. Keeler, and J.M. Kowalski, Layered Neural Networks 
with Gaussian Hidden Units as Universal Approximations. Neural 
Computation, 1990. 2(2): p. 210-215. 
197. Hornik, K., M. Stinchcombe, and H. White, Multilayer feedforward networks 
are universal approximators. Neural Networks, 1989. 2(5): p. 359-366. 
198. Jordan, M. Attractor dynamics and parallelism in a connectionist sequential 
machine. in Proceedings of the Eighth Annual Conference of the Cognitive 
Science Society. 1986. Englewood Cliffs, NJ: IEEE Tutorials. 
199. Broomhead, D.L., D, Multivariable Functional Interpolation and Adaptive 
Networks. Complex Systems, 1988. 2: p. 321-355. 
200. Haykin, S.S., Neural networks : a comprehensive foundation1994, New York 
Toronto: Macmillan ; 
Maxwell Macmillan Canada ; 
Maxwell Macmillan International. xix, 696 p. 
201. Moody, J. and C.J. Darken, Fast Learning in Networks of Locally-Tuned 
Processing Units. Neural Computation, 1989. 1(2): p. 281-294. 
202. Kohonen, T., Self-organized formation of topologically correct feature maps. 
Biological Cybernetics, 1982. 43(1): p. 59-69. 
203. Patterson, D.W., Artificial neural networks : theory and applications1996, 
Singapore ; New York: Prentice Hall. xiv, 477 p. 
204 
 
204. McCullagh, P. and J.A. Nelder, Generalized linear models. 2nd ed. 
Monographs on statistics and applied probability1989, London ; New York: 
Chapman and Hall. xix, 511 p. 
205. Auer, P., H. Burgsteiner, and W. Maass, A learning rule for very simple 
universal approximators consisting of a single layer of perceptrons. Neural 
networks : the official journal of the International Neural Network Society, 
2008. 21(5): p. 786-95. 
206. Breiman, L., Classification and regression trees. Wadsworth 
statistics/probability series1984, Belmont, Calif.: Wadsworth International 
Group. x, 358 p. 
207. Breiman, L., The Little Bootstrap and Other Methods for Dimensionality 
Selection in Regression: X-Fixed Prediction Error. Journal of the American 
Statistical Association, 1992. 87(419): p. 738-754. 
208. Quinlan, J.R. and E.B. Hunt, A Formal Deductive Problem-Solving System. J. 
ACM, 1968. 15(4): p. 625-646. 
209. Quinlan, J.R., Induction of decision trees. Machine Learning, 1986. 1(1): p. 
81-106. 
210. Quinlan, J.R., C4.5 : programs for machine learning. Morgan Kaufmann 
series in machine learning1993, San Mateo, Calif.: Morgan Kaufmann 
Publishers. x, 302 p. 
211. Duda, R.H., P, Pattern classification and Scene Analysis1973: Wiley. 
205 
 
212. Langley P, I.W., Thompson K. An analysis of Bayesian classifiers. in Tenth 
national conference on arti cial intelligence. 1992. AAAI Press amd MIT 
Press. 
213. Vapnik, V.N., Statistical learning theory. Adaptive and learning systems for 
signal processing, communications, and control1998, New York: Wiley. 
xxiv, 736 p. 
214. Yang, Y. and X. Liu, A re-examination of text categorization methods. 
Proceedings of SIGIR: International Conference on R&D in Information 
Retrieval, 1999. 22: p. 42-49. 
215. Holland, R.R., Decision Tables. JAMA: The Journal of the American 
Medical     Association, 1975. 233(5): p. 455-457. 
216. L.A, Z., Fuzzy sets. Information and Control, 1965. 8(3): p. 338-353. 
217. R, K. A Study of Cross-Validation and Bootstrap for Accuracy Estimation 
and Model Selection. in International Joint Conference on Artificial 
Intelligence (IJCAI). 1995. Montreal, Canada: Morgan-Kaufmann. 
218. H. M. Finucan, R.F.G.a.M.S., Moments Without Tears in Simple Random 
Sampling from a Finite Population. Biometrika, 1974. 61(1): p. 151-154. 
219. Efron, B. and R.J. Tibshirani, An Introduction to the Bootstrap (Chapman & 
Hall/CRC Monographs on Statistics & Applied Probability)1994: Chapman 
and Hall/CRC. 
206 
 
220. Efron, B., Estimating the Error Rate of a Prediction Rule: Improvement on 
Cross-Validation. Journal of the American Statistical Association, 1983. 
78(382): p. 316-331. 
221. Efron, B., The Jackknife, the Bootstrap, and Other Resampling Plans 
(CBMS-NSF Regional Conference Series in Applied Mathematics)1987: 
Society for Industrial Mathematics. 
222. Drew, P.J. and J.R. Monson, Artificial neural networks. Surgery, 2000. 
127(1): p. 3-11. 
223. Kandaswamy, A., et al., Neural classification of lung sounds using wavelet 
coefficients. Computers in Biology and Medicine, 2004. 34(6): p. 523-537. 
224. Tourassi, G.D., et al., A neural network approach to breast cancer diagnosis 
as a constraint satisfaction problem. Medical physics, 2001. 28(5): p. 804-
11. 
225. Tourassi, G.D., et al., Application of the mutual information criterion for 
feature selection in computer-aided diagnosis. Medical physics, 2001. 
28(12): p. 2394-402. 
226. Baxt, W.G., Application of artificial neural networks to clinical medicine. 
Lancet, 1995. 346(8983): p. 1135-8. 
227. Baxt, W.G., Use of an artificial neural network for the diagnosis of 
myocardial infarction. Annals of internal medicine, 1991. 115(11): p. 843-8. 
207 
 
228. Baxt, W.G. and J. Skora, Prospective validation of artificial neural network 
trained to identify acute myocardial infarction. Lancet, 1996. 347(8993): p. 
12-5. 
229. Needham, C.J., et al., Predicting the effect of missense mutations on protein 
function: analysis with Bayesian networks. BMC Bioinformatics, 2006. 7: p. 
405. 
230. Luk, J., et al., Artificial neural networks and decision tree model analysis of 
liver cancer proteomes. Biochemical and Biophysical Research 
Communications, 2007. 361(1): p. 68-73. 
231. Horowitz, N., et al., Applying Data Mining Techniques in the Development of 
a Diagnostics Questionnaire for GERD. Digestive Diseases and Sciences, 
2007. 52(8): p. 1871-1878. 
232. Mofidi, R., et al., Identification of severe acute pancreatitis using an 
artificial neural network. Surgery, 2007. 141(1): p. 59-66. 
233. Liew, P., et al., Comparison of artificial neural networks with logistic 
regression in prediction of gallbladder disease among obese patients. 
Digestive and Liver Disease, 2007. 39(4): p. 356-362. 
234. Patil, S., et al., Neural network in the clinical diagnosis of acute pulmonary 
embolism. Chest, 1993. 104(6): p. 1685-9. 
235. Saftoiu, A., et al., Neural network analysis of dynamic sequences of EUS 
elastography used for the differential diagnosis of chronic pancreatitis and 
pancreatic cancer. Gastrointestinal Endoscopy, 2008. 68(6): p. 1086-94. 
208 
 
236. Wu, E.J., et al., Artificial neural network: border detection in 
echocardiography. Medical & biological engineering & computing, 2008. 
46(9): p. 841-8. 
237. Harrison, R. and R. Kennedy, Artificial Neural Network Models for 
Prediction of Acute Coronary Syndromes Using Clinical Data From the Time 
of Presentation. Annals of Emergency Medicine, 2005. 46(5): p. 431-439. 
238. Cucchetti, A., et al., Artificial neural network is superior to MELD in 
predicting mortality of patients with end-stage liver disease. Gut, 2007. 
56(2): p. 253-258. 
239. Daskalakis, A., et al., Design of a multi-classifier system for discriminating 
benign from malignant thyroid nodules using routinely H&E-stained 
cytological images. Computers in Biology and Medicine, 2008. 38(2): p. 
196-203. 
240. Mat-Isa, N.A., M.Y. Mashor, and N.H. Othman, An automated cervical pre-
cancerous diagnostic system. Artificial Intelligence in Medicine, 2008. 42(1): 
p. 1-11. 
241. van Gerven, M.A., B.G. Taal, and P.J. Lucas, Dynamic Bayesian networks as 
prognostic models for clinical patient management. Journal of Biomedical 
Informatics, 2008. 41(4): p. 515-29. 
242. Peng, S.Y. and S.K. Peng, Predicting adverse outcomes of cardiac surgery 
with the application of artificial neural networks. Anaesthesia, 2008. 63(7): 
p. 705-13. 
209 
 
243. Barbini, E., et al., A comparative analysis of predictive models of morbidity 
in intensive care unit after cardiac surgery – Part I: model planning. BMC 
Medical Informatics and Decision Making, 2007. 7(1): p. 35. 
244. Rowan, M., et al., The use of artificial neural networks to stratify the length 
of stay of cardiac patients based on preoperative and initial postoperative 
factors. Artificial Intelligence in Medicine, 2007. 40(3): p. 211-221. 
245. Bottaci, L., et al., Artificial neural networks applied to outcome prediction 
for colorectal cancer patients in separate institutions. The Lancet, 1997. 
350(9076): p. 469-472. 
246. Dolgobrodov, S.G., et al., Artificial neural network: predicted vs observed 
survival in patients with colonic cancer. Diseases of the colon and rectum, 
2007. 50(2): p. 184-91. 
247. Lin, C.S., et al., Predicting hypotensive episodes during spinal anesthesia 
with the application of artificial neural networks. Computer Methods and 
Programs in Biomedicine, 2008. 92(2): p. 193-7. 
248. Lisboa and P., A Bayesian neural network approach for modelling censored 
data with an application to prognosis after surgery for breast cancer. 
Artificial Intelligence in Medicine, 2003. 28(1): p. 1-25. 
249. Lisboa, P.J., et al., Time-to-event analysis with artificial neural networks: an 
integrated analytical and rule-based study for breast cancer. Neural 
networks : the official journal of the International Neural Network Society, 
2008. 21(2-3): p. 414-26. 
210 
 
250. Wu, Y., et al., Artificial neural networks in mammography: application to 
decision making in the diagnosis of breast cancer. Radiology, 1993. 187(1): 
p. 81-7. 
251. Jarman, I.H., et al., An integrated framework for risk profiling of breast 
cancer patients following surgery. Artificial Intelligence in Medicine, 2008. 
42(3): p. 165-88. 
252. Mofidi, R., et al., Prediction of survival from carcinoma of oesophagus and 
oesophago‐gastric junction following surgical resection using an artificial 
neural network☆. European Journal of Surgical Oncology, 2006. 32(5): p. 
533-539. 
253. Copeland, G.P., D. Jones, and M. Walters, POSSUM: a scoring system for 
surgical audit. The British journal of surgery, 1991. 78(3): p. 355-60. 
254. Prytherch, D.R., et al., POSSUM and Portsmouth POSSUM for predicting 
mortality. Physiological and Operative Severity Score for the enUmeration of 
Mortality and morbidity. The British journal of surgery, 1998. 85(9): p. 1217-
20. 
255. Tekkis, P.P., et al., Risk-adjusted prediction of operative mortality in 
oesophagogastric surgery with O-POSSUM. The British journal of surgery, 
2004. 91(3): p. 288-95. 
256. Tekkis, P.P., et al., Development of a dedicated risk-adjustment scoring 
system for colorectal surgery (colorectal POSSUM). The British journal of 
surgery, 2004. 91(9): p. 1174-82. 
211 
 
257. Hart, A.W., J, Connectionist mdels in medicine:an investigation of their 
potential, in "nd European Conference on Artificial Intelligence in Medicine, 
J.C. Hunter, J Wyatt, J, Editor 1989, Springer: Heidberg. p. 115-124. 
258. Baxt, W.G., Use of an Artificial Neural Network for Data Analysis in 
Clinical Decision-Making: The Diagnosis of Acute Coronary Occlusion. 
Neural Computation, 1990. 2(4): p. 480-489. 
259. Goldman, L., et al., A computer protocol to predict myocardial infarction in 
emergency department patients with chest pain. The New England journal of 
medicine, 1988. 318(13): p. 797-803. 
260. Boon, M.E. and L.P. Kok, Neural network processing can provide means to 
catch errors that slip through human screening of pap smears. Diagnostic 
cytopathology, 1993. 9(4): p. 411-6. 
261. Burke, H.B., D.B. Rosen, and P.H. Goodman. Comparing artificial neural 
networks to other statistical methods for medical outcome prediction. in 
Neural Networks, 1994. IEEE World Congress on Computational 
Intelligence., 1994 IEEE International Conference on. 1994. 
262. Fraser HS, K.R., Ross P, Harrison R, A Comparison Of Radial Basis 
Functions And Back-Propagation In The Diagnosis Of Myocardial 
Infarction, in International Conference of Expert Systems and Neural 
Networks in Medicine1994: Plymouth. 
263. Fricker, J., Artificial neural networks improve diagnosis of acute myocardial 
infarction. The Lancet, 1997. 350(9082): p. 935. 
212 
 
264. Chu, A., et al., A decision support system to facilitate management of patients 
with acute gastrointestinal bleeding. Artificial Intelligence in Medicine, 
2008. 42(3): p. 247-259. 
265. WEKA, Waikato Environment for Knowledge Analysis, University of 
Waikato. 
266. Berry, W.F., S, Multiple regression in practice. Quantative applications in 
the social sciences1985: SAGE. 
267. Studenmund, A.H., Cassidy, H.J, Using econometrics: A practical 
guide1987, Boston: Little Brown. 
268. Beart, R.W., et al., Management and survival of patients with 
adenocarcinoma of the colon and rectum: a national survey of the 
Commission on Cancer. Journal of the American College of Surgeons, 1995. 
181(3): p. 225-36. 
269. Ferraris, R., et al., Predictive value of rectal bleeding for distal colonic 
neoplastic lesions in a screened population. European journal of cancer, 
2004. 40(2): p. 245-52. 
270. Helfand, M., et al., History of visible rectal bleeding in a primary care 
population. Initial assessment and 10-year follow-up. JAMA : the journal of 
the American Medical Association, 1997. 277(1): p. 44-8. 
271. Leung, E., et al., The effectiveness of the '2-week wait' referral service for 
colorectal cancer. International journal of clinical practice, 2010. 64(12): p. 
1671-4. 
213 
 
272. Smith, R.A., et al., Outcomes in 2748 patients referred to a colorectal two-
week rule clinic. Colorectal Disease, 2007. 9(4): p. 340-343. 
273. Cook, I.J., et al., Gastrointestinal investigation of iron deficiency anaemia. 
British medical journal, 1986. 292(6532): p. 1380-2. 
274. Hardwick, R.H. and C.P. Armstrong, Synchronous upper and lower 
gastrointestinal endoscopy is an effective method of investigating iron-
deficiency anaemia. The British journal of surgery, 1997. 84(12): p. 1725-8. 
275. Zuckerman, G. and J. Benitez, A prospective study of bidirectional endoscopy 
(colonoscopy and upper endoscopy) in the evaluation of patients with occult 
gastrointestinal bleeding. The American journal of gastroenterology, 1992. 
87(1): p. 62-6. 
276. James, M.W., et al., Risk factors for gastrointestinal malignancy in patients 
with iron-deficiency anaemia. European journal of gastroenterology & 
hepatology, 2005. 17(11): p. 1197-203. 
277. Maslekar, S., et al., Artificial neural networks to predict presence of 
significant pathology in patients presenting to routine colorectal clinics. 
Colorectal disease : the official journal of the Association of Coloproctology 
of Great Britain and Ireland, 2010. 12(12): p. 1254-9. 
278. Davies, R.J., et al., A prospective study to assess the implementation of a fast-
track system to meet the two-week target for colorectal cancer in Somerset. 
Colorectal disease : the official journal of the Association of Coloproctology 
of Great Britain and Ireland, 2002. 4(1): p. 28-30. 
214 
 
279. Mahon, C.C., et al., Preliminary evaluation of United Kingdom National 
Referral Guidelines for lower gastrointestinal tract cancer. Colorectal 
disease : the official journal of the Association of Coloproctology of Great 
Britain and Ireland, 2002. 4(2): p. 111-114. 
280. Walsh, S., et al., The fourteen-day rule and colorectal cancer. Annals of the 
Royal College of Surgeons of England, 2002. 84(6): p. 386-8. 
281. Lundin, M., et al., Artificial neural networks applied to survival prediction in 
breast cancer. Oncology, 1999. 57(4): p. 281-6. 
282. Hunt, D.L., et al., Effects of computer-based clinical decision support 
systems on physician performance and patient outcomes: a systematic 
review. JAMA : the journal of the American Medical Association, 1998. 
280(15): p. 1339-46. 
283. Huo, Z., M.L. Giger, and C.E. Metz, Effect of dominant features on neural 
network performance in the classification of mammographic lesions. Physics 
in medicine and biology, 1999. 44(10): p. 2579-95. 
284. Qureshi, K.N., et al., Neural network analysis of clinicopathological and 
molecular markers in bladder cancer. The Journal of urology, 2000. 163(2): 
p. 630-3. 
285. Witten I, F.E., Data Mining: Practical machine learning tools and 
techniques2005, San Francisco: Elseiver. 
286. Atkin, W.S., et al., Once-only flexible sigmoidoscopy screening in prevention 
of colorectal cancer: a multicentre randomised controlled trial. The Lancet, 
2010. 375(9726): p. 1624-1633. 
215 
 
287. Weissfeld, J.L., et al., Flexible Sigmoidoscopy in the PLCO Cancer 
Screening Trial: Results From the Baseline Screening Examination of a 
Randomized Trial. Journal of the National Cancer Institute, 2005. 97(13): p. 
989-997. 
288. Lieberman, D.A., et al., Use of colonoscopy to screen asymptomatic adults 
for colorectal cancer. Veterans Affairs Cooperative Study Group 380. The 
New England journal of medicine, 2000. 343(3): p. 162-8. 
289. Schoenfeld, P., et al., Colonoscopic screening of average-risk women for 
colorectal neoplasia. The New England journal of medicine, 2005. 352(20): 
p. 2061-8. 
290. Mango L J. Tjon R, H.J., Computer assisted Pap Smear screening using 
neural networks. World Congress on Neural Networks: 1994 International 
Neural Network Society, 1994. 1: p. 84-89. 
291. Dolgobrodov, S.G., et al., Artificial Neural Network: Predicted vs. Observed 
Survival in Patients with Colonic Cancer. Diseases of the Colon & Rectum, 
2006. 50(2): p. 184-191. 
292. Lin, C., et al., Predicting hypotensive episodes during spinal anesthesia with 
the application of artificial neural networks. Computer Methods and 
Programs in Biomedicine, 2008. 92(2): p. 193-197. 
293. Belacel, N. and M.R. Boulassel, Multicriteria fuzzy assignment method: a 
useful tool to assist medical diagnosis. Artificial intelligence in medicine, 
2001. 21(1-3): p. 201-7. 
216 
 
294. Seker, H., et al., A fuzzy logic based-method for prognostic decision making 
in breast and prostate cancers. IEEE transactions on information technology 
in biomedicine : a publication of the IEEE Engineering in Medicine and 
Biology Society, 2003. 7(2): p. 114-22. 
295. Kim MW, R.J., Optimized fuzzy classification using genetic 
algorithm, in Lecture notes in artificial intelligence,, J.Y. Wang L, Editor 2005, 
Springer: Berlin. p. 392-401. 
296. Sivasankar, E.R., R.S, Knowledge discovery in medical datasets using a 
Fuzzy Logic rule based classifier. Electronic Computer Technology 
(ICECT), 2010 International Conference, 2010: p. 208 - 213. 
297. Rowan, M., et al., The use of artificial neural networks to stratify the length 
of stay of cardiac patients based on preoperative and initial postoperative 
factors. Artificial Intelligence in Medicine, 2007. 40(3): p. 211-21. 
 
 
 
